id	sid	tid	token	lemma	pos
bjp-26620	1	1	introduction	introduction	NOUN
bjp-26620	1	2	breast	breast	NOUN
bjp-26620	1	3	cancer	cancer	NOUN
bjp-26620	1	4	is	be	AUX
bjp-26620	1	5	a	a	DET
bjp-26620	1	6	major	major	ADJ
bjp-26620	1	7	challenge	challenge	NOUN
bjp-26620	1	8	to	to	ADP
bjp-26620	1	9	the	the	DET
bjp-26620	1	10	clinicians	clinician	NOUN
bjp-26620	1	11	today	today	NOUN
bjp-26620	1	12	throughout	throughout	ADP
bjp-26620	1	13	the	the	DET
bjp-26620	1	14	world	world	NOUN
bjp-26620	1	15	because	because	SCONJ
bjp-26620	1	16	of	of	ADP
bjp-26620	1	17	an	an	DET
bjp-26620	1	18	incidence	incidence	NOUN
bjp-26620	1	19	of	of	ADP
bjp-26620	1	20	more	more	ADJ
bjp-26620	1	21	than	than	ADP
bjp-26620	1	22	1	1	NUM
bjp-26620	1	23	million	million	NUM
bjp-26620	1	24	new	new	ADJ
bjp-26620	1	25	cases	case	NOUN
bjp-26620	1	26	and	and	CCONJ
bjp-26620	1	27	more	more	ADJ
bjp-26620	1	28	than	than	ADP
bjp-26620	1	29	370,000	370,000	NUM
bjp-26620	1	30	deaths	death	NOUN
bjp-26620	1	31	annually	annually	ADV
bjp-26620	1	32	.	.	PUNCT
bjp-26620	2	1	treatment	treatment	NOUN
bjp-26620	2	2	of	of	ADP
bjp-26620	2	3	the	the	DET
bjp-26620	2	4	breast	breast	NOUN
bjp-26620	2	5	cancer	cancer	NOUN
bjp-26620	2	6	in	in	ADP
bjp-26620	2	7	initial	initial	ADJ
bjp-26620	2	8	stage	stage	NOUN
bjp-26620	2	9	is	be	AUX
bjp-26620	2	10	highly	highly	ADV
bjp-26620	2	11	desired	desire	VERB
bjp-26620	2	12	as	as	SCONJ
bjp-26620	2	13	the	the	DET
bjp-26620	2	14	advanced	advanced	ADJ
bjp-26620	2	15	disease	disease	NOUN
bjp-26620	2	16	will	will	AUX
bjp-26620	2	17	eventually	eventually	ADV
bjp-26620	2	18	develop	develop	VERB
bjp-26620	2	19	resistance	resistance	NOUN
bjp-26620	2	20	to	to	ADP
bjp-26620	2	21	treatment	treatment	NOUN
bjp-26620	2	22	(	(	PUNCT
bjp-26620	2	23	ali	ali	PROPN
bjp-26620	2	24	and	and	CCONJ
bjp-26620	2	25	coombes	coombe	NOUN
bjp-26620	2	26	,	,	PUNCT
bjp-26620	2	27	2002	2002	NUM
bjp-26620	2	28	)	)	PUNCT
bjp-26620	2	29	.	.	PUNCT
bjp-26620	3	1	the	the	DET
bjp-26620	3	2	expression	expression	NOUN
bjp-26620	3	3	of	of	ADP
bjp-26620	3	4	the	the	DET
bjp-26620	3	5	gene	gene	NOUN
bjp-26620	3	6	,	,	PUNCT
bjp-26620	3	7	synuclein	synuclein	NOUN
bjp-26620	3	8	-	-	PUNCT
bjp-26620	3	9	a	a	PRON
bjp-26620	3	10	is	be	AUX
bjp-26620	3	11	associated	associate	VERB
bjp-26620	3	12	with	with	ADP
bjp-26620	3	13	the	the	DET
bjp-26620	3	14	development	development	NOUN
bjp-26620	3	15	and	and	CCONJ
bjp-26620	3	16	progress	progress	NOUN
bjp-26620	3	17	of	of	ADP
bjp-26620	3	18	breast	breast	NOUN
bjp-26620	3	19	cancer	cancer	NOUN
bjp-26620	3	20	(	(	PUNCT
bjp-26620	3	21	ji	ji	X
bjp-26620	3	22	et	et	PROPN
bjp-26620	3	23	al	al	PROPN
bjp-26620	3	24	.	.	PROPN
bjp-26620	3	25	,	,	PUNCT
bjp-26620	3	26	1997	1997	NUM
bjp-26620	3	27	)	)	PUNCT
bjp-26620	3	28	.	.	PUNCT
bjp-26620	4	1	synuclein	synuclein	NOUN
bjp-26620	4	2	-	-	PUNCT
bjp-26620	4	3	a	a	PRON
bjp-26620	4	4	is	be	AUX
bjp-26620	4	5	highly	highly	ADV
bjp-26620	4	6	expressed	express	VERB
bjp-26620	4	7	in	in	ADP
bjp-26620	4	8	the	the	DET
bjp-26620	4	9	cancer	cancer	NOUN
bjp-26620	4	10	cells	cell	NOUN
bjp-26620	4	11	resistant	resistant	ADJ
bjp-26620	4	12	to	to	ADP
bjp-26620	4	13	chemotherapeutic	chemotherapeutic	ADJ
bjp-26620	4	14	agents	agent	NOUN
bjp-26620	4	15	,	,	PUNCT
bjp-26620	4	16	possessing	possess	VERB
bjp-26620	4	17	higher	high	ADJ
bjp-26620	4	18	invasive	invasive	ADJ
bjp-26620	4	19	and	and	CCONJ
bjp-26620	4	20	migration	migration	NOUN
bjp-26620	4	21	potential	potential	NOUN
bjp-26620	4	22	but	but	CCONJ
bjp-26620	4	23	is	be	AUX
bjp-26620	4	24	not	not	PART
bjp-26620	4	25	found	find	VERB
bjp-26620	4	26	in	in	ADP
bjp-26620	4	27	the	the	DET
bjp-26620	4	28	normal	normal	ADJ
bjp-26620	4	29	breast	breast	NOUN
bjp-26620	4	30	cancer	cancer	NOUN
bjp-26620	4	31	cells	cell	NOUN
bjp-26620	4	32	(	(	PUNCT
bjp-26620	4	33	bruening	bruene	VERB
bjp-26620	4	34	et	et	NOUN
bjp-26620	4	35	al	al	PROPN
bjp-26620	4	36	.	.	PROPN
bjp-26620	4	37	,	,	PUNCT
bjp-26620	4	38	2000	2000	NUM
bjp-26620	4	39	;	;	PUNCT
bjp-26620	4	40	wu	wu	PROPN
bjp-26620	4	41	et	et	PROPN
bjp-26620	4	42	al	al	PROPN
bjp-26620	4	43	.	.	PROPN
bjp-26620	4	44	,	,	PUNCT
bjp-26620	4	45	2003	2003	NUM
bjp-26620	4	46	)	)	PUNCT
bjp-26620	4	47	.	.	PUNCT
bjp-26620	5	1	analysis	analysis	NOUN
bjp-26620	5	2	of	of	ADP
bjp-26620	5	3	the	the	DET
bjp-26620	5	4	effects	effect	NOUN
bjp-26620	5	5	of	of	ADP
bjp-26620	5	6	synuclein	synuclein	NOUN
bjp-26620	5	7	-	-	PUNCT
bjp-26620	5	8	a	a	PRON
bjp-26620	5	9	led	lead	VERB
bjp-26620	5	10	to	to	ADP
bjp-26620	5	11	understanding	understanding	NOUN
bjp-26620	5	12	of	of	ADP
bjp-26620	5	13	its	its	PRON
bjp-26620	5	14	role	role	NOUN
bjp-26620	5	15	in	in	ADP
bjp-26620	5	16	promoting	promote	VERB
bjp-26620	5	17	carcinoma	carcinoma	NOUN
bjp-26620	5	18	cell	cell	NOUN
bjp-26620	5	19	proliferation	proliferation	NOUN
bjp-26620	5	20	,	,	PUNCT
bjp-26620	5	21	increasing	increase	VERB
bjp-26620	5	22	invasive	invasive	ADJ
bjp-26620	5	23	and	and	CCONJ
bjp-26620	5	24	migratory	migratory	ADJ
bjp-26620	5	25	potential	potential	NOUN
bjp-26620	5	26	(	(	PUNCT
bjp-26620	5	27	liu	liu	PROPN
bjp-26620	5	28	et	et	PROPN
bjp-26620	5	29	al	al	PROPN
bjp-26620	5	30	.	.	PROPN
bjp-26620	5	31	,	,	PUNCT
bjp-26620	5	32	2000	2000	NUM
bjp-26620	5	33	;	;	PUNCT
bjp-26620	5	34	lu	lu	PROPN
bjp-26620	5	35	et	et	PROPN
bjp-26620	5	36	al	al	PROPN
bjp-26620	5	37	.	.	PROPN
bjp-26620	5	38	,	,	PUNCT
bjp-26620	5	39	2002	2002	NUM
bjp-26620	5	40	)	)	PUNCT
bjp-26620	5	41	.	.	PUNCT
bjp-26620	6	1	synuclein	synuclein	NOUN
bjp-26620	6	2	-	-	PUNCT
bjp-26620	6	3	a	a	PRON
bjp-26620	6	4	exhibits	exhibit	VERB
bjp-26620	6	5	its	its	PRON
bjp-26620	6	6	effect	effect	NOUN
bjp-26620	6	7	through	through	ADP
bjp-26620	6	8	a	a	DET
bjp-26620	6	9	mitotic	mitotic	ADJ
bjp-26620	6	10	checkpoint	checkpoint	NOUN
bjp-26620	6	11	kinase	kinase	NOUN
bjp-26620	6	12	in	in	ADP
bjp-26620	6	13	the	the	DET
bjp-26620	6	14	breast	breast	NOUN
bjp-26620	6	15	carcinoma	carcinoma	NOUN
bjp-26620	6	16	cells	cell	NOUN
bjp-26620	6	17	(	(	PUNCT
bjp-26620	6	18	gupta	gupta	PROPN
bjp-26620	6	19	et	et	PROPN
bjp-26620	6	20	al	al	PROPN
bjp-26620	6	21	.	.	PROPN
bjp-26620	6	22	,	,	PUNCT
bjp-26620	6	23	2003	2003	NUM
bjp-26620	6	24	)	)	PUNCT
bjp-26620	6	25	.	.	PUNCT
bjp-26620	7	1	the	the	DET
bjp-26620	7	2	chemotherapeutic	chemotherapeutic	ADJ
bjp-26620	7	3	agents	agent	NOUN
bjp-26620	7	4	used	use	VERB
bjp-26620	7	5	for	for	ADP
bjp-26620	7	6	the	the	DET
bjp-26620	7	7	treatment	treatment	NOUN
bjp-26620	7	8	of	of	ADP
bjp-26620	7	9	breast	breast	NOUN
bjp-26620	7	10	cancer	cancer	NOUN
bjp-26620	7	11	including	include	VERB
bjp-26620	7	12	taxol	taxol	PROPN
bjp-26620	7	13	induce	induce	VERB
bjp-26620	7	14	cell	cell	NOUN
bjp-26620	7	15	cycle	cycle	NOUN
bjp-26620	7	16	arrest	arrest	NOUN
bjp-26620	7	17	in	in	ADP
bjp-26620	7	18	the	the	DET
bjp-26620	7	19	mitotic	mitotic	ADJ
bjp-26620	7	20	phase	phase	NOUN
bjp-26620	7	21	and	and	CCONJ
bjp-26620	7	22	finally	finally	ADV
bjp-26620	7	23	lead	lead	VERB
bjp-26620	7	24	to	to	ADP
bjp-26620	7	25	apoptosis	apoptosis	NOUN
bjp-26620	7	26	(	(	PUNCT
bjp-26620	7	27	blajeski	blajeski	NOUN
bjp-26620	7	28	et	et	PROPN
bjp-26620	7	29	al	al	PROPN
bjp-26620	7	30	.	.	PROPN
bjp-26620	7	31	,	,	PUNCT
bjp-26620	7	32	2002	2002	NUM
bjp-26620	7	33	;	;	PUNCT
bjp-26620	7	34	shin	shin	PROPN
bjp-26620	7	35	et	et	PROPN
bjp-26620	7	36	al	al	PROPN
bjp-26620	7	37	.	.	PROPN
bjp-26620	7	38	,	,	PUNCT
bjp-26620	7	39	2003	2003	NUM
bjp-26620	7	40	)	)	PUNCT
bjp-26620	7	41	.	.	PUNCT
bjp-26620	8	1	however	however	ADV
bjp-26620	8	2	,	,	PUNCT
bjp-26620	8	3	it	it	PRON
bjp-26620	8	4	has	have	AUX
bjp-26620	8	5	been	be	AUX
bjp-26620	8	6	observed	observe	VERB
bjp-26620	8	7	that	that	SCONJ
bjp-26620	8	8	synuclein	synuclein	NOUN
bjp-26620	8	9	-	-	PUNCT
bjp-26620	8	10	a	a	PRON
bjp-26620	8	11	prevents	prevent	VERB
bjp-26620	8	12	the	the	DET
bjp-26620	8	13	cancer	cancer	NOUN
bjp-26620	8	14	cells	cell	NOUN
bjp-26620	8	15	from	from	ADP
bjp-26620	8	16	cell	cell	NOUN
bjp-26620	8	17	cycle	cycle	NOUN
bjp-26620	8	18	arrest	arrest	NOUN
bjp-26620	8	19	in	in	ADP
bjp-26620	8	20	the	the	DET
bjp-26620	8	21	mitotic	mitotic	ADJ
bjp-26620	8	22	phase	phase	NOUN
bjp-26620	8	23	leading	lead	VERB
bjp-26620	8	24	to	to	ADP
bjp-26620	8	25	drug	drug	NOUN
bjp-26620	8	26	resistance	resistance	NOUN
bjp-26620	8	27	(	(	PUNCT
bjp-26620	8	28	pan	pan	NOUN
bjp-26620	8	29	et	et	PROPN
bjp-26620	8	30	al	al	PROPN
bjp-26620	8	31	.	.	PROPN
bjp-26620	8	32	,	,	PUNCT
bjp-26620	8	33	2002	2002	NUM
bjp-26620	8	34	)	)	PUNCT
bjp-26620	8	35	.	.	PUNCT
bjp-26620	9	1	therefore	therefore	ADV
bjp-26620	9	2	,	,	PUNCT
bjp-26620	9	3	inhibition	inhibition	NOUN
bjp-26620	9	4	of	of	ADP
bjp-26620	9	5	the	the	DET
bjp-26620	9	6	synuclein	synuclein	NOUN
bjp-26620	9	7	-	-	PUNCT
bjp-26620	9	8	a	a	DET
bjp-26620	9	9	expression	expression	NOUN
bjp-26620	9	10	can	can	AUX
bjp-26620	9	11	be	be	AUX
bjp-26620	9	12	of	of	ADP
bjp-26620	9	13	immense	immense	ADJ
bjp-26620	9	14	importance	importance	NOUN
bjp-26620	9	15	for	for	ADP
bjp-26620	9	16	the	the	DET
bjp-26620	9	17	treatment	treatment	NOUN
bjp-26620	9	18	of	of	ADP
bjp-26620	9	19	breast	breast	NOUN
bjp-26620	9	20	cancer	cancer	NOUN
bjp-26620	9	21	either	either	CCONJ
bjp-26620	9	22	directly	directly	ADV
bjp-26620	9	23	or	or	CCONJ
bjp-26620	9	24	by	by	ADP
bjp-26620	9	25	facilitating	facilitate	VERB
bjp-26620	9	26	the	the	DET
bjp-26620	9	27	action	action	NOUN
bjp-26620	9	28	of	of	ADP
bjp-26620	9	29	other	other	ADJ
bjp-26620	9	30	chemotherapeutic	chemotherapeutic	ADJ
bjp-26620	9	31	agents	agent	NOUN
bjp-26620	9	32	.	.	PUNCT
bjp-26620	10	1	bryostatin	bryostatin	VERB
bjp-26620	10	2	i	i	PRON
bjp-26620	10	3	exhibits	exhibit	VERB
bjp-26620	10	4	remarkable	remarkable	ADJ
bjp-26620	10	5	biological	biological	ADJ
bjp-26620	10	6	activities	activity	NOUN
bjp-26620	10	7	in	in	ADP
bjp-26620	10	8	the	the	DET
bjp-26620	10	9	cancer	cancer	NOUN
bjp-26620	10	10	therapy	therapy	NOUN
bjp-26620	10	11	through	through	ADP
bjp-26620	10	12	alterations	alteration	NOUN
bjp-26620	10	13	in	in	ADP
bjp-26620	10	14	the	the	DET
bjp-26620	10	15	function	function	NOUN
bjp-26620	10	16	of	of	ADP
bjp-26620	10	17	apoptosis	apoptosis	NOUN
bjp-26620	10	18	factors	factor	NOUN
bjp-26620	10	19	(	(	PUNCT
bjp-26620	10	20	wall	wall	NOUN
bjp-26620	10	21	et	et	PROPN
bjp-26620	10	22	al	al	PROPN
bjp-26620	10	23	.	.	PROPN
bjp-26620	10	24	,	,	PUNCT
bjp-26620	10	25	1999	1999	NUM
bjp-26620	10	26	)	)	PUNCT
bjp-26620	10	27	,	,	PUNCT
bjp-26620	10	28	reversal	reversal	NOUN
bjp-26620	10	29	of	of	ADP
bjp-26620	10	30	a	a	DET
bjp-26620	10	31	journal	journal	NOUN
bjp-26620	10	32	of	of	ADP
bjp-26620	10	33	the	the	DET
bjp-26620	10	34	bangladesh	bangladesh	NOUN
bjp-26620	10	35	pharmacological	pharmacological	ADJ
bjp-26620	10	36	society	society	NOUN
bjp-26620	10	37	(	(	PUNCT
bjp-26620	10	38	bdps	bdps	NOUN
bjp-26620	10	39	)	)	PUNCT
bjp-26620	10	40	bangladesh	bangladesh	PROPN
bjp-26620	10	41	j	j	PROPN
bjp-26620	10	42	pharmacol	pharmacol	PROPN
bjp-26620	10	43	2016	2016	NUM
bjp-26620	10	44	;	;	PUNCT
bjp-26620	10	45	11	11	NUM
bjp-26620	10	46	:	:	PUNCT
bjp-26620	10	47	615	615	NUM
bjp-26620	10	48	-	-	SYM
bjp-26620	10	49	620	620	NUM
bjp-26620	10	50	journal	journal	NOUN
bjp-26620	10	51	homepage	homepage	NOUN
bjp-26620	10	52	:	:	PUNCT
bjp-26620	10	53	www.banglajol.info	www.banglajol.info	PROPN
bjp-26620	10	54	abstracted	abstract	VERB
bjp-26620	10	55	/	/	SYM
bjp-26620	10	56	indexed	index	VERB
bjp-26620	10	57	in	in	ADP
bjp-26620	10	58	academic	academic	ADJ
bjp-26620	10	59	search	search	NOUN
bjp-26620	10	60	complete	complete	ADJ
bjp-26620	10	61	,	,	PUNCT
bjp-26620	10	62	asia	asia	PROPN
bjp-26620	10	63	journals	journal	NOUN
bjp-26620	10	64	online	online	ADV
bjp-26620	10	65	,	,	PUNCT
bjp-26620	10	66	bangladesh	bangladesh	NOUN
bjp-26620	10	67	journals	journal	NOUN
bjp-26620	10	68	online	online	ADV
bjp-26620	10	69	,	,	PUNCT
bjp-26620	10	70	biological	biological	ADJ
bjp-26620	10	71	abstracts	abstract	NOUN
bjp-26620	10	72	,	,	PUNCT
bjp-26620	10	73	biosis	biosis	NOUN
bjp-26620	10	74	previews	preview	NOUN
bjp-26620	10	75	,	,	PUNCT
bjp-26620	10	76	cab	cab	NOUN
bjp-26620	10	77	abstracts	abstract	NOUN
bjp-26620	10	78	,	,	PUNCT
bjp-26620	10	79	current	current	ADJ
bjp-26620	10	80	abstracts	abstract	NOUN
bjp-26620	10	81	,	,	PUNCT
bjp-26620	10	82	embase	embase	NOUN
bjp-26620	10	83	/	/	SYM
bjp-26620	10	84	excerpta	excerpta	NOUN
bjp-26620	10	85	medica	medica	NOUN
bjp-26620	10	86	,	,	PUNCT
bjp-26620	10	87	google	google	PROPN
bjp-26620	10	88	scholar	scholar	NOUN
bjp-26620	10	89	,	,	PUNCT
bjp-26620	10	90	hinari	hinari	X
bjp-26620	10	91	(	(	PUNCT
bjp-26620	10	92	who	who	PRON
bjp-26620	10	93	)	)	PUNCT
bjp-26620	10	94	,	,	PUNCT
bjp-26620	10	95	international	international	ADJ
bjp-26620	10	96	pharmaceutical	pharmaceutical	ADJ
bjp-26620	10	97	abstracts	abstract	NOUN
bjp-26620	10	98	,	,	PUNCT
bjp-26620	10	99	open	open	ADJ
bjp-26620	10	100	j	j	PROPN
bjp-26620	10	101	-	-	PUNCT
bjp-26620	10	102	gate	gate	NOUN
bjp-26620	10	103	,	,	PUNCT
bjp-26620	10	104	science	science	NOUN
bjp-26620	10	105	citation	citation	NOUN
bjp-26620	10	106	index	index	NOUN
bjp-26620	10	107	expanded	expand	VERB
bjp-26620	10	108	,	,	PUNCT
bjp-26620	10	109	scopus	scopus	NOUN
bjp-26620	10	110	and	and	CCONJ
bjp-26620	10	111	social	social	ADJ
bjp-26620	10	112	sciences	sciences	PROPN
bjp-26620	10	113	citation	citation	NOUN
bjp-26620	10	114	index	index	NOUN
bjp-26620	10	115	;	;	PUNCT
bjp-26620	10	116	issn	issn	PROPN
bjp-26620	10	117	:	:	PUNCT
bjp-26620	10	118	1991	1991	NUM
bjp-26620	10	119	-	-	SYM
bjp-26620	10	120	0088	0088	NUM
bjp-26620	10	121	abstract	abstract	NOUN
bjp-26620	10	122	the	the	DET
bjp-26620	10	123	present	present	ADJ
bjp-26620	10	124	study	study	NOUN
bjp-26620	10	125	was	be	AUX
bjp-26620	10	126	aimed	aim	VERB
bjp-26620	10	127	to	to	PART
bjp-26620	10	128	investigate	investigate	VERB
bjp-26620	10	129	the	the	DET
bjp-26620	10	130	effect	effect	NOUN
bjp-26620	10	131	of	of	ADP
bjp-26620	10	132	bryostatin	bryostatin	VERB
bjp-26620	10	133	i	i	PRON
bjp-26620	10	134	on	on	ADP
bjp-26620	10	135	the	the	DET
bjp-26620	10	136	expression	expression	NOUN
bjp-26620	10	137	of	of	ADP
bjp-26620	10	138	synuclein	synuclein	NOUN
bjp-26620	10	139	-	-	PUNCT
bjp-26620	10	140	a	a	NOUN
bjp-26620	10	141	in	in	ADP
bjp-26620	10	142	breast	breast	NOUN
bjp-26620	10	143	cancer	cancer	NOUN
bjp-26620	10	144	cells	cell	NOUN
bjp-26620	10	145	.	.	PUNCT
bjp-26620	11	1	western	western	ADJ
bjp-26620	11	2	blot	blot	NOUN
bjp-26620	11	3	analysis	analysis	NOUN
bjp-26620	11	4	showed	show	VERB
bjp-26620	11	5	a	a	DET
bjp-26620	11	6	significant	significant	ADJ
bjp-26620	11	7	(	(	PUNCT
bjp-26620	11	8	p<0.005	p<0.005	NOUN
bjp-26620	11	9	)	)	PUNCT
bjp-26620	11	10	reduction	reduction	NOUN
bjp-26620	11	11	in	in	ADP
bjp-26620	11	12	the	the	DET
bjp-26620	11	13	expression	expression	NOUN
bjp-26620	11	14	of	of	ADP
bjp-26620	11	15	synuclein	synuclein	NOUN
bjp-26620	11	16	-	-	PUNCT
bjp-26620	11	17	a	a	NOUN
bjp-26620	11	18	from	from	ADP
bjp-26620	11	19	a	a	DET
bjp-26620	11	20	concentration	concentration	NOUN
bjp-26620	11	21	of	of	ADP
bjp-26620	11	22	20	20	NUM
bjp-26620	11	23	µm	µm	NOUN
bjp-26620	11	24	in	in	ADP
bjp-26620	11	25	h3922	h3922	PROPN
bjp-26620	11	26	cells	cell	NOUN
bjp-26620	11	27	.	.	PUNCT
bjp-26620	12	1	the	the	DET
bjp-26620	12	2	inhibitory	inhibitory	ADJ
bjp-26620	12	3	effect	effect	NOUN
bjp-26620	12	4	of	of	ADP
bjp-26620	12	5	bryostatin	bryostatin	VERB
bjp-26620	12	6	i	i	PRON
bjp-26620	12	7	on	on	ADP
bjp-26620	12	8	synuclein	synuclein	NOUN
bjp-26620	12	9	-	-	PUNCT
bjp-26620	12	10	a	a	DET
bjp-26620	12	11	expression	expression	NOUN
bjp-26620	12	12	was	be	AUX
bjp-26620	12	13	further	far	ADV
bjp-26620	12	14	confirmed	confirm	VERB
bjp-26620	12	15	by	by	ADP
bjp-26620	12	16	the	the	DET
bjp-26620	12	17	treatment	treatment	NOUN
bjp-26620	12	18	of	of	ADP
bjp-26620	12	19	h3922	h3922	PROPN
bjp-26620	12	20	cells	cell	NOUN
bjp-26620	12	21	with	with	ADP
bjp-26620	12	22	known	know	VERB
bjp-26620	12	23	synuclein	synuclein	NOUN
bjp-26620	12	24	-	-	PUNCT
bjp-26620	12	25	a	a	DET
bjp-26620	12	26	inhibitor	inhibitor	NOUN
bjp-26620	12	27	,	,	PUNCT
bjp-26620	12	28	cytokine	cytokine	VERB
bjp-26620	12	29	oncostatin	oncostatin	NOUN
bjp-26620	12	30	m.	m.	NOUN
bjp-26620	12	31	bryostatin	bryostatin	NOUN
bjp-26620	12	32	i	i	PRON
bjp-26620	12	33	treatment	treatment	NOUN
bjp-26620	12	34	of	of	ADP
bjp-26620	12	35	h3922	h3922	PROPN
bjp-26620	12	36	cells	cell	NOUN
bjp-26620	12	37	also	also	ADV
bjp-26620	12	38	significantly	significantly	ADV
bjp-26620	12	39	increased	increase	VERB
bjp-26620	12	40	their	their	PRON
bjp-26620	12	41	sensitivity	sensitivity	NOUN
bjp-26620	12	42	to	to	ADP
bjp-26620	12	43	the	the	DET
bjp-26620	12	44	taxol	taxol	NOUN
bjp-26620	12	45	.	.	PUNCT
bjp-26620	13	1	incubation	incubation	NOUN
bjp-26620	13	2	of	of	ADP
bjp-26620	13	3	the	the	DET
bjp-26620	13	4	cells	cell	NOUN
bjp-26620	13	5	with	with	ADP
bjp-26620	13	6	25	25	NUM
bjp-26620	13	7	µm	µm	ADP
bjp-26620	13	8	concentration	concentration	NOUN
bjp-26620	13	9	of	of	ADP
bjp-26620	13	10	bryostatin	bryostatin	PROPN
bjp-26620	13	11	i	i	PRON
bjp-26620	13	12	followed	follow	VERB
bjp-26620	13	13	by	by	ADP
bjp-26620	13	14	treatment	treatment	NOUN
bjp-26620	13	15	with	with	ADP
bjp-26620	13	16	0.5	0.5	NUM
bjp-26620	13	17	μm	μm	NOUN
bjp-26620	13	18	concentration	concentration	NOUN
bjp-26620	13	19	of	of	ADP
bjp-26620	13	20	taxol	taxol	NOUN
bjp-26620	13	21	induced	induce	VERB
bjp-26620	13	22	apoptosis	apoptosis	NOUN
bjp-26620	13	23	in	in	ADP
bjp-26620	13	24	89	89	NUM
bjp-26620	13	25	%	%	NOUN
bjp-26620	13	26	cells	cell	NOUN
bjp-26620	13	27	compared	compare	VERB
bjp-26620	13	28	to	to	ADP
bjp-26620	13	29	9	9	NUM
bjp-26620	13	30	%	%	NOUN
bjp-26620	13	31	cells	cell	NOUN
bjp-26620	13	32	in	in	ADP
bjp-26620	13	33	the	the	DET
bjp-26620	13	34	taxol	taxol	PROPN
bjp-26620	13	35	alone	alone	ADV
bjp-26620	13	36	treated	treat	VERB
bjp-26620	13	37	cultures	culture	NOUN
bjp-26620	13	38	.	.	PUNCT
bjp-26620	14	1	treatment	treatment	NOUN
bjp-26620	14	2	of	of	ADP
bjp-26620	14	3	the	the	DET
bjp-26620	14	4	h3922	h3922	PROPN
bjp-26620	14	5	cells	cell	NOUN
bjp-26620	14	6	with	with	ADP
bjp-26620	14	7	bryostatin	bryostatin	PROPN
bjp-26620	14	8	i	i	PRON
bjp-26620	14	9	at	at	ADP
bjp-26620	14	10	25	25	NUM
bjp-26620	14	11	µm	µm	ADP
bjp-26620	14	12	concentration	concentration	NOUN
bjp-26620	14	13	led	lead	VERB
bjp-26620	14	14	to	to	ADP
bjp-26620	14	15	a	a	DET
bjp-26620	14	16	significant	significant	ADJ
bjp-26620	14	17	increase	increase	NOUN
bjp-26620	14	18	in	in	ADP
bjp-26620	14	19	the	the	DET
bjp-26620	14	20	activation	activation	NOUN
bjp-26620	14	21	of	of	ADP
bjp-26620	14	22	histone	histone	NOUN
bjp-26620	14	23	h1	h1	PROPN
bjp-26620	14	24	protein	protein	NOUN
bjp-26620	14	25	.	.	PUNCT
bjp-26620	15	1	the	the	DET
bjp-26620	15	2	results	result	NOUN
bjp-26620	15	3	from	from	ADP
bjp-26620	15	4	mtt	mtt	NOUN
bjp-26620	15	5	assay	assay	NOUN
bjp-26620	15	6	showed	show	VERB
bjp-26620	15	7	a	a	DET
bjp-26620	15	8	significant	significant	ADJ
bjp-26620	15	9	decrease	decrease	NOUN
bjp-26620	15	10	in	in	ADP
bjp-26620	15	11	the	the	DET
bjp-26620	15	12	cell	cell	NOUN
bjp-26620	15	13	viability	viability	NOUN
bjp-26620	15	14	from	from	ADP
bjp-26620	15	15	10	10	NUM
bjp-26620	15	16	µm	µm	ADP
bjp-26620	15	17	concentration	concentration	NOUN
bjp-26620	15	18	of	of	ADP
bjp-26620	15	19	bryostatin	bryostatin	PROPN
bjp-26620	15	20	i.	i.	PROPN
bjp-26620	15	21	thus	thus	ADV
bjp-26620	15	22	,	,	PUNCT
bjp-26620	15	23	bryostatin	bryostatin	VERB
bjp-26620	15	24	i	i	PRON
bjp-26620	15	25	inhibits	inhibit	VERB
bjp-26620	15	26	the	the	DET
bjp-26620	15	27	growth	growth	NOUN
bjp-26620	15	28	of	of	ADP
bjp-26620	15	29	breast	breast	NOUN
bjp-26620	15	30	cancer	cancer	NOUN
bjp-26620	15	31	cells	cell	NOUN
bjp-26620	15	32	through	through	ADP
bjp-26620	15	33	inhibition	inhibition	NOUN
bjp-26620	15	34	of	of	ADP
bjp-26620	15	35	synuclein	synuclein	NOUN
bjp-26620	15	36	-	-	PUNCT
bjp-26620	15	37	a	a	DET
bjp-26620	15	38	expression	expression	NOUN
bjp-26620	15	39	and	and	CCONJ
bjp-26620	15	40	can	can	AUX
bjp-26620	15	41	be	be	AUX
bjp-26620	15	42	used	use	VERB
bjp-26620	15	43	for	for	ADP
bjp-26620	15	44	breast	breast	NOUN
bjp-26620	15	45	cancer	cancer	NOUN
bjp-26620	15	46	treatment	treatment	NOUN
bjp-26620	15	47	.	.	PUNCT
bjp-26620	16	1	article	article	NOUN
bjp-26620	16	2	info	info	NOUN
bjp-26620	16	3	received	receive	VERB
bjp-26620	16	4	:	:	PUNCT
bjp-26620	16	5	27	27	NUM
bjp-26620	16	6	january	january	PROPN
bjp-26620	16	7	2016	2016	NUM
bjp-26620	16	8	accepted	accept	VERB
bjp-26620	16	9	:	:	PUNCT
bjp-26620	16	10	8	8	NUM
bjp-26620	16	11	march	march	PROPN
bjp-26620	16	12	2016	2016	NUM
bjp-26620	16	13	available	available	ADJ
bjp-26620	16	14	online	online	ADV
bjp-26620	16	15	:	:	PUNCT
bjp-26620	16	16	13	13	NUM
bjp-26620	16	17	june	june	PROPN
bjp-26620	16	18	2016	2016	NUM
bjp-26620	16	19	doi	doi	NOUN
bjp-26620	16	20	:	:	PUNCT
bjp-26620	16	21	10.3329	10.3329	NUM
bjp-26620	16	22	/	/	SYM
bjp-26620	16	23	bjp.v11i3.26620	bjp.v11i3.26620	PROPN
bjp-26620	16	24	cite	cite	VERB
bjp-26620	16	25	this	this	DET
bjp-26620	16	26	article	article	NOUN
bjp-26620	16	27	:	:	PUNCT
bjp-26620	16	28	sun	sun	PROPN
bjp-26620	16	29	jx	jx	PROPN
bjp-26620	16	30	,	,	PUNCT
bjp-26620	16	31	yan	yan	PROPN
bjp-26620	16	32	y	y	PROPN
bjp-26620	16	33	,	,	PUNCT
bjp-26620	16	34	xia	xia	PROPN
bjp-26620	16	35	jh	jh	PROPN
bjp-26620	16	36	,	,	PUNCT
bjp-26620	16	37	zhou	zhou	PROPN
bjp-26620	16	38	lq	lq	PROPN
bjp-26620	16	39	.	.	PUNCT
bjp-26620	17	1	bryostatin	bryostatin	PROPN
bjp-26620	17	2	i	i	PRON
bjp-26620	17	3	inhibits	inhibit	VERB
bjp-26620	17	4	growth	growth	NOUN
bjp-26620	17	5	of	of	ADP
bjp-26620	17	6	breast	breast	NOUN
bjp-26620	17	7	cancer	cancer	NOUN
bjp-26620	17	8	cells	cell	NOUN
bjp-26620	17	9	through	through	ADP
bjp-26620	17	10	the	the	DET
bjp-26620	17	11	inhibition	inhibition	NOUN
bjp-26620	17	12	of	of	ADP
bjp-26620	17	13	synuclein	synuclein	NOUN
bjp-26620	17	14	-	-	PUNCT
bjp-26620	17	15	a	a	DET
bjp-26620	17	16	expression	expression	NOUN
bjp-26620	17	17	.	.	PUNCT
bjp-26620	18	1	bangladesh	bangladesh	PROPN
bjp-26620	18	2	j	j	PROPN
bjp-26620	18	3	pharmacol	pharmacol	PROPN
bjp-26620	18	4	.	.	PROPN
bjp-26620	19	1	2016	2016	NUM
bjp-26620	19	2	;	;	PUNCT
bjp-26620	19	3	11	11	NUM
bjp-26620	19	4	:	:	PUNCT
bjp-26620	19	5	615	615	NUM
bjp-26620	19	6	-	-	SYM
bjp-26620	19	7	20	20	NUM
bjp-26620	19	8	.	.	PUNCT
bjp-26620	20	1	bryostatin	bryostatin	VERB
bjp-26620	20	2	i	i	PRON
bjp-26620	20	3	inhibits	inhibit	VERB
bjp-26620	20	4	growth	growth	NOUN
bjp-26620	20	5	of	of	ADP
bjp-26620	20	6	breast	breast	NOUN
bjp-26620	20	7	cancer	cancer	NOUN
bjp-26620	20	8	cells	cell	NOUN
bjp-26620	20	9	through	through	ADP
bjp-26620	20	10	the	the	DET
bjp-26620	20	11	inhibition	inhibition	NOUN
bjp-26620	20	12	of	of	ADP
bjp-26620	20	13	synuclein	synuclein	NOUN
bjp-26620	20	14	-	-	PUNCT
bjp-26620	20	15	a	a	DET
bjp-26620	20	16	expression	expression	NOUN
bjp-26620	20	17	jun	jun	PROPN
bjp-26620	20	18	-	-	PUNCT
bjp-26620	20	19	xia	xia	PROPN
bjp-26620	20	20	sun	sun	PROPN
bjp-26620	20	21	,	,	PUNCT
bjp-26620	20	22	yan	yan	PROPN
bjp-26620	20	23	yan	yan	PROPN
bjp-26620	20	24	,	,	PUNCT
bjp-26620	20	25	jian	jian	PROPN
bjp-26620	20	26	-	-	PUNCT
bjp-26620	20	27	hong	hong	PROPN
bjp-26620	20	28	xia	xia	PROPN
bjp-26620	20	29	and	and	CCONJ
bjp-26620	20	30	li	li	PROPN
bjp-26620	20	31	-	-	PROPN
bjp-26620	20	32	qing	qing	PROPN
bjp-26620	20	33	zhou	zhou	PROPN
bjp-26620	20	34	department	department	PROPN
bjp-26620	20	35	of	of	ADP
bjp-26620	20	36	radiotherapy	radiotherapy	PROPN
bjp-26620	20	37	,	,	PUNCT
bjp-26620	20	38	the	the	DET
bjp-26620	20	39	second	second	ADJ
bjp-26620	20	40	people	people	NOUN
bjp-26620	20	41	’s	’s	PART
bjp-26620	20	42	hospital	hospital	NOUN
bjp-26620	20	43	of	of	ADP
bjp-26620	20	44	huaian	huaian	NOUN
bjp-26620	20	45	,	,	PUNCT
bjp-26620	20	46	jiangsu	jiangsu	PROPN
bjp-26620	20	47	223	223	NUM
bjp-26620	20	48	-	-	PUNCT
bjp-26620	20	49	002	002	NUM
bjp-26620	20	50	,	,	PUNCT
bjp-26620	20	51	china	china	PROPN
bjp-26620	20	52	.	.	PUNCT
bjp-26620	21	1	http://www.bioxbio.com/if/html/bangl-j-pharmacol.html	http://www.bioxbio.com/if/html/bangl-j-pharmacol.html	PROPN
bjp-26620	21	2	multidrug	multidrug	VERB
bjp-26620	21	3	resistance	resistance	NOUN
bjp-26620	21	4	(	(	PUNCT
bjp-26620	21	5	spitaler	spitaler	PROPN
bjp-26620	21	6	et	et	PROPN
bjp-26620	21	7	al	al	PROPN
bjp-26620	21	8	.	.	PROPN
bjp-26620	21	9	,	,	PUNCT
bjp-26620	21	10	1998	1998	NUM
bjp-26620	21	11	)	)	PUNCT
bjp-26620	21	12	,	,	PUNCT
bjp-26620	21	13	and	and	CCONJ
bjp-26620	21	14	activation	activation	NOUN
bjp-26620	21	15	of	of	ADP
bjp-26620	21	16	the	the	DET
bjp-26620	21	17	immune	immune	ADJ
bjp-26620	21	18	system	system	NOUN
bjp-26620	21	19	(	(	PUNCT
bjp-26620	21	20	oz	oz	X
bjp-26620	21	21	et	et	PROPN
bjp-26620	21	22	al	al	PROPN
bjp-26620	21	23	.	.	PROPN
bjp-26620	21	24	,	,	PUNCT
bjp-26620	21	25	2000	2000	NUM
bjp-26620	21	26	)	)	PUNCT
bjp-26620	21	27	.	.	PUNCT
bjp-26620	22	1	the	the	DET
bjp-26620	22	2	efficacy	efficacy	NOUN
bjp-26620	22	3	of	of	ADP
bjp-26620	22	4	bryostatin	bryostatin	PROPN
bjp-26620	22	5	i	i	PRON
bjp-26620	22	6	varies	vary	VERB
bjp-26620	22	7	in	in	ADP
bjp-26620	22	8	different	different	ADJ
bjp-26620	22	9	types	type	NOUN
bjp-26620	22	10	of	of	ADP
bjp-26620	22	11	cancers	cancer	NOUN
bjp-26620	22	12	.	.	PUNCT
bjp-26620	23	1	various	various	ADJ
bjp-26620	23	2	studies	study	NOUN
bjp-26620	23	3	have	have	AUX
bjp-26620	23	4	demonstrated	demonstrate	VERB
bjp-26620	23	5	that	that	SCONJ
bjp-26620	23	6	it	it	PRON
bjp-26620	23	7	enhances	enhance	VERB
bjp-26620	23	8	the	the	DET
bjp-26620	23	9	efficiency	efficiency	NOUN
bjp-26620	23	10	of	of	ADP
bjp-26620	23	11	other	other	ADJ
bjp-26620	23	12	oncolytics	oncolytic	NOUN
bjp-26620	23	13	against	against	ADP
bjp-26620	23	14	various	various	ADJ
bjp-26620	23	15	types	type	NOUN
bjp-26620	23	16	of	of	ADP
bjp-26620	23	17	cancers	cancer	NOUN
bjp-26620	23	18	(	(	PUNCT
bjp-26620	23	19	dowlati	dowlati	PROPN
bjp-26620	23	20	et	et	PROPN
bjp-26620	23	21	al	al	PROPN
bjp-26620	23	22	.	.	PROPN
bjp-26620	23	23	,	,	PUNCT
bjp-26620	23	24	2003	2003	NUM
bjp-26620	23	25	)	)	PUNCT
bjp-26620	23	26	.	.	PUNCT
bjp-26620	24	1	bryostatin	bryostatin	VERB
bjp-26620	24	2	i	i	PRON
bjp-26620	24	3	and	and	CCONJ
bjp-26620	24	4	its	its	PRON
bjp-26620	24	5	synthetic	synthetic	ADJ
bjp-26620	24	6	analogs	analog	NOUN
bjp-26620	24	7	have	have	AUX
bjp-26620	24	8	shown	show	VERB
bjp-26620	24	9	promising	promising	ADJ
bjp-26620	24	10	results	result	NOUN
bjp-26620	24	11	in	in	ADP
bjp-26620	24	12	the	the	DET
bjp-26620	24	13	treatment	treatment	NOUN
bjp-26620	24	14	of	of	ADP
bjp-26620	24	15	cancer	cancer	NOUN
bjp-26620	24	16	at	at	ADP
bjp-26620	24	17	very	very	ADV
bjp-26620	24	18	low	low	ADJ
bjp-26620	24	19	doses	dose	NOUN
bjp-26620	24	20	(	(	PUNCT
bjp-26620	24	21	shaha	shaha	VERB
bjp-26620	24	22	et	et	PROPN
bjp-26620	24	23	al	al	PROPN
bjp-26620	24	24	.	.	PROPN
bjp-26620	24	25	,	,	PUNCT
bjp-26620	24	26	2009	2009	NUM
bjp-26620	24	27	)	)	PUNCT
bjp-26620	24	28	.	.	PUNCT
bjp-26620	25	1	in	in	ADP
bjp-26620	25	2	the	the	DET
bjp-26620	25	3	present	present	ADJ
bjp-26620	25	4	study	study	NOUN
bjp-26620	25	5	effect	effect	NOUN
bjp-26620	25	6	of	of	ADP
bjp-26620	25	7	bryostatin	bryostatin	VERB
bjp-26620	25	8	i	i	PRON
bjp-26620	25	9	on	on	ADP
bjp-26620	25	10	expression	expression	NOUN
bjp-26620	25	11	of	of	ADP
bjp-26620	25	12	synuclein	synuclein	NOUN
bjp-26620	25	13	-	-	PUNCT
bjp-26620	25	14	a	a	NOUN
bjp-26620	25	15	and	and	CCONJ
bjp-26620	25	16	viability	viability	NOUN
bjp-26620	25	17	of	of	ADP
bjp-26620	25	18	cells	cell	NOUN
bjp-26620	25	19	in	in	ADP
bjp-26620	25	20	breast	breast	NOUN
bjp-26620	25	21	cancer	cancer	NOUN
bjp-26620	25	22	cells	cell	NOUN
bjp-26620	25	23	was	be	AUX
bjp-26620	25	24	investigated	investigate	VERB
bjp-26620	25	25	.	.	PUNCT
bjp-26620	26	1	bryostatin	bryostatin	VERB
bjp-26620	26	2	i	i	PRON
bjp-26620	26	3	inhibits	inhibit	VERB
bjp-26620	26	4	the	the	DET
bjp-26620	26	5	expression	expression	NOUN
bjp-26620	26	6	of	of	ADP
bjp-26620	26	7	synuclein	synuclein	NOUN
bjp-26620	26	8	-	-	PUNCT
bjp-26620	26	9	a	a	NOUN
bjp-26620	26	10	and	and	CCONJ
bjp-26620	26	11	viability	viability	NOUN
bjp-26620	26	12	of	of	ADP
bjp-26620	26	13	breast	breast	NOUN
bjp-26620	26	14	cancer	cancer	NOUN
bjp-26620	26	15	cells	cell	NOUN
bjp-26620	26	16	.	.	PUNCT
bjp-26620	27	1	materials	material	NOUN
bjp-26620	27	2	and	and	CCONJ
bjp-26620	27	3	methods	method	NOUN
bjp-26620	27	4	reagents	reagent	NOUN
bjp-26620	27	5	and	and	CCONJ
bjp-26620	27	6	antibody	antibody	NOUN
bjp-26620	27	7	bryostatin	bryostatin	NOUN
bjp-26620	27	8	i	i	PRON
bjp-26620	27	9	was	be	AUX
bjp-26620	27	10	purchased	purchase	VERB
bjp-26620	27	11	from	from	ADP
bjp-26620	27	12	the	the	DET
bjp-26620	27	13	sigma	sigma	PROPN
bjp-26620	27	14	-	-	PUNCT
bjp-26620	27	15	aldrich	aldrich	PROPN
bjp-26620	27	16	(	(	PUNCT
bjp-26620	27	17	usa	usa	PROPN
bjp-26620	27	18	)	)	PUNCT
bjp-26620	27	19	.	.	PUNCT
bjp-26620	28	1	the	the	DET
bjp-26620	28	2	antibodies	antibody	NOUN
bjp-26620	28	3	against	against	ADP
bjp-26620	28	4	cdc2	cdc2	NOUN
bjp-26620	28	5	and	and	CCONJ
bjp-26620	28	6	synuclein	synuclein	NOUN
bjp-26620	28	7	-	-	PUNCT
bjp-26620	28	8	a	a	NOUN
bjp-26620	28	9	were	be	AUX
bjp-26620	28	10	purchased	purchase	VERB
bjp-26620	28	11	from	from	ADP
bjp-26620	28	12	santa	santa	PROPN
bjp-26620	28	13	cruz	cruz	PROPN
bjp-26620	28	14	biotechnology	biotechnology	PROPN
bjp-26620	28	15	(	(	PUNCT
bjp-26620	28	16	usa	usa	PROPN
bjp-26620	28	17	)	)	PUNCT
bjp-26620	28	18	.	.	PUNCT
bjp-26620	29	1	cell	cell	NOUN
bjp-26620	29	2	lines	line	NOUN
bjp-26620	29	3	and	and	CCONJ
bjp-26620	29	4	culture	culture	VERB
bjp-26620	29	5	h3922	h3922	PROPN
bjp-26620	29	6	cell	cell	NOUN
bjp-26620	29	7	line	line	NOUN
bjp-26620	29	8	was	be	AUX
bjp-26620	29	9	supplied	supply	VERB
bjp-26620	29	10	by	by	ADP
bjp-26620	29	11	the	the	DET
bjp-26620	29	12	american	american	ADJ
bjp-26620	29	13	type	type	NOUN
bjp-26620	29	14	culture	culture	NOUN
bjp-26620	29	15	collection	collection	NOUN
bjp-26620	29	16	(	(	PUNCT
bjp-26620	29	17	usa	usa	PROPN
bjp-26620	29	18	)	)	PUNCT
bjp-26620	29	19	.	.	PUNCT
bjp-26620	30	1	the	the	DET
bjp-26620	30	2	cells	cell	NOUN
bjp-26620	30	3	were	be	AUX
bjp-26620	30	4	cultured	cultured	ADJ
bjp-26620	30	5	for	for	ADP
bjp-26620	30	6	24	24	NUM
bjp-26620	30	7	hours	hour	NOUN
bjp-26620	30	8	in	in	ADP
bjp-26620	30	9	rpmi‑1640	rpmi‑1640	NUM
bjp-26620	30	10	medium	medium	NOUN
bjp-26620	30	11	in	in	ADP
bjp-26620	30	12	an	an	DET
bjp-26620	30	13	incubator	incubator	NOUN
bjp-26620	30	14	with	with	ADP
bjp-26620	30	15	humidified	humidified	ADJ
bjp-26620	30	16	atmosphere	atmosphere	NOUN
bjp-26620	30	17	of	of	ADP
bjp-26620	30	18	5	5	NUM
bjp-26620	30	19	%	%	NOUN
bjp-26620	30	20	co2	co2	NOUN
bjp-26620	30	21	at	at	ADP
bjp-26620	30	22	37˚c	37˚c	NUM
bjp-26620	30	23	.	.	PUNCT
bjp-26620	31	1	the	the	DET
bjp-26620	31	2	medium	medium	NOUN
bjp-26620	31	3	contained	contain	VERB
bjp-26620	31	4	fetal	fetal	ADJ
bjp-26620	31	5	bovine	bovine	NOUN
bjp-26620	31	6	serum	serum	NOUN
bjp-26620	31	7	(	(	PUNCT
bjp-26620	31	8	10	10	NUM
bjp-26620	31	9	%	%	NOUN
bjp-26620	31	10	)	)	PUNCT
bjp-26620	31	11	.	.	PUNCT
bjp-26620	32	1	cell	cell	NOUN
bjp-26620	32	2	viability	viability	NOUN
bjp-26620	32	3	assay	assay	PROPN
bjp-26620	32	4	(	(	PUNCT
bjp-26620	32	5	video	video	NOUN
bjp-26620	32	6	clip	clip	NOUN
bjp-26620	32	7	)	)	PUNCT
bjp-26620	32	8	the	the	DET
bjp-26620	32	9	effect	effect	NOUN
bjp-26620	32	10	of	of	ADP
bjp-26620	32	11	synuclein	synuclein	NOUN
bjp-26620	32	12	-	-	PUNCT
bjp-26620	32	13	a	a	NOUN
bjp-26620	32	14	on	on	ADP
bjp-26620	32	15	the	the	DET
bjp-26620	32	16	viability	viability	NOUN
bjp-26620	32	17	of	of	ADP
bjp-26620	32	18	h3922	h3922	PROPN
bjp-26620	32	19	breast	breast	NOUN
bjp-26620	32	20	cancer	cancer	NOUN
bjp-26620	32	21	cells	cell	NOUN
bjp-26620	32	22	was	be	AUX
bjp-26620	32	23	examined	examine	VERB
bjp-26620	32	24	by	by	ADP
bjp-26620	32	25	mtt	mtt	NOUN
bjp-26620	32	26	assay	assay	NOUN
bjp-26620	32	27	.	.	PUNCT
bjp-26620	33	1	briefly	briefly	ADV
bjp-26620	33	2	,	,	PUNCT
bjp-26620	33	3	the	the	DET
bjp-26620	33	4	cells	cell	NOUN
bjp-26620	33	5	growing	grow	VERB
bjp-26620	33	6	exponentially	exponentially	ADV
bjp-26620	33	7	were	be	AUX
bjp-26620	33	8	collected	collect	VERB
bjp-26620	33	9	and	and	CCONJ
bjp-26620	33	10	put	put	VERB
bjp-26620	33	11	into	into	ADP
bjp-26620	33	12	96	96	NUM
bjp-26620	33	13	-	-	PUNCT
bjp-26620	33	14	well	well	NOUN
bjp-26620	33	15	plates	plate	NOUN
bjp-26620	33	16	at	at	ADP
bjp-26620	33	17	a	a	DET
bjp-26620	33	18	density	density	NOUN
bjp-26620	33	19	of	of	ADP
bjp-26620	33	20	2.5	2.5	NUM
bjp-26620	33	21	x	x	SYM
bjp-26620	33	22	106	106	NUM
bjp-26620	33	23	cells	cell	NOUN
bjp-26620	33	24	per	per	ADP
bjp-26620	33	25	well	well	ADV
bjp-26620	33	26	.	.	PUNCT
bjp-26620	34	1	after	after	ADP
bjp-26620	34	2	incubation	incubation	NOUN
bjp-26620	34	3	for	for	ADP
bjp-26620	34	4	a	a	DET
bjp-26620	34	5	period	period	NOUN
bjp-26620	34	6	of	of	ADP
bjp-26620	34	7	24	24	NUM
bjp-26620	34	8	hours	hour	NOUN
bjp-26620	34	9	at	at	ADP
bjp-26620	34	10	37˚c	37˚c	NUM
bjp-26620	34	11	temperature	temperature	NOUN
bjp-26620	34	12	,	,	PUNCT
bjp-26620	34	13	different	different	ADJ
bjp-26620	34	14	concentrations	concentration	NOUN
bjp-26620	34	15	of	of	ADP
bjp-26620	34	16	synuclein	synuclein	NOUN
bjp-26620	34	17	-	-	PUNCT
bjp-26620	34	18	a	a	DET
bjp-26620	34	19	(	(	PUNCT
bjp-26620	34	20	5	5	NUM
bjp-26620	34	21	,	,	PUNCT
bjp-26620	34	22	10	10	NUM
bjp-26620	34	23	,	,	PUNCT
bjp-26620	34	24	15	15	NUM
bjp-26620	34	25	,	,	PUNCT
bjp-26620	34	26	20	20	NUM
bjp-26620	34	27	,	,	PUNCT
bjp-26620	34	28	25	25	NUM
bjp-26620	34	29	and	and	CCONJ
bjp-26620	34	30	30	30	NUM
bjp-26620	34	31	m	m	NOUN
bjp-26620	34	32	)	)	PUNCT
bjp-26620	34	33	were	be	AUX
bjp-26620	34	34	added	add	VERB
bjp-26620	34	35	to	to	ADP
bjp-26620	34	36	the	the	DET
bjp-26620	34	37	wells	well	NOUN
bjp-26620	34	38	and	and	CCONJ
bjp-26620	34	39	incubation	incubation	NOUN
bjp-26620	34	40	was	be	AUX
bjp-26620	34	41	continued	continue	VERB
bjp-26620	34	42	for	for	ADP
bjp-26620	34	43	48	48	NUM
bjp-26620	34	44	hours	hour	NOUN
bjp-26620	34	45	.	.	PUNCT
bjp-26620	35	1	then	then	ADV
bjp-26620	35	2	,	,	PUNCT
bjp-26620	35	3	to	to	ADP
bjp-26620	35	4	each	each	DET
bjp-26620	35	5	well	well	NOUN
bjp-26620	35	6	of	of	ADP
bjp-26620	35	7	the	the	DET
bjp-26620	35	8	plate	plate	NOUN
bjp-26620	35	9	20	20	NUM
bjp-26620	35	10	µl	µl	NOUN
bjp-26620	35	11	of	of	ADP
bjp-26620	35	12	mtt	mtt	NOUN
bjp-26620	35	13	solution	solution	NOUN
bjp-26620	35	14	was	be	AUX
bjp-26620	35	15	added	add	VERB
bjp-26620	35	16	and	and	CCONJ
bjp-26620	35	17	incubation	incubation	NOUN
bjp-26620	35	18	of	of	ADP
bjp-26620	35	19	the	the	DET
bjp-26620	35	20	plates	plate	NOUN
bjp-26620	35	21	was	be	AUX
bjp-26620	35	22	performed	perform	VERB
bjp-26620	35	23	for	for	ADP
bjp-26620	35	24	4	4	NUM
bjp-26620	35	25	hours	hour	NOUN
bjp-26620	35	26	more	more	ADJ
bjp-26620	35	27	.	.	PUNCT
bjp-26620	36	1	following	follow	VERB
bjp-26620	36	2	incubation	incubation	NOUN
bjp-26620	36	3	,	,	PUNCT
bjp-26620	36	4	the	the	DET
bjp-26620	36	5	supernatant	supernatant	NOUN
bjp-26620	36	6	was	be	AUX
bjp-26620	36	7	removed	remove	VERB
bjp-26620	36	8	and	and	CCONJ
bjp-26620	36	9	to	to	ADP
bjp-26620	36	10	each	each	DET
bjp-26620	36	11	well	well	ADV
bjp-26620	36	12	was	be	AUX
bjp-26620	36	13	added	add	VERB
bjp-26620	36	14	150	150	NUM
bjp-26620	36	15	µl	µl	ADP
bjp-26620	36	16	dmso	dmso	NOUN
bjp-26620	36	17	.	.	PUNCT
bjp-26620	37	1	for	for	SCONJ
bjp-26620	37	2	each	each	PRON
bjp-26620	37	3	of	of	ADP
bjp-26620	37	4	the	the	DET
bjp-26620	37	5	well	well	ADV
bjp-26620	37	6	optical	optical	ADJ
bjp-26620	37	7	density	density	NOUN
bjp-26620	37	8	was	be	AUX
bjp-26620	37	9	recorded	record	VERB
bjp-26620	37	10	at	at	ADP
bjp-26620	37	11	470	470	NUM
bjp-26620	37	12	nm	nm	NOUN
bjp-26620	37	13	using	use	VERB
bjp-26620	37	14	a	a	DET
bjp-26620	37	15	microplate	microplate	NOUN
bjp-26620	37	16	reader	reader	NOUN
bjp-26620	37	17	(	(	PUNCT
bjp-26620	37	18	biorad	biorad	NOUN
bjp-26620	37	19	instruments	instrument	NOUN
bjp-26620	37	20	,	,	PUNCT
bjp-26620	37	21	usa	usa	PROPN
bjp-26620	37	22	)	)	PUNCT
bjp-26620	37	23	.	.	PUNCT
bjp-26620	38	1	apoptosis	apoptosis	NOUN
bjp-26620	38	2	analysis	analysis	NOUN
bjp-26620	38	3	the	the	DET
bjp-26620	38	4	cells	cell	NOUN
bjp-26620	38	5	were	be	AUX
bjp-26620	38	6	cultured	cultured	ADJ
bjp-26620	38	7	in	in	ADP
bjp-26620	38	8	medium	medium	ADJ
bjp-26620	38	9	supplemented	supplement	VERB
bjp-26620	38	10	with	with	ADP
bjp-26620	38	11	dimethyl	dimethyl	NOUN
bjp-26620	38	12	sulfoxide	sulfoxide	NOUN
bjp-26620	38	13	or	or	CCONJ
bjp-26620	38	14	various	various	ADJ
bjp-26620	38	15	concentration	concentration	NOUN
bjp-26620	38	16	of	of	ADP
bjp-26620	38	17	bryostatin	bryostatin	PROPN
bjp-26620	38	18	i	i	PRON
bjp-26620	38	19	for	for	ADP
bjp-26620	38	20	48	48	NUM
bjp-26620	38	21	hours	hour	NOUN
bjp-26620	38	22	.	.	PUNCT
bjp-26620	39	1	following	follow	VERB
bjp-26620	39	2	incubation	incubation	NOUN
bjp-26620	39	3	,	,	PUNCT
bjp-26620	39	4	h3922	h3922	PROPN
bjp-26620	39	5	cells	cell	NOUN
bjp-26620	39	6	were	be	AUX
bjp-26620	39	7	subjected	subject	VERB
bjp-26620	39	8	to	to	ADP
bjp-26620	39	9	annexin	annexin	NOUN
bjp-26620	39	10	v‑egfp	v‑egfp	PROPN
bjp-26620	39	11	staining	stain	VERB
bjp-26620	39	12	using	use	VERB
bjp-26620	39	13	apoptosis	apoptosis	NOUN
bjp-26620	39	14	detection	detection	NOUN
bjp-26620	39	15	kits	kit	NOUN
bjp-26620	39	16	(	(	PUNCT
bjp-26620	39	17	medical	medical	ADJ
bjp-26620	39	18	and	and	CCONJ
bjp-26620	39	19	biological	biological	ADJ
bjp-26620	39	20	laboratories	laboratory	NOUN
bjp-26620	39	21	,	,	PUNCT
bjp-26620	39	22	japan	japan	PROPN
bjp-26620	39	23	)	)	PUNCT
bjp-26620	39	24	as	as	ADP
bjp-26620	39	25	per	per	ADP
bjp-26620	39	26	the	the	DET
bjp-26620	39	27	manual	manual	ADJ
bjp-26620	39	28	protocol	protocol	NOUN
bjp-26620	39	29	.	.	PUNCT
bjp-26620	40	1	facscan	facscan	PROPN
bjp-26620	40	2	(	(	PUNCT
bjp-26620	40	3	becton	becton	PROPN
bjp-26620	40	4	-	-	PUNCT
bjp-26620	40	5	dickinson	dickinson	PROPN
bjp-26620	40	6	immunocytometry	immunocytometry	NOUN
bjp-26620	40	7	systems	systems	PROPN
bjp-26620	40	8	,	,	PUNCT
bjp-26620	40	9	usa	usa	PROPN
bjp-26620	40	10	)	)	PUNCT
bjp-26620	40	11	was	be	AUX
bjp-26620	40	12	used	use	VERB
bjp-26620	40	13	for	for	ADP
bjp-26620	40	14	the	the	DET
bjp-26620	40	15	analysis	analysis	NOUN
bjp-26620	40	16	of	of	ADP
bjp-26620	40	17	positively	positively	ADV
bjp-26620	40	18	stained	stain	VERB
bjp-26620	40	19	cells	cell	NOUN
bjp-26620	40	20	.	.	PUNCT
bjp-26620	41	1	cell	cell	NOUN
bjp-26620	41	2	cycle	cycle	NOUN
bjp-26620	41	3	analysis	analysis	NOUN
bjp-26620	41	4	using	use	VERB
bjp-26620	41	5	flow	flow	NOUN
bjp-26620	41	6	cytometry	cytometry	NOUN
bjp-26620	41	7	breast	breast	NOUN
bjp-26620	41	8	cancer	cancer	NOUN
bjp-26620	41	9	cell	cell	NOUN
bjp-26620	41	10	after	after	SCONJ
bjp-26620	41	11	treatment	treatment	NOUN
bjp-26620	41	12	with	with	ADP
bjp-26620	41	13	bryostatin	bryostatin	PROPN
bjp-26620	41	14	i	i	PRON
bjp-26620	41	15	or	or	CCONJ
bjp-26620	41	16	control	control	NOUN
bjp-26620	41	17	cells	cell	NOUN
bjp-26620	41	18	were	be	AUX
bjp-26620	41	19	collected	collect	VERB
bjp-26620	41	20	,	,	PUNCT
bjp-26620	41	21	washed	wash	VERB
bjp-26620	41	22	twice	twice	ADV
bjp-26620	41	23	with	with	ADP
bjp-26620	41	24	pbs	pbs	PROPN
bjp-26620	41	25	and	and	CCONJ
bjp-26620	41	26	put	put	VERB
bjp-26620	41	27	(	(	PUNCT
bjp-26620	41	28	106	106	NUM
bjp-26620	41	29	/	/	SYM
bjp-26620	41	30	ml	ml	NOUN
bjp-26620	41	31	)	)	PUNCT
bjp-26620	41	32	in	in	ADP
bjp-26620	41	33	a	a	DET
bjp-26620	41	34	hypotonic	hypotonic	ADJ
bjp-26620	41	35	fluorochrome	fluorochrome	NOUN
bjp-26620	41	36	solution	solution	NOUN
bjp-26620	41	37	(	(	PUNCT
bjp-26620	41	38	50	50	NUM
bjp-26620	41	39	mg	mg	NUM
bjp-26620	41	40	/	/	SYM
bjp-26620	41	41	ml	ml	NOUN
bjp-26620	41	42	propidium	propidium	NOUN
bjp-26620	41	43	iodide	iodide	NOUN
bjp-26620	41	44	in	in	ADP
bjp-26620	41	45	0.1	0.1	NUM
bjp-26620	41	46	%	%	NOUN
bjp-26620	41	47	sodium	sodium	NOUN
bjp-26620	41	48	citrate	citrate	NOUN
bjp-26620	41	49	plus	plus	CCONJ
bjp-26620	41	50	0.1	0.1	NUM
bjp-26620	41	51	%	%	NOUN
bjp-26620	41	52	triton	triton	PROPN
bjp-26620	41	53	x-100	x-100	PROPN
bjp-26620	41	54	;	;	PUNCT
bjp-26620	41	55	sigma	sigma	PROPN
bjp-26620	41	56	-	-	PUNCT
bjp-26620	41	57	aldrich	aldrich	NOUN
bjp-26620	41	58	)	)	PUNCT
bjp-26620	41	59	.	.	PUNCT
bjp-26620	42	1	after	after	ADP
bjp-26620	42	2	incubation	incubation	NOUN
bjp-26620	42	3	for	for	ADP
bjp-26620	42	4	2	2	NUM
bjp-26620	42	5	hours	hour	NOUN
bjp-26620	42	6	at	at	ADP
bjp-26620	42	7	50˚c	50˚c	NUM
bjp-26620	42	8	under	under	ADP
bjp-26620	42	9	dark	dark	ADJ
bjp-26620	42	10	conditions	condition	NOUN
bjp-26620	42	11	,	,	PUNCT
bjp-26620	42	12	facscaliber	facscaliber	PROPN
bjp-26620	42	13	flow	flow	NOUN
bjp-26620	42	14	cytometer	cytometer	NOUN
bjp-26620	42	15	(	(	PUNCT
bjp-26620	42	16	bd	bd	PROPN
bjp-26620	42	17	biosciences	biosciences	PROPN
bjp-26620	42	18	,	,	PUNCT
bjp-26620	42	19	usa	usa	PROPN
bjp-26620	42	20	)	)	PUNCT
bjp-26620	42	21	with	with	ADP
bjp-26620	42	22	modfit	modfit	NOUN
bjp-26620	42	23	cell	cell	NOUN
bjp-26620	42	24	cycle	cycle	NOUN
bjp-26620	42	25	analysis	analysis	NOUN
bjp-26620	42	26	software	software	NOUN
bjp-26620	42	27	version	version	NOUN
bjp-26620	42	28	2.01.2	2.01.2	NUM
bjp-26620	42	29	(	(	PUNCT
bjp-26620	42	30	bd	bd	PROPN
bjp-26620	42	31	biosciences	bioscience	NOUN
bjp-26620	42	32	)	)	PUNCT
bjp-26620	42	33	was	be	AUX
bjp-26620	42	34	used	use	VERB
bjp-26620	42	35	for	for	ADP
bjp-26620	42	36	analysis	analysis	NOUN
bjp-26620	42	37	of	of	ADP
bjp-26620	42	38	propidium	propidium	NOUN
bjp-26620	42	39	iodide	iodide	NOUN
bjp-26620	42	40	fluorescence	fluorescence	NOUN
bjp-26620	42	41	a.	a.	NOUN
bjp-26620	43	1	the	the	DET
bjp-26620	43	2	experiments	experiment	NOUN
bjp-26620	43	3	were	be	AUX
bjp-26620	43	4	performed	perform	VERB
bjp-26620	43	5	in	in	ADP
bjp-26620	43	6	triplicates	triplicate	NOUN
bjp-26620	43	7	for	for	ADP
bjp-26620	43	8	each	each	DET
bjp-26620	43	9	condition	condition	NOUN
bjp-26620	43	10	.	.	PUNCT
bjp-26620	44	1	analysis	analysis	NOUN
bjp-26620	44	2	of	of	ADP
bjp-26620	44	3	cdc2	cdc2	PROPN
bjp-26620	44	4	kinase	kinase	NOUN
bjp-26620	44	5	activity	activity	NOUN
bjp-26620	44	6	the	the	DET
bjp-26620	44	7	cell	cell	NOUN
bjp-26620	44	8	lysate	lysate	NOUN
bjp-26620	44	9	(	(	PUNCT
bjp-26620	44	10	1	1	NUM
bjp-26620	44	11	mg	mg	NUM
bjp-26620	44	12	)	)	PUNCT
bjp-26620	44	13	was	be	AUX
bjp-26620	44	14	subjected	subject	VERB
bjp-26620	44	15	to	to	ADP
bjp-26620	44	16	incubation	incubation	NOUN
bjp-26620	44	17	with	with	ADP
bjp-26620	44	18	rabbit	rabbit	NOUN
bjp-26620	44	19	monoclonal	monoclonal	NOUN
bjp-26620	44	20	antibody	antibody	NOUN
bjp-26620	44	21	against	against	ADP
bjp-26620	44	22	cdc2	cdc2	NOUN
bjp-26620	44	23	at	at	ADP
bjp-26620	44	24	4˚c	4˚c	NUM
bjp-26620	44	25	for	for	ADP
bjp-26620	44	26	2	2	NUM
bjp-26620	44	27	hours	hour	NOUN
bjp-26620	44	28	.	.	PUNCT
bjp-26620	45	1	20	20	NUM
bjp-26620	45	2	μl	μl	ADP
bjp-26620	45	3	of	of	ADP
bjp-26620	45	4	sepharose	sepharose	NOUN
bjp-26620	45	5	a	a	DET
bjp-26620	45	6	protein	protein	NOUN
bjp-26620	45	7	was	be	AUX
bjp-26620	45	8	added	add	VERB
bjp-26620	45	9	to	to	ADP
bjp-26620	45	10	cell	cell	NOUN
bjp-26620	45	11	lysates	lysate	NOUN
bjp-26620	45	12	followed	follow	VERB
bjp-26620	45	13	by	by	ADP
bjp-26620	45	14	dilution	dilution	NOUN
bjp-26620	45	15	with	with	ADP
bjp-26620	45	16	2x	2x	NUM
bjp-26620	45	17	propidium	propidium	NOUN
bjp-26620	45	18	iodide	iodide	NOUN
bjp-26620	45	19	buffer	buffer	NOUN
bjp-26620	45	20	.	.	PUNCT
bjp-26620	46	1	after	after	ADP
bjp-26620	46	2	dilution	dilution	NOUN
bjp-26620	46	3	,	,	PUNCT
bjp-26620	46	4	the	the	DET
bjp-26620	46	5	samples	sample	NOUN
bjp-26620	46	6	were	be	AUX
bjp-26620	46	7	incubated	incubate	VERB
bjp-26620	46	8	at	at	ADP
bjp-26620	46	9	4˚c	4˚c	NUM
bjp-26620	46	10	for	for	ADP
bjp-26620	46	11	2	2	NUM
bjp-26620	46	12	hours	hour	NOUN
bjp-26620	46	13	and	and	CCONJ
bjp-26620	46	14	then	then	ADV
bjp-26620	46	15	centrifuged	centrifuge	VERB
bjp-26620	46	16	.	.	PUNCT
bjp-26620	47	1	the	the	DET
bjp-26620	47	2	1x	1x	NUM
bjp-26620	47	3	propidium	propidium	NOUN
bjp-26620	47	4	iodide	iodide	NOUN
bjp-26620	47	5	buffer	buffer	NOUN
bjp-26620	47	6	(	(	PUNCT
bjp-26620	47	7	1	1	NUM
bjp-26620	47	8	%	%	NOUN
bjp-26620	47	9	triton	triton	PROPN
bjp-26620	47	10	x-100	x-100	PROPN
bjp-26620	47	11	,	,	PUNCT
bjp-26620	47	12	10	10	NUM
bjp-26620	47	13	mm	mm	PROPN
bjp-26620	47	14	tris	tris	NOUN
bjp-26620	47	15	,	,	PUNCT
bjp-26620	47	16	ph	ph	NOUN
bjp-26620	47	17	7.4	7.4	NUM
bjp-26620	47	18	,	,	PUNCT
bjp-26620	47	19	0.5	0.5	NUM
bjp-26620	47	20	%	%	NOUN
bjp-26620	47	21	np-40	np-40	PRON
bjp-26620	47	22	,	,	PUNCT
bjp-26620	47	23	150	150	NUM
bjp-26620	47	24	mm	mm	NOUN
bjp-26620	47	25	nacl	nacl	NOUN
bjp-26620	47	26	,	,	PUNCT
bjp-26620	47	27	1	1	NUM
bjp-26620	47	28	mm	mm	NUM
bjp-26620	47	29	edta	edta	NOUN
bjp-26620	47	30	,	,	PUNCT
bjp-26620	47	31	1	1	NUM
bjp-26620	47	32	mm	mm	NOUN
bjp-26620	47	33	egta	egta	PROPN
bjp-26620	47	34	ph	ph	PROPN
bjp-26620	47	35	8.0	8.0	NUM
bjp-26620	47	36	)	)	PUNCT
bjp-26620	47	37	supplemented	supplement	VERB
bjp-26620	47	38	with	with	ADP
bjp-26620	47	39	protease	protease	NOUN
bjp-26620	47	40	inhibitor	inhibitor	NOUN
bjp-26620	47	41	cocktail	cocktail	NOUN
bjp-26620	47	42	was	be	AUX
bjp-26620	47	43	used	use	VERB
bjp-26620	47	44	for	for	ADP
bjp-26620	47	45	washing	wash	VERB
bjp-26620	47	46	the	the	DET
bjp-26620	47	47	complex	complex	NOUN
bjp-26620	47	48	.	.	PUNCT
bjp-26620	48	1	the	the	DET
bjp-26620	48	2	pellets	pellet	NOUN
bjp-26620	48	3	washed	wash	VERB
bjp-26620	48	4	with	with	ADP
bjp-26620	48	5	kinase	kinase	NOUN
bjp-26620	48	6	buffer	buffer	NOUN
bjp-26620	48	7	(	(	PUNCT
bjp-26620	48	8	10	10	NUM
bjp-26620	48	9	mm	mm	NOUN
bjp-26620	48	10	tris	tris	NOUN
bjp-26620	48	11	ph	ph	VERB
bjp-26620	48	12	7.4	7.4	NUM
bjp-26620	48	13	,	,	PUNCT
bjp-26620	48	14	150	150	NUM
bjp-26620	48	15	mm	mm	NOUN
bjp-26620	48	16	nacl	nacl	NOUN
bjp-26620	48	17	,	,	PUNCT
bjp-26620	48	18	10	10	NUM
bjp-26620	48	19	mm	mm	NOUN
bjp-26620	48	20	mgcl2	mgcl2	PROPN
bjp-26620	48	21	,	,	PUNCT
bjp-26620	48	22	and	and	CCONJ
bjp-26620	48	23	0.5	0.5	NUM
bjp-26620	48	24	mm	mm	NOUN
bjp-26620	48	25	dtt	dtt	NOUN
bjp-26620	48	26	)	)	PUNCT
bjp-26620	48	27	were	be	AUX
bjp-26620	48	28	centrifuged	centrifuge	VERB
bjp-26620	48	29	,	,	PUNCT
bjp-26620	48	30	incubated	incubate	VERB
bjp-26620	48	31	with	with	ADP
bjp-26620	48	32	30	30	NUM
bjp-26620	48	33	μl	μl	ADP
bjp-26620	48	34	of	of	ADP
bjp-26620	48	35	the	the	DET
bjp-26620	48	36	kinase	kinase	PROPN
bjp-26620	48	37	buffer	buffer	NOUN
bjp-26620	48	38	containing	contain	VERB
bjp-26620	48	39	15	15	NUM
bjp-26620	48	40	μm	μm	NOUN
bjp-26620	48	41	atp	atp	NOUN
bjp-26620	48	42	,	,	PUNCT
bjp-26620	48	43	5	5	NUM
bjp-26620	48	44	μci	μci	NOUN
bjp-26620	48	45	[	[	X
bjp-26620	48	46	32p]áatp	32p]áatp	NUM
bjp-26620	48	47	,	,	PUNCT
bjp-26620	48	48	and	and	CCONJ
bjp-26620	48	49	8	8	NUM
bjp-26620	48	50	μg	μg	PROPN
bjp-26620	48	51	histone	histone	PROPN
bjp-26620	48	52	h1	h1	PROPN
bjp-26620	48	53	.	.	PUNCT
bjp-26620	49	1	sds	sds	PROPN
bjp-26620	49	2	sample	sample	NOUN
bjp-26620	49	3	buffer	buffer	NOUN
bjp-26620	49	4	was	be	AUX
bjp-26620	49	5	added	add	VERB
bjp-26620	49	6	to	to	PART
bjp-26620	49	7	quench	quench	VERB
bjp-26620	49	8	the	the	DET
bjp-26620	49	9	reaction	reaction	NOUN
bjp-26620	49	10	of	of	ADP
bjp-26620	49	11	kinase	kinase	PROPN
bjp-26620	49	12	.	.	PUNCT
bjp-26620	50	1	sds	sds	PROPN
bjp-26620	50	2	-	-	PUNCT
bjp-26620	50	3	page	page	NOUN
bjp-26620	50	4	was	be	AUX
bjp-26620	50	5	used	use	VERB
bjp-26620	50	6	for	for	ADP
bjp-26620	50	7	the	the	DET
bjp-26620	50	8	isolation	isolation	NOUN
bjp-26620	50	9	of	of	ADP
bjp-26620	50	10	phosphorylated	phosphorylate	VERB
bjp-26620	50	11	h1	h1	NOUN
bjp-26620	50	12	which	which	PRON
bjp-26620	50	13	was	be	AUX
bjp-26620	50	14	then	then	ADV
bjp-26620	50	15	detected	detect	VERB
bjp-26620	50	16	by	by	ADP
bjp-26620	50	17	phosphoimager	phosphoimager	NOUN
bjp-26620	50	18	.	.	PUNCT
bjp-26620	51	1	western	western	ADJ
bjp-26620	51	2	blot	blot	NOUN
bjp-26620	51	3	analysis	analysis	NOUN
bjp-26620	51	4	the	the	DET
bjp-26620	51	5	mmp-2	mmp-2	NUM
bjp-26620	51	6	and	and	CCONJ
bjp-26620	51	7	mmp-9	mmp-9	NOUN
bjp-26620	51	8	activities	activity	NOUN
bjp-26620	51	9	in	in	ADP
bjp-26620	51	10	the	the	DET
bjp-26620	51	11	breast	breast	NOUN
bjp-26620	51	12	cancer	cancer	NOUN
bjp-26620	51	13	cells	cell	NOUN
bjp-26620	51	14	were	be	AUX
bjp-26620	51	15	determined	determine	VERB
bjp-26620	51	16	by	by	ADP
bjp-26620	51	17	a	a	DET
bjp-26620	51	18	standard	standard	ADJ
bjp-26620	51	19	western	western	ADJ
bjp-26620	51	20	blot	blot	NOUN
bjp-26620	51	21	analysis	analysis	NOUN
bjp-26620	51	22	.	.	PUNCT
bjp-26620	52	1	h3922	h3922	PROPN
bjp-26620	52	2	breast	breast	NOUN
bjp-26620	52	3	cancer	cancer	NOUN
bjp-26620	52	4	cells	cell	NOUN
bjp-26620	52	5	that	that	PRON
bjp-26620	52	6	were	be	AUX
bjp-26620	52	7	treated	treat	VERB
bjp-26620	52	8	with	with	ADP
bjp-26620	52	9	various	various	ADJ
bjp-26620	52	10	concentrations	concentration	NOUN
bjp-26620	52	11	of	of	ADP
bjp-26620	52	12	bryostatin	bryostatin	PROPN
bjp-26620	52	13	i	i	PRON
bjp-26620	52	14	for	for	ADP
bjp-26620	52	15	48	48	NUM
bjp-26620	52	16	hours	hour	NOUN
bjp-26620	52	17	.	.	PUNCT
bjp-26620	53	1	the	the	DET
bjp-26620	53	2	cells	cell	NOUN
bjp-26620	53	3	were	be	AUX
bjp-26620	53	4	then	then	ADV
bjp-26620	53	5	treated	treat	VERB
bjp-26620	53	6	with	with	ADP
bjp-26620	53	7	cell	cell	NOUN
bjp-26620	53	8	lysis	lysis	NOUN
bjp-26620	53	9	buffer	buffer	NOUN
bjp-26620	53	10	under	under	ADP
bjp-26620	53	11	ice	ice	NOUN
bjp-26620	53	12	-	-	PUNCT
bjp-26620	53	13	cold	cold	ADJ
bjp-26620	53	14	conditions	condition	NOUN
bjp-26620	53	15	.	.	PUNCT
bjp-26620	54	1	the	the	DET
bjp-26620	54	2	bca	bca	PROPN
bjp-26620	54	3	protein	protein	NOUN
bjp-26620	54	4	quantification	quantification	NOUN
bjp-26620	54	5	kit	kit	NOUN
bjp-26620	54	6	(	(	PUNCT
bjp-26620	54	7	joincare	joincare	PROPN
bjp-26620	54	8	biosciences	bioscience	NOUN
bjp-26620	54	9	,	,	PUNCT
bjp-26620	54	10	china	china	PROPN
bjp-26620	54	11	)	)	PUNCT
bjp-26620	54	12	was	be	AUX
bjp-26620	54	13	used	use	VERB
bjp-26620	54	14	for	for	ADP
bjp-26620	54	15	determination	determination	NOUN
bjp-26620	54	16	of	of	ADP
bjp-26620	54	17	protein	protein	NOUN
bjp-26620	54	18	concentration	concentration	NOUN
bjp-26620	54	19	in	in	ADP
bjp-26620	54	20	the	the	DET
bjp-26620	54	21	cell	cell	NOUN
bjp-26620	54	22	lysates	lysate	NOUN
bjp-26620	54	23	according	accord	VERB
bjp-26620	54	24	to	to	ADP
bjp-26620	54	25	the	the	DET
bjp-26620	54	26	manufacturer	manufacturer	NOUN
bjp-26620	54	27	's	's	PART
bjp-26620	54	28	instructions	instruction	NOUN
bjp-26620	54	29	.	.	PUNCT
bjp-26620	55	1	separation	separation	NOUN
bjp-26620	55	2	of	of	ADP
bjp-26620	55	3	the	the	DET
bjp-26620	55	4	proteins	protein	NOUN
bjp-26620	55	5	was	be	AUX
bjp-26620	55	6	achieved	achieve	VERB
bjp-26620	55	7	on	on	ADP
bjp-26620	55	8	the	the	DET
bjp-26620	55	9	sds	sds	NOUN
bjp-26620	55	10	-	-	PUNCT
bjp-26620	55	11	polyacrylamide	polyacrylamide	NOUN
bjp-26620	55	12	gel	gel	NOUN
bjp-26620	55	13	by	by	ADP
bjp-26620	55	14	electrophoresis	electrophoresis	NOUN
bjp-26620	55	15	(	(	PUNCT
bjp-26620	55	16	page	page	NOUN
bjp-26620	55	17	)	)	PUNCT
bjp-26620	55	18	.	.	PUNCT
bjp-26620	56	1	the	the	DET
bjp-26620	56	2	nitrocellulose	nitrocellulose	NOUN
bjp-26620	56	3	membranes	membrane	NOUN
bjp-26620	56	4	on	on	ADP
bjp-26620	56	5	which	which	PRON
bjp-26620	56	6	proteins	protein	NOUN
bjp-26620	56	7	were	be	AUX
bjp-26620	56	8	transferred	transfer	VERB
bjp-26620	56	9	were	be	AUX
bjp-26620	56	10	incubated	incubate	VERB
bjp-26620	56	11	with	with	ADP
bjp-26620	56	12	rabbit	rabbit	NOUN
bjp-26620	56	13	polyclonal	polyclonal	ADJ
bjp-26620	56	14	primary	primary	ADJ
bjp-26620	56	15	antibodies	antibody	NOUN
bjp-26620	56	16	against	against	ADP
bjp-26620	56	17	mmp-2	mmp-2	NUM
bjp-26620	56	18	,	,	PUNCT
bjp-26620	56	19	mmp-9	mmp-9	NOUN
bjp-26620	56	20	and	and	CCONJ
bjp-26620	56	21	gapdh	gapdh	NOUN
bjp-26620	56	22	(	(	PUNCT
bjp-26620	56	23	1:1,000	1:1,000	NUM
bjp-26620	56	24	dilution	dilution	NOUN
bjp-26620	56	25	)	)	PUNCT
bjp-26620	56	26	at	at	ADP
bjp-26620	56	27	4˚c	4˚c	NUM
bjp-26620	56	28	for	for	ADP
bjp-26620	56	29	overnight	overnight	ADV
bjp-26620	56	30	.	.	PUNCT
bjp-26620	57	1	following	follow	VERB
bjp-26620	57	2	incubations	incubation	NOUN
bjp-26620	57	3	the	the	DET
bjp-26620	57	4	membranes	membrane	NOUN
bjp-26620	57	5	washed	wash	VERB
bjp-26620	57	6	with	with	ADP
bjp-26620	57	7	pbs	pbs	PROPN
bjp-26620	57	8	and	and	CCONJ
bjp-26620	57	9	subsequently	subsequently	ADV
bjp-26620	57	10	incubated	incubate	VERB
bjp-26620	57	11	with	with	ADP
bjp-26620	57	12	anti	anti	ADJ
bjp-26620	57	13	-	-	ADJ
bjp-26620	57	14	rabbit	rabbit	ADJ
bjp-26620	57	15	secondary	secondary	ADJ
bjp-26620	57	16	antibodies	antibody	NOUN
bjp-26620	57	17	conjugated	conjugate	VERB
bjp-26620	57	18	with	with	ADP
bjp-26620	57	19	horseradish	horseradish	ADJ
bjp-26620	57	20	peroxidase	peroxidase	NOUN
bjp-26620	57	21	(	(	PUNCT
bjp-26620	57	22	1:20,000	1:20,000	NUM
bjp-26620	57	23	dilution	dilution	NOUN
bjp-26620	57	24	)	)	PUNCT
bjp-26620	57	25	for	for	ADP
bjp-26620	57	26	2	2	NUM
bjp-26620	57	27	hours	hour	NOUN
bjp-26620	57	28	.	.	PUNCT
bjp-26620	58	1	the	the	DET
bjp-26620	58	2	enhanced	enhanced	ADJ
bjp-26620	58	3	chemiluminescence	chemiluminescence	NOUN
bjp-26620	58	4	reagent	reagent	NOUN
bjp-26620	58	5	(	(	PUNCT
bjp-26620	58	6	amersham	amersham	PROPN
bjp-26620	58	7	pharmacia	pharmacia	PROPN
bjp-26620	58	8	biotechnology	biotechnology	PROPN
bjp-26620	58	9	,	,	PUNCT
bjp-26620	58	10	usa	usa	PROPN
bjp-26620	58	11	)	)	PUNCT
bjp-26620	58	12	was	be	AUX
bjp-26620	58	13	used	use	VERB
bjp-26620	58	14	for	for	ADP
bjp-26620	58	15	detection	detection	NOUN
bjp-26620	58	16	of	of	ADP
bjp-26620	58	17	the	the	DET
bjp-26620	58	18	blots	blot	NOUN
bjp-26620	58	19	and	and	CCONJ
bjp-26620	58	20	analysis	analysis	NOUN
bjp-26620	58	21	was	be	AUX
bjp-26620	58	22	performed	perform	VERB
bjp-26620	58	23	using	use	VERB
bjp-26620	58	24	quantity	quantity	NOUN
bjp-26620	58	25	one	one	NUM
bjp-26620	58	26	1d	1d	NUM
bjp-26620	58	27	analysis	analysis	NOUN
bjp-26620	58	28	software	software	NOUN
bjp-26620	58	29	(	(	PUNCT
bjp-26620	58	30	version	version	NOUN
bjp-26620	58	31	4.4	4.4	NUM
bjp-26620	58	32	;	;	PUNCT
bjp-26620	58	33	biorad	biorad	NOUN
bjp-26620	58	34	)	)	PUNCT
bjp-26620	58	35	.	.	PUNCT
bjp-26620	59	1	616	616	NUM
bjp-26620	59	2	bangladesh	bangladesh	NOUN
bjp-26620	59	3	j	j	PROPN
bjp-26620	59	4	pharmacol	pharmacol	PROPN
bjp-26620	59	5	2016	2016	NUM
bjp-26620	59	6	;	;	PUNCT
bjp-26620	59	7	11	11	NUM
bjp-26620	59	8	:	:	PUNCT
bjp-26620	59	9	615	615	NUM
bjp-26620	59	10	-	-	SYM
bjp-26620	59	11	620	620	NUM
bjp-26620	59	12	https://youtube.com/v/vzewcemjrja	https://youtube.com/v/vzewcemjrja	PROPN
bjp-26620	59	13	statistical	statistical	ADJ
bjp-26620	59	14	analysis	analysis	NOUN
bjp-26620	59	15	the	the	DET
bjp-26620	59	16	data	datum	NOUN
bjp-26620	59	17	presented	present	VERB
bjp-26620	59	18	as	as	ADP
bjp-26620	59	19	the	the	DET
bjp-26620	59	20	mean	mean	PROPN
bjp-26620	59	21	±	±	NOUN
bjp-26620	59	22	standard	standard	NOUN
bjp-26620	59	23	error	error	NOUN
bjp-26620	59	24	of	of	ADP
bjp-26620	59	25	the	the	DET
bjp-26620	59	26	mean	mean	NOUN
bjp-26620	59	27	(	(	PUNCT
bjp-26620	59	28	sem	sem	NOUN
bjp-26620	59	29	)	)	PUNCT
bjp-26620	59	30	.	.	PUNCT
bjp-26620	60	1	the	the	DET
bjp-26620	60	2	data	data	NOUN
bjp-26620	60	3	analysis	analysis	NOUN
bjp-26620	60	4	for	for	ADP
bjp-26620	60	5	statistical	statistical	ADJ
bjp-26620	60	6	significance	significance	NOUN
bjp-26620	60	7	was	be	AUX
bjp-26620	60	8	performed	perform	VERB
bjp-26620	60	9	using	use	VERB
bjp-26620	60	10	an	an	DET
bjp-26620	60	11	analysis	analysis	NOUN
bjp-26620	60	12	of	of	ADP
bjp-26620	60	13	variance	variance	NOUN
bjp-26620	60	14	(	(	PUNCT
bjp-26620	60	15	anova	anova	PROPN
bjp-26620	60	16	)	)	PUNCT
bjp-26620	60	17	.	.	PUNCT
bjp-26620	61	1	the	the	DET
bjp-26620	61	2	statistically	statistically	ADV
bjp-26620	61	3	significant	significant	ADJ
bjp-26620	61	4	differences	difference	NOUN
bjp-26620	61	5	were	be	AUX
bjp-26620	61	6	considered	consider	VERB
bjp-26620	61	7	at	at	ADP
bjp-26620	61	8	p<0.05	p<0.05	NOUN
bjp-26620	61	9	.	.	PUNCT
bjp-26620	62	1	results	result	NOUN
bjp-26620	62	2	bryostatin	bryostatin	VERB
bjp-26620	62	3	i	i	PRON
bjp-26620	62	4	inhibits	inhibit	VERB
bjp-26620	62	5	expression	expression	NOUN
bjp-26620	62	6	of	of	ADP
bjp-26620	62	7	synuclein	synuclein	NOUN
bjp-26620	62	8	-	-	PUNCT
bjp-26620	62	9	a	a	DET
bjp-26620	62	10	bryostatin	bryostatin	NOUN
bjp-26620	62	11	i	i	PRON
bjp-26620	62	12	treatment	treatment	NOUN
bjp-26620	62	13	of	of	ADP
bjp-26620	62	14	h3922	h3922	PROPN
bjp-26620	62	15	breast	breast	NOUN
bjp-26620	62	16	cancer	cancer	NOUN
bjp-26620	62	17	cells	cell	NOUN
bjp-26620	62	18	led	lead	VERB
bjp-26620	62	19	to	to	ADP
bjp-26620	62	20	the	the	DET
bjp-26620	62	21	inhibition	inhibition	NOUN
bjp-26620	62	22	of	of	ADP
bjp-26620	62	23	synuclein	synuclein	NOUN
bjp-26620	62	24	-	-	PUNCT
bjp-26620	62	25	a	a	DET
bjp-26620	62	26	expression	expression	NOUN
bjp-26620	62	27	in	in	ADP
bjp-26620	62	28	a	a	DET
bjp-26620	62	29	concentration	concentration	NOUN
bjp-26620	62	30	dependent	dependent	ADJ
bjp-26620	62	31	manner	manner	NOUN
bjp-26620	62	32	.	.	PUNCT
bjp-26620	63	1	h3922	h3922	PROPN
bjp-26620	63	2	cells	cell	NOUN
bjp-26620	63	3	were	be	AUX
bjp-26620	63	4	incubated	incubate	VERB
bjp-26620	63	5	with	with	ADP
bjp-26620	63	6	5	5	NUM
bjp-26620	63	7	,	,	PUNCT
bjp-26620	63	8	10	10	NUM
bjp-26620	63	9	,	,	PUNCT
bjp-26620	63	10	15	15	NUM
bjp-26620	63	11	,	,	PUNCT
bjp-26620	63	12	20	20	NUM
bjp-26620	63	13	,	,	PUNCT
bjp-26620	63	14	25	25	NUM
bjp-26620	63	15	and	and	CCONJ
bjp-26620	63	16	30	30	NUM
bjp-26620	63	17	µm	µm	ADP
bjp-26620	63	18	concentrations	concentration	NOUN
bjp-26620	63	19	of	of	ADP
bjp-26620	63	20	bryostatin	bryostatin	PROPN
bjp-26620	63	21	i	i	PRON
bjp-26620	63	22	for	for	ADP
bjp-26620	63	23	48	48	NUM
bjp-26620	63	24	hours	hour	NOUN
bjp-26620	63	25	.	.	PUNCT
bjp-26620	64	1	the	the	DET
bjp-26620	64	2	results	result	NOUN
bjp-26620	64	3	from	from	ADP
bjp-26620	64	4	western	western	ADJ
bjp-26620	64	5	blot	blot	NOUN
bjp-26620	64	6	analysis	analysis	NOUN
bjp-26620	64	7	revealed	reveal	VERB
bjp-26620	64	8	a	a	DET
bjp-26620	64	9	significant	significant	ADJ
bjp-26620	64	10	(	(	PUNCT
bjp-26620	64	11	p<0.005	p<0.005	NOUN
bjp-26620	64	12	)	)	PUNCT
bjp-26620	64	13	reduction	reduction	NOUN
bjp-26620	64	14	in	in	ADP
bjp-26620	64	15	the	the	DET
bjp-26620	64	16	expression	expression	NOUN
bjp-26620	64	17	of	of	ADP
bjp-26620	64	18	synuclein	synuclein	NOUN
bjp-26620	64	19	-	-	PUNCT
bjp-26620	64	20	a	a	NOUN
bjp-26620	64	21	from	from	ADP
bjp-26620	64	22	a	a	DET
bjp-26620	64	23	concentration	concentration	NOUN
bjp-26620	64	24	of	of	ADP
bjp-26620	64	25	20	20	NUM
bjp-26620	64	26	µm	µm	NOUN
bjp-26620	64	27	in	in	ADP
bjp-26620	64	28	h3922	h3922	PROPN
bjp-26620	64	29	cells	cell	NOUN
bjp-26620	64	30	(	(	PUNCT
bjp-26620	64	31	figure	figure	NOUN
bjp-26620	64	32	1	1	NUM
bjp-26620	64	33	)	)	PUNCT
bjp-26620	64	34	.	.	PUNCT
bjp-26620	65	1	the	the	DET
bjp-26620	65	2	inhibitory	inhibitory	ADJ
bjp-26620	65	3	effect	effect	NOUN
bjp-26620	65	4	of	of	ADP
bjp-26620	65	5	bryostatin	bryostatin	VERB
bjp-26620	65	6	i	i	PRON
bjp-26620	65	7	on	on	ADP
bjp-26620	65	8	synuclein	synuclein	NOUN
bjp-26620	65	9	-	-	PUNCT
bjp-26620	65	10	a	a	DET
bjp-26620	65	11	expression	expression	NOUN
bjp-26620	65	12	was	be	AUX
bjp-26620	65	13	further	far	ADV
bjp-26620	65	14	confirmed	confirm	VERB
bjp-26620	65	15	by	by	ADP
bjp-26620	65	16	the	the	DET
bjp-26620	65	17	treatment	treatment	NOUN
bjp-26620	65	18	with	with	ADP
bjp-26620	65	19	known	know	VERB
bjp-26620	65	20	synuclein	synuclein	NOUN
bjp-26620	65	21	-	-	PUNCT
bjp-26620	65	22	a	a	DET
bjp-26620	65	23	inhibitor	inhibitor	NOUN
bjp-26620	65	24	,	,	PUNCT
bjp-26620	65	25	cytokine	cytokine	VERB
bjp-26620	65	26	oncostatin	oncostatin	NOUN
bjp-26620	65	27	m.	m.	NOUN
bjp-26620	65	28	treatment	treatment	NOUN
bjp-26620	65	29	of	of	ADP
bjp-26620	65	30	the	the	DET
bjp-26620	65	31	h3922	h3922	PROPN
bjp-26620	65	32	cells	cell	NOUN
bjp-26620	65	33	with	with	ADP
bjp-26620	65	34	0.5	0.5	NUM
bjp-26620	65	35	µm	µm	ADP
bjp-26620	65	36	concentration	concentration	NOUN
bjp-26620	65	37	of	of	ADP
bjp-26620	65	38	cytokine	cytokine	ADJ
bjp-26620	65	39	oncostatin	oncostatin	NOUN
bjp-26620	65	40	m	m	AUX
bjp-26620	65	41	led	lead	VERB
bjp-26620	65	42	to	to	ADP
bjp-26620	65	43	a	a	DET
bjp-26620	65	44	significant	significant	ADJ
bjp-26620	65	45	reduction	reduction	NOUN
bjp-26620	65	46	in	in	ADP
bjp-26620	65	47	the	the	DET
bjp-26620	65	48	expression	expression	NOUN
bjp-26620	65	49	of	of	ADP
bjp-26620	65	50	synuclein	synuclein	NOUN
bjp-26620	65	51	-	-	PUNCT
bjp-26620	65	52	a.	a.	NOUN
bjp-26620	65	53	bryostatin	bryostatin	PROPN
bjp-26620	65	54	i	i	PRON
bjp-26620	65	55	increases	increase	VERB
bjp-26620	65	56	the	the	DET
bjp-26620	65	57	sensitivity	sensitivity	NOUN
bjp-26620	65	58	of	of	ADP
bjp-26620	65	59	h3922	h3922	PROPN
bjp-26620	65	60	cells	cell	NOUN
bjp-26620	65	61	to	to	PART
bjp-26620	65	62	taxol	taxol	VERB
bjp-26620	65	63	the	the	DET
bjp-26620	65	64	results	result	NOUN
bjp-26620	65	65	from	from	ADP
bjp-26620	65	66	western	western	ADJ
bjp-26620	65	67	blot	blot	NOUN
bjp-26620	65	68	analysis	analysis	NOUN
bjp-26620	65	69	showed	show	VERB
bjp-26620	65	70	that	that	SCONJ
bjp-26620	65	71	treatment	treatment	NOUN
bjp-26620	65	72	of	of	ADP
bjp-26620	65	73	h3922	h3922	PROPN
bjp-26620	65	74	cells	cell	NOUN
bjp-26620	65	75	with	with	ADP
bjp-26620	65	76	bryostatin	bryostatin	PROPN
bjp-26620	65	77	i	i	PRON
bjp-26620	65	78	significantly	significantly	ADV
bjp-26620	65	79	increased	increase	VERB
bjp-26620	65	80	their	their	PRON
bjp-26620	65	81	sensitivity	sensitivity	NOUN
bjp-26620	65	82	to	to	ADP
bjp-26620	65	83	taxol	taxol	PROPN
bjp-26620	65	84	.	.	PUNCT
bjp-26620	66	1	incubation	incubation	NOUN
bjp-26620	66	2	of	of	ADP
bjp-26620	66	3	h3922	h3922	PROPN
bjp-26620	66	4	cells	cell	NOUN
bjp-26620	66	5	with	with	ADP
bjp-26620	66	6	25	25	NUM
bjp-26620	66	7	µm	µm	ADP
bjp-26620	66	8	concentration	concentration	NOUN
bjp-26620	66	9	of	of	ADP
bjp-26620	66	10	bryostatin	bryostatin	PROPN
bjp-26620	66	11	i	i	PRON
bjp-26620	66	12	followed	follow	VERB
bjp-26620	66	13	by	by	ADP
bjp-26620	66	14	treatment	treatment	NOUN
bjp-26620	66	15	with	with	ADP
bjp-26620	66	16	0.5	0.5	NUM
bjp-26620	66	17	μm	μm	NOUN
bjp-26620	66	18	concentration	concentration	NOUN
bjp-26620	66	19	of	of	ADP
bjp-26620	66	20	taxol	taxol	NOUN
bjp-26620	66	21	induced	induce	VERB
bjp-26620	66	22	apoptosis	apoptosis	NOUN
bjp-26620	66	23	in	in	ADP
bjp-26620	66	24	89	89	NUM
bjp-26620	66	25	%	%	NOUN
bjp-26620	66	26	cells	cell	NOUN
bjp-26620	66	27	compared	compare	VERB
bjp-26620	66	28	to	to	ADP
bjp-26620	66	29	9	9	NUM
bjp-26620	66	30	%	%	NOUN
bjp-26620	66	31	cells	cell	NOUN
bjp-26620	66	32	in	in	ADP
bjp-26620	66	33	the	the	DET
bjp-26620	66	34	taxol	taxol	PROPN
bjp-26620	66	35	treated	treat	VERB
bjp-26620	66	36	cultures	culture	NOUN
bjp-26620	66	37	(	(	PUNCT
bjp-26620	66	38	figure	figure	NOUN
bjp-26620	66	39	2	2	NUM
bjp-26620	66	40	)	)	PUNCT
bjp-26620	66	41	.	.	PUNCT
bjp-26620	67	1	effect	effect	NOUN
bjp-26620	67	2	of	of	ADP
bjp-26620	67	3	bryostatin	bryostatin	VERB
bjp-26620	67	4	i	i	PRON
bjp-26620	67	5	on	on	ADP
bjp-26620	67	6	viability	viability	NOUN
bjp-26620	67	7	of	of	ADP
bjp-26620	67	8	h3922	h3922	PROPN
bjp-26620	67	9	cells	cell	NOUN
bjp-26620	67	10	treatment	treatment	NOUN
bjp-26620	67	11	of	of	ADP
bjp-26620	67	12	h3922	h3922	PROPN
bjp-26620	67	13	cells	cell	NOUN
bjp-26620	67	14	with	with	ADP
bjp-26620	67	15	bryostatin	bryostatin	PROPN
bjp-26620	67	16	i	i	PRON
bjp-26620	67	17	for	for	ADP
bjp-26620	67	18	48	48	NUM
bjp-26620	67	19	hours	hour	NOUN
bjp-26620	67	20	showed	show	VERB
bjp-26620	67	21	reduction	reduction	NOUN
bjp-26620	67	22	in	in	ADP
bjp-26620	67	23	the	the	DET
bjp-26620	67	24	cell	cell	NOUN
bjp-26620	67	25	viability	viability	NOUN
bjp-26620	67	26	in	in	ADP
bjp-26620	67	27	concentration	concentration	NOUN
bjp-26620	67	28	dependent	dependent	ADJ
bjp-26620	67	29	manner	manner	NOUN
bjp-26620	67	30	.	.	PUNCT
bjp-26620	68	1	the	the	DET
bjp-26620	68	2	cells	cell	NOUN
bjp-26620	68	3	were	be	AUX
bjp-26620	68	4	incubated	incubate	VERB
bjp-26620	68	5	with	with	ADP
bjp-26620	68	6	various	various	ADJ
bjp-26620	68	7	concentrations	concentration	NOUN
bjp-26620	68	8	(	(	PUNCT
bjp-26620	68	9	5	5	NUM
bjp-26620	68	10	,	,	PUNCT
bjp-26620	68	11	10	10	NUM
bjp-26620	68	12	,	,	PUNCT
bjp-26620	68	13	20	20	NUM
bjp-26620	68	14	,	,	PUNCT
bjp-26620	68	15	25	25	NUM
bjp-26620	68	16	and	and	CCONJ
bjp-26620	68	17	30	30	NUM
bjp-26620	68	18	µm	µm	NOUN
bjp-26620	68	19	)	)	PUNCT
bjp-26620	68	20	of	of	ADP
bjp-26620	68	21	bryostatin	bryostatin	VERB
bjp-26620	68	22	i	i	PRON
bjp-26620	68	23	for	for	ADP
bjp-26620	68	24	48	48	NUM
bjp-26620	68	25	hours	hour	NOUN
bjp-26620	68	26	and	and	CCONJ
bjp-26620	68	27	then	then	ADV
bjp-26620	68	28	examined	examine	VERB
bjp-26620	68	29	using	use	VERB
bjp-26620	68	30	mtt	mtt	NOUN
bjp-26620	68	31	assay	assay	NOUN
bjp-26620	68	32	.	.	PUNCT
bjp-26620	69	1	the	the	DET
bjp-26620	69	2	results	result	NOUN
bjp-26620	69	3	showed	show	VERB
bjp-26620	69	4	a	a	DET
bjp-26620	69	5	significant	significant	ADJ
bjp-26620	69	6	decrease	decrease	NOUN
bjp-26620	69	7	in	in	ADP
bjp-26620	69	8	the	the	DET
bjp-26620	69	9	cell	cell	NOUN
bjp-26620	69	10	viability	viability	NOUN
bjp-26620	69	11	from	from	ADP
bjp-26620	69	12	10	10	NUM
bjp-26620	69	13	µm	µm	ADP
bjp-26620	69	14	concentration	concentration	NOUN
bjp-26620	69	15	of	of	ADP
bjp-26620	69	16	bryostatin	bryostatin	PROPN
bjp-26620	69	17	i.	i.	PROPN
bjp-26620	69	18	the	the	DET
bjp-26620	69	19	cell	cell	NOUN
bjp-26620	69	20	viability	viability	NOUN
bjp-26620	69	21	was	be	AUX
bjp-26620	69	22	reduced	reduce	VERB
bjp-26620	69	23	to	to	ADP
bjp-26620	69	24	2.5	2.5	NUM
bjp-26620	69	25	,	,	PUNCT
bjp-26620	69	26	12.6	12.6	NUM
bjp-26620	69	27	,	,	PUNCT
bjp-26620	69	28	34.1	34.1	NUM
bjp-26620	69	29	,	,	PUNCT
bjp-26620	69	30	59.9	59.9	NUM
bjp-26620	69	31	and	and	CCONJ
bjp-26620	69	32	87.2	87.2	NUM
bjp-26620	69	33	%	%	NOUN
bjp-26620	69	34	on	on	ADP
bjp-26620	69	35	treatment	treatment	NOUN
bjp-26620	69	36	with	with	ADP
bjp-26620	69	37	5	5	NUM
bjp-26620	69	38	,	,	PUNCT
bjp-26620	69	39	10	10	NUM
bjp-26620	69	40	,	,	PUNCT
bjp-26620	69	41	20	20	NUM
bjp-26620	69	42	,	,	PUNCT
bjp-26620	69	43	25	25	NUM
bjp-26620	69	44	and	and	CCONJ
bjp-26620	69	45	30	30	NUM
bjp-26620	69	46	µm	µm	ADP
bjp-26620	69	47	concentration	concentration	NOUN
bjp-26620	69	48	of	of	ADP
bjp-26620	69	49	bryostatin	bryostatin	PROPN
bjp-26620	69	50	i	i	PRON
bjp-26620	69	51	for	for	ADP
bjp-26620	69	52	48	48	NUM
bjp-26620	69	53	hours	hour	NOUN
bjp-26620	69	54	compared	compare	VERB
bjp-26620	69	55	to	to	ADP
bjp-26620	69	56	2.0	2.0	NUM
bjp-26620	69	57	%	%	NOUN
bjp-26620	69	58	in	in	ADP
bjp-26620	69	59	the	the	DET
bjp-26620	69	60	control	control	NOUN
bjp-26620	69	61	(	(	PUNCT
bjp-26620	69	62	figure	figure	NOUN
bjp-26620	69	63	3	3	NUM
bjp-26620	69	64	)	)	PUNCT
bjp-26620	69	65	.	.	PUNCT
bjp-26620	70	1	effect	effect	NOUN
bjp-26620	70	2	of	of	ADP
bjp-26620	70	3	bryostatin	bryostatin	VERB
bjp-26620	70	4	i	i	PRON
bjp-26620	70	5	on	on	ADP
bjp-26620	70	6	activation	activation	NOUN
bjp-26620	70	7	of	of	ADP
bjp-26620	70	8	histone	histone	NOUN
bjp-26620	70	9	h1	h1	NOUN
bjp-26620	70	10	protein	protein	NOUN
bjp-26620	70	11	0	0	NUM
bjp-26620	70	12	5	5	NUM
bjp-26620	70	13	10	10	NUM
bjp-26620	70	14	15	15	NUM
bjp-26620	70	15	20	20	NUM
bjp-26620	70	16	30	30	NUM
bjp-26620	70	17	(	(	PUNCT
bjp-26620	70	18	µm	µm	NOUN
bjp-26620	70	19	)	)	PUNCT
bjp-26620	70	20	cytokine	cytokine	NOUN
bjp-26620	70	21	bryostatin	bryostatin	NOUN
bjp-26620	70	22	i	i	PRON
bjp-26620	70	23	synuclein	synuclein	VERB
bjp-26620	70	24	a	a	DET
bjp-26620	70	25	β	β	NOUN
bjp-26620	70	26	-	-	PUNCT
bjp-26620	70	27	actin	actin	ADJ
bjp-26620	70	28	figure	figure	NOUN
bjp-26620	70	29	1	1	NUM
bjp-26620	70	30	:	:	PUNCT
bjp-26620	70	31	inhibition	inhibition	NOUN
bjp-26620	70	32	of	of	ADP
bjp-26620	70	33	synuclein	synuclein	NOUN
bjp-26620	70	34	-	-	PUNCT
bjp-26620	70	35	a	a	DET
bjp-26620	70	36	expression	expression	NOUN
bjp-26620	70	37	by	by	ADP
bjp-26620	70	38	bryostatin	bryostatin	NOUN
bjp-26620	70	39	i	i	PRON
bjp-26620	70	40	treatment	treatment	NOUN
bjp-26620	70	41	in	in	ADP
bjp-26620	70	42	h3922	h3922	PROPN
bjp-26620	70	43	breast	breast	NOUN
bjp-26620	70	44	cancer	cancer	NOUN
bjp-26620	70	45	cells	cell	NOUN
bjp-26620	70	46	in	in	ADP
bjp-26620	70	47	a	a	DET
bjp-26620	70	48	concentration	concentration	NOUN
bjp-26620	70	49	dependent	dependent	ADJ
bjp-26620	70	50	manner	manner	NOUN
bjp-26620	70	51	.	.	PUNCT
bjp-26620	71	1	cytokine	cytokine	VERB
bjp-26620	71	2	oncostatin	oncostatin	NOUN
bjp-26620	71	3	m	m	VERB
bjp-26620	71	4	also	also	ADV
bjp-26620	71	5	inhibits	inhibit	VERB
bjp-26620	71	6	the	the	DET
bjp-26620	71	7	expression	expression	NOUN
bjp-26620	71	8	of	of	ADP
bjp-26620	71	9	synuclein	synuclein	NOUN
bjp-26620	71	10	-	-	PUNCT
bjp-26620	71	11	a	a	NOUN
bjp-26620	71	12	in	in	ADP
bjp-26620	71	13	h3922	h3922	PROPN
bjp-26620	71	14	cells	cell	NOUN
bjp-26620	71	15	.	.	PUNCT
bjp-26620	72	1	the	the	DET
bjp-26620	72	2	cells	cell	NOUN
bjp-26620	72	3	were	be	AUX
bjp-26620	72	4	treated	treat	VERB
bjp-26620	72	5	with	with	ADP
bjp-26620	72	6	5	5	NUM
bjp-26620	72	7	,	,	PUNCT
bjp-26620	72	8	10	10	NUM
bjp-26620	72	9	,	,	PUNCT
bjp-26620	72	10	20	20	NUM
bjp-26620	72	11	,	,	PUNCT
bjp-26620	72	12	25	25	NUM
bjp-26620	72	13	and	and	CCONJ
bjp-26620	72	14	30	30	NUM
bjp-26620	72	15	µm	µm	ADP
bjp-26620	72	16	concentrations	concentration	NOUN
bjp-26620	72	17	of	of	ADP
bjp-26620	72	18	bryostatin	bryostatin	PROPN
bjp-26620	72	19	i	i	PRON
bjp-26620	72	20	and	and	CCONJ
bjp-26620	72	21	0.5	0.5	NUM
bjp-26620	72	22	µm	µm	ADP
bjp-26620	72	23	concentration	concentration	NOUN
bjp-26620	72	24	of	of	ADP
bjp-26620	72	25	cytokine	cytokine	ADJ
bjp-26620	72	26	oncostatin	oncostatin	NOUN
bjp-26620	72	27	m	m	NOUN
bjp-26620	72	28	for	for	ADP
bjp-26620	72	29	48	48	NUM
bjp-26620	72	30	hours	hour	NOUN
bjp-26620	72	31	and	and	CCONJ
bjp-26620	72	32	then	then	ADV
bjp-26620	72	33	examined	examine	VERB
bjp-26620	72	34	by	by	ADP
bjp-26620	72	35	western	western	ADJ
bjp-26620	72	36	blot	blot	NOUN
bjp-26620	72	37	assay	assay	NOUN
bjp-26620	72	38	control	control	NOUN
bjp-26620	72	39	104	104	NUM
bjp-26620	72	40	103	103	NUM
bjp-26620	72	41	102	102	NUM
bjp-26620	73	1	101	101	NUM
bjp-26620	73	2	p	p	NOUN
bjp-26620	73	3	1	1	NUM
bjp-26620	73	4	101	101	NUM
bjp-26620	73	5	102	102	NUM
bjp-26620	73	6	103	103	NUM
bjp-26620	73	7	104	104	NUM
bjp-26620	73	8	taxol	taxol	NOUN
bjp-26620	73	9	104	104	NUM
bjp-26620	73	10	103	103	NUM
bjp-26620	73	11	102	102	NUM
bjp-26620	73	12	101	101	NUM
bjp-26620	73	13	p	p	NOUN
bjp-26620	73	14	1	1	NUM
bjp-26620	73	15	101	101	NUM
bjp-26620	73	16	102	102	NUM
bjp-26620	73	17	103	103	NUM
bjp-26620	73	18	104	104	NUM
bjp-26620	73	19	bro	bro	NOUN
bjp-26620	73	20	+	+	CCONJ
bjp-26620	73	21	taxol	taxol	PROPN
bjp-26620	73	22	104	104	NUM
bjp-26620	73	23	103	103	NUM
bjp-26620	73	24	102	102	NUM
bjp-26620	73	25	101	101	NUM
bjp-26620	73	26	p	p	NOUN
bjp-26620	73	27	1	1	NUM
bjp-26620	73	28	101	101	NUM
bjp-26620	73	29	102	102	NUM
bjp-26620	73	30	103	103	NUM
bjp-26620	73	31	104	104	NUM
bjp-26620	73	32	taxol	taxol	NOUN
bjp-26620	73	33	104	104	NUM
bjp-26620	73	34	103	103	NUM
bjp-26620	73	35	102	102	NUM
bjp-26620	73	36	101	101	NUM
bjp-26620	73	37	p	p	NOUN
bjp-26620	73	38	1	1	NUM
bjp-26620	73	39	101	101	NUM
bjp-26620	73	40	102	102	NUM
bjp-26620	73	41	103	103	NUM
bjp-26620	73	42	104	104	NUM
bjp-26620	73	43	annexin	annexin	NOUN
bjp-26620	73	44	v	v	ADP
bjp-26620	73	45	100	100	NUM
bjp-26620	73	46	80	80	NUM
bjp-26620	73	47	60	60	NUM
bjp-26620	73	48	40	40	NUM
bjp-26620	73	49	20	20	NUM
bjp-26620	73	50	0	0	NUM
bjp-26620	73	51	control	control	NOUN
bjp-26620	73	52	taxol	taxol	PROPN
bjp-26620	73	53	bryo	bryo	PROPN
bjp-26620	73	54	bryo	bryo	PROPN
bjp-26620	73	55	+	+	CCONJ
bjp-26620	73	56	taxol	taxol	PROPN
bjp-26620	73	57	figure	figure	NOUN
bjp-26620	73	58	2	2	NUM
bjp-26620	73	59	:	:	PUNCT
bjp-26620	73	60	bryostatin	bryostatin	NOUN
bjp-26620	73	61	i	i	PRON
bjp-26620	73	62	increased	increase	VERB
bjp-26620	73	63	the	the	DET
bjp-26620	73	64	sensitivity	sensitivity	NOUN
bjp-26620	73	65	of	of	ADP
bjp-26620	73	66	h3922	h3922	PROPN
bjp-26620	73	67	cells	cell	NOUN
bjp-26620	73	68	to	to	ADP
bjp-26620	73	69	taxol	taxol	PROPN
bjp-26620	73	70	.	.	PUNCT
bjp-26620	74	1	the	the	DET
bjp-26620	74	2	cells	cell	NOUN
bjp-26620	74	3	after	after	ADP
bjp-26620	74	4	incubation	incubation	NOUN
bjp-26620	74	5	with	with	ADP
bjp-26620	74	6	taxol	taxol	PROPN
bjp-26620	74	7	alone	alone	ADJ
bjp-26620	74	8	or	or	CCONJ
bjp-26620	74	9	pre	pre	ADJ
bjp-26620	74	10	-	-	NOUN
bjp-26620	74	11	treatment	treatment	NOUN
bjp-26620	74	12	with	with	ADP
bjp-26620	74	13	bryostatin	bryostatin	PROPN
bjp-26620	74	14	i	i	PRON
bjp-26620	74	15	followed	follow	VERB
bjp-26620	74	16	by	by	ADP
bjp-26620	74	17	incubation	incubation	NOUN
bjp-26620	74	18	with	with	ADP
bjp-26620	74	19	taxol	taxol	PROPN
bjp-26620	74	20	were	be	AUX
bjp-26620	74	21	analyzed	analyze	VERB
bjp-26620	74	22	of	of	ADP
bjp-26620	74	23	apoptosis	apoptosis	NOUN
bjp-26620	74	24	induction	induction	NOUN
bjp-26620	74	25	a	a	DET
bjp-26620	74	26	po	po	NOUN
bjp-26620	74	27	pt	pt	INTJ
bjp-26620	74	28	os	os	NOUN
bjp-26620	74	29	is	be	AUX
bjp-26620	74	30	(	(	PUNCT
bjp-26620	74	31	%	%	NOUN
bjp-26620	74	32	)	)	PUNCT
bjp-26620	74	33	bangladesh	bangladesh	PROPN
bjp-26620	74	34	j	j	PROPN
bjp-26620	74	35	pharmacol	pharmacol	PROPN
bjp-26620	74	36	2016	2016	NUM
bjp-26620	74	37	;	;	PUNCT
bjp-26620	74	38	11	11	NUM
bjp-26620	74	39	:	:	PUNCT
bjp-26620	74	40	615	615	NUM
bjp-26620	74	41	-	-	SYM
bjp-26620	74	42	620	620	NUM
bjp-26620	74	43	617	617	NUM
bjp-26620	74	44	treatment	treatment	NOUN
bjp-26620	74	45	of	of	ADP
bjp-26620	74	46	the	the	DET
bjp-26620	74	47	h3922	h3922	PROPN
bjp-26620	74	48	cells	cell	NOUN
bjp-26620	74	49	with	with	ADP
bjp-26620	74	50	bryostatin	bryostatin	PROPN
bjp-26620	74	51	i	i	PRON
bjp-26620	74	52	at	at	ADP
bjp-26620	74	53	25	25	NUM
bjp-26620	74	54	µm	µm	ADP
bjp-26620	74	55	concentration	concentration	NOUN
bjp-26620	74	56	led	lead	VERB
bjp-26620	74	57	to	to	ADP
bjp-26620	74	58	a	a	DET
bjp-26620	74	59	significant	significant	ADJ
bjp-26620	74	60	(	(	PUNCT
bjp-26620	74	61	p<0.002	p<0.002	NOUN
bjp-26620	74	62	)	)	PUNCT
bjp-26620	74	63	increase	increase	NOUN
bjp-26620	74	64	in	in	ADP
bjp-26620	74	65	the	the	DET
bjp-26620	74	66	activation	activation	NOUN
bjp-26620	74	67	of	of	ADP
bjp-26620	74	68	the	the	DET
bjp-26620	74	69	histone	histone	NOUN
bjp-26620	74	70	h1	h1	PROPN
bjp-26620	74	71	protein	protein	NOUN
bjp-26620	74	72	.	.	PUNCT
bjp-26620	75	1	the	the	DET
bjp-26620	75	2	phosphorylation	phosphorylation	NOUN
bjp-26620	75	3	of	of	ADP
bjp-26620	75	4	the	the	DET
bjp-26620	75	5	histone	histone	NOUN
bjp-26620	75	6	h1	h1	NOUN
bjp-26620	75	7	was	be	AUX
bjp-26620	75	8	not	not	PART
bjp-26620	75	9	observed	observe	VERB
bjp-26620	75	10	in	in	ADP
bjp-26620	75	11	the	the	DET
bjp-26620	75	12	control	control	NOUN
bjp-26620	75	13	h3922	h3922	PROPN
bjp-26620	75	14	cells	cell	NOUN
bjp-26620	75	15	(	(	PUNCT
bjp-26620	75	16	figure	figure	NOUN
bjp-26620	75	17	4	4	NUM
bjp-26620	75	18	)	)	PUNCT
bjp-26620	75	19	.	.	PUNCT
bjp-26620	76	1	effect	effect	NOUN
bjp-26620	76	2	of	of	ADP
bjp-26620	76	3	bryostatin	bryostatin	VERB
bjp-26620	76	4	i	i	PRON
bjp-26620	76	5	on	on	ADP
bjp-26620	76	6	the	the	DET
bjp-26620	76	7	cell	cell	NOUN
bjp-26620	76	8	cycle	cycle	NOUN
bjp-26620	76	9	distribution	distribution	NOUN
bjp-26620	76	10	bryostatin	bryostatin	VERB
bjp-26620	76	11	i	i	PRON
bjp-26620	76	12	treatment	treatment	NOUN
bjp-26620	76	13	of	of	ADP
bjp-26620	76	14	h3922	h3922	PROPN
bjp-26620	76	15	cells	cell	NOUN
bjp-26620	76	16	at	at	ADP
bjp-26620	76	17	a	a	DET
bjp-26620	76	18	concentration	concentration	NOUN
bjp-26620	76	19	of	of	ADP
bjp-26620	76	20	25	25	NUM
bjp-26620	76	21	µm	µm	NOUN
bjp-26620	76	22	significantly	significantly	ADV
bjp-26620	76	23	(	(	PUNCT
bjp-26620	76	24	p<0.002	p<0.002	NOUN
bjp-26620	76	25	)	)	PUNCT
bjp-26620	76	26	enhanced	enhance	VERB
bjp-26620	76	27	the	the	DET
bjp-26620	76	28	population	population	NOUN
bjp-26620	76	29	of	of	ADP
bjp-26620	76	30	cells	cell	NOUN
bjp-26620	76	31	in	in	ADP
bjp-26620	76	32	the	the	DET
bjp-26620	76	33	g1	g1	PROPN
bjp-26620	76	34	phase	phase	NOUN
bjp-26620	76	35	compared	compare	VERB
bjp-26620	76	36	to	to	ADP
bjp-26620	76	37	the	the	DET
bjp-26620	76	38	control	control	NOUN
bjp-26620	76	39	cells	cell	NOUN
bjp-26620	76	40	.	.	PUNCT
bjp-26620	77	1	the	the	DET
bjp-26620	77	2	increase	increase	NOUN
bjp-26620	77	3	in	in	ADP
bjp-26620	77	4	population	population	NOUN
bjp-26620	77	5	of	of	ADP
bjp-26620	77	6	h3922	h3922	PROPN
bjp-26620	77	7	cells	cell	NOUN
bjp-26620	77	8	in	in	ADP
bjp-26620	77	9	the	the	DET
bjp-26620	77	10	g1	g1	PROPN
bjp-26620	77	11	phase	phase	NOUN
bjp-26620	77	12	was	be	AUX
bjp-26620	77	13	accompanied	accompany	VERB
bjp-26620	77	14	by	by	ADP
bjp-26620	77	15	a	a	DET
bjp-26620	77	16	simultaneous	simultaneous	ADJ
bjp-26620	77	17	reduction	reduction	NOUN
bjp-26620	77	18	in	in	ADP
bjp-26620	77	19	g2	g2	PROPN
bjp-26620	77	20	/	/	SYM
bjp-26620	77	21	m	m	PROPN
bjp-26620	77	22	phase	phase	NOUN
bjp-26620	77	23	.	.	PUNCT
bjp-26620	78	1	the	the	DET
bjp-26620	78	2	population	population	NOUN
bjp-26620	78	3	of	of	ADP
bjp-26620	78	4	h3922	h3922	PROPN
bjp-26620	78	5	cells	cell	NOUN
bjp-26620	78	6	in	in	ADP
bjp-26620	78	7	the	the	DET
bjp-26620	78	8	g1	g1	PROPN
bjp-26620	78	9	phase	phase	NOUN
bjp-26620	78	10	was	be	AUX
bjp-26620	78	11	increased	increase	VERB
bjp-26620	78	12	from	from	ADP
bjp-26620	78	13	34.8	34.8	NUM
bjp-26620	78	14	to	to	PART
bjp-26620	78	15	76.5	76.5	NUM
bjp-26620	78	16	%	%	NOUN
bjp-26620	78	17	while	while	SCONJ
bjp-26620	78	18	as	as	SCONJ
bjp-26620	78	19	that	that	PRON
bjp-26620	78	20	in	in	ADP
bjp-26620	78	21	the	the	DET
bjp-26620	78	22	g2	g2	PROPN
bjp-26620	78	23	/	/	SYM
bjp-26620	78	24	m	m	PROPN
bjp-26620	78	25	phase	phase	NOUN
bjp-26620	78	26	was	be	AUX
bjp-26620	78	27	decreased	decrease	VERB
bjp-26620	78	28	from	from	ADP
bjp-26620	78	29	58.3	58.3	NUM
bjp-26620	78	30	to	to	ADP
bjp-26620	78	31	11.6	11.6	NUM
bjp-26620	78	32	%	%	NOUN
bjp-26620	78	33	on	on	ADP
bjp-26620	78	34	treatment	treatment	NOUN
bjp-26620	78	35	with	with	ADP
bjp-26620	78	36	25	25	NUM
bjp-26620	78	37	µm	µm	ADP
bjp-26620	78	38	concentration	concentration	NOUN
bjp-26620	78	39	of	of	ADP
bjp-26620	78	40	bryostatin	bryostatin	PROPN
bjp-26620	78	41	i	i	PRON
bjp-26620	78	42	for	for	ADP
bjp-26620	78	43	48	48	NUM
bjp-26620	78	44	hours	hour	NOUN
bjp-26620	78	45	(	(	PUNCT
bjp-26620	78	46	figure	figure	NOUN
bjp-26620	78	47	5	5	NUM
bjp-26620	78	48	)	)	PUNCT
bjp-26620	78	49	.	.	PUNCT
bjp-26620	79	1	inhibition	inhibition	NOUN
bjp-26620	79	2	of	of	ADP
bjp-26620	79	3	mmp฀2	mmp฀2	PROPN
bjp-26620	79	4	and	and	CCONJ
bjp-26620	79	5	mmp฀9	mmp฀9	ADJ
bjp-26620	79	6	level	level	NOUN
bjp-26620	79	7	in	in	ADP
bjp-26620	79	8	h3922	h3922	PROPN
bjp-26620	79	9	cells	cell	NOUN
bjp-26620	79	10	by	by	ADP
bjp-26620	79	11	bryostatin	bryostatin	NOUN
bjp-26620	79	12	i	i	PRON
bjp-26620	79	13	bryostatin	bryostatin	VERB
bjp-26620	79	14	i	i	PRON
bjp-26620	79	15	treatment	treatment	NOUN
bjp-26620	79	16	significantly	significantly	ADV
bjp-26620	79	17	inhibits	inhibit	VERB
bjp-26620	79	18	the	the	DET
bjp-26620	79	19	expression	expression	NOUN
bjp-26620	79	20	of	of	ADP
bjp-26620	79	21	mmp-2	mmp-2	NUM
bjp-26620	79	22	and	and	CCONJ
bjp-26620	79	23	mmp-9	mmp-9	ADJ
bjp-26620	79	24	inh3922	inh3922	NOUN
bjp-26620	79	25	cells	cell	NOUN
bjp-26620	79	26	.	.	PUNCT
bjp-26620	80	1	gelatin	gelatin	NOUN
bjp-26620	80	2	zymography	zymography	PROPN
bjp-26620	80	3	revealed	reveal	VERB
bjp-26620	80	4	that	that	SCONJ
bjp-26620	80	5	the	the	DET
bjp-26620	80	6	expression	expression	NOUN
bjp-26620	80	7	of	of	ADP
bjp-26620	80	8	mmp-2	mmp-2	DET
bjp-26620	80	9	activity	activity	NOUN
bjp-26620	80	10	was	be	AUX
bjp-26620	80	11	reduced	reduce	VERB
bjp-26620	80	12	from	from	ADP
bjp-26620	80	13	64.2	64.2	NUM
bjp-26620	80	14	±	±	NUM
bjp-26620	80	15	4.3	4.3	NUM
bjp-26620	80	16	to	to	ADP
bjp-26620	80	17	16.3	16.3	NUM
bjp-26620	80	18	±	±	NUM
bjp-26620	80	19	2.7	2.7	NUM
bjp-26620	80	20	%	%	NOUN
bjp-26620	80	21	with	with	ADP
bjp-26620	80	22	the	the	DET
bjp-26620	80	23	increase	increase	NOUN
bjp-26620	80	24	in	in	ADP
bjp-26620	80	25	concentration	concentration	NOUN
bjp-26620	80	26	of	of	ADP
bjp-26620	80	27	bryostatin	bryostatin	PROPN
bjp-26620	80	28	i	i	PRON
bjp-26620	80	29	from	from	ADP
bjp-26620	80	30	5	5	NUM
bjp-26620	80	31	and	and	CCONJ
bjp-26620	80	32	25	25	NUM
bjp-26620	80	33	µm	µm	NOUN
bjp-26620	80	34	.	.	PUNCT
bjp-26620	81	1	similarly	similarly	ADV
bjp-26620	81	2	,	,	PUNCT
bjp-26620	81	3	the	the	DET
bjp-26620	81	4	level	level	NOUN
bjp-26620	81	5	of	of	ADP
bjp-26620	81	6	mmp-9	mmp-9	NOUN
bjp-26620	81	7	was	be	AUX
bjp-26620	81	8	found	find	VERB
bjp-26620	81	9	to	to	PART
bjp-26620	81	10	be	be	AUX
bjp-26620	81	11	69.5	69.5	NUM
bjp-26620	81	12	±	±	NUM
bjp-26620	81	13	5.1	5.1	NUM
bjp-26620	81	14	and	and	CCONJ
bjp-26620	81	15	37.8	37.8	NUM
bjp-26620	81	16	±	±	NUM
bjp-26620	81	17	3.4	3.4	NUM
bjp-26620	81	18	%	%	NOUN
bjp-26620	81	19	at	at	ADP
bjp-26620	81	20	5	5	NUM
bjp-26620	81	21	and	and	CCONJ
bjp-26620	81	22	25	25	NUM
bjp-26620	81	23	µm	µm	ADP
bjp-26620	81	24	concentrations	concentration	NOUN
bjp-26620	81	25	of	of	ADP
bjp-26620	81	26	bryostatin	bryostatin	PROPN
bjp-26620	81	27	i	i	PRON
bjp-26620	81	28	,	,	PUNCT
bjp-26620	81	29	respectively	respectively	ADV
bjp-26620	81	30	(	(	PUNCT
bjp-26620	81	31	figure	figure	NOUN
bjp-26620	81	32	6	6	NUM
bjp-26620	81	33	)	)	PUNCT
bjp-26620	81	34	.	.	PUNCT
bjp-26620	82	1	discussion	discussion	NOUN
bjp-26620	82	2	the	the	DET
bjp-26620	82	3	current	current	ADJ
bjp-26620	82	4	study	study	NOUN
bjp-26620	82	5	demonstrates	demonstrate	VERB
bjp-26620	82	6	the	the	DET
bjp-26620	82	7	effect	effect	NOUN
bjp-26620	82	8	of	of	ADP
bjp-26620	82	9	bryostatin	bryostatin	VERB
bjp-26620	82	10	i	i	PRON
bjp-26620	82	11	on	on	ADP
bjp-26620	82	12	the	the	DET
bjp-26620	82	13	viability	viability	NOUN
bjp-26620	82	14	of	of	ADP
bjp-26620	82	15	h3922	h3922	PROPN
bjp-26620	82	16	breast	breast	NOUN
bjp-26620	82	17	cancer	cancer	NOUN
bjp-26620	82	18	cells	cell	NOUN
bjp-26620	82	19	.	.	PUNCT
bjp-26620	83	1	bryostatin	bryostatin	VERB
bjp-26620	83	2	i	i	PRON
bjp-26620	83	3	treatment	treatment	NOUN
bjp-26620	83	4	caused	cause	VERB
bjp-26620	83	5	inhibition	inhibition	NOUN
bjp-26620	83	6	of	of	ADP
bjp-26620	83	7	h3922	h3922	PROPN
bjp-26620	83	8	cell	cell	NOUN
bjp-26620	83	9	viability	viability	NOUN
bjp-26620	83	10	through	through	ADP
bjp-26620	83	11	suppression	suppression	NOUN
bjp-26620	83	12	of	of	ADP
bjp-26620	83	13	synuclein	synuclein	NOUN
bjp-26620	83	14	-	-	PUNCT
bjp-26620	83	15	a	a	DET
bjp-26620	83	16	expression	expression	NOUN
bjp-26620	83	17	and	and	CCONJ
bjp-26620	83	18	induction	induction	NOUN
bjp-26620	83	19	of	of	ADP
bjp-26620	83	20	apoptosis	apoptosis	NOUN
bjp-26620	83	21	.	.	PUNCT
bjp-26620	84	1	synuclein	synuclein	NOUN
bjp-26620	84	2	-	-	PUNCT
bjp-26620	84	3	a	a	PRON
bjp-26620	84	4	is	be	AUX
bjp-26620	84	5	an	an	DET
bjp-26620	84	6	oncogenic	oncogenic	ADJ
bjp-26620	84	7	protein	protein	NOUN
bjp-26620	84	8	which	which	PRON
bjp-26620	84	9	promotes	promote	VERB
bjp-26620	84	10	proliferation	proliferation	NOUN
bjp-26620	84	11	,	,	PUNCT
bjp-26620	84	12	enhances	enhance	VERB
bjp-26620	84	13	invasive	invasive	ADJ
bjp-26620	84	14	and	and	CCONJ
bjp-26620	84	15	migratory	migratory	ADJ
bjp-26620	84	16	potential	potential	ADJ
bjp-26620	84	17	breast	breast	NOUN
bjp-26620	84	18	cancer	cancer	NOUN
bjp-26620	84	19	cells	cell	NOUN
bjp-26620	84	20	(	(	PUNCT
bjp-26620	84	21	liu	liu	PROPN
bjp-26620	84	22	et	et	PROPN
bjp-26620	84	23	al	al	PROPN
bjp-26620	84	24	.	.	PROPN
bjp-26620	84	25	,	,	PUNCT
bjp-26620	84	26	2000	2000	NUM
bjp-26620	84	27	;	;	PUNCT
bjp-26620	85	1	lu	lu	PROPN
bjp-26620	85	2	et	et	PROPN
bjp-26620	85	3	al	al	PROPN
bjp-26620	85	4	.	.	PROPN
bjp-26620	85	5	,	,	PUNCT
bjp-26620	85	6	2002	2002	NUM
bjp-26620	85	7	)	)	PUNCT
bjp-26620	85	8	.	.	PUNCT
bjp-26620	86	1	its	its	PRON
bjp-26620	86	2	expression	expression	NOUN
bjp-26620	86	3	also	also	ADV
bjp-26620	86	4	results	result	VERB
bjp-26620	86	5	in	in	ADP
bjp-26620	86	6	the	the	DET
bjp-26620	86	7	development	development	NOUN
bjp-26620	86	8	of	of	ADP
bjp-26620	86	9	resistance	resistance	NOUN
bjp-26620	86	10	to	to	ADP
bjp-26620	86	11	various	various	ADJ
bjp-26620	86	12	chemotherapeutic	chemotherapeutic	ADJ
bjp-26620	86	13	agents	agent	NOUN
bjp-26620	86	14	(	(	PUNCT
bjp-26620	86	15	gupta	gupta	PROPN
bjp-26620	86	16	et	et	PROPN
bjp-26620	86	17	al	al	PROPN
bjp-26620	86	18	.	.	PROPN
bjp-26620	86	19	,	,	PUNCT
bjp-26620	86	20	2003	2003	NUM
bjp-26620	86	21	;	;	PUNCT
bjp-26620	86	22	inaba	inaba	PROPN
bjp-26620	86	23	et	et	PROPN
bjp-26620	86	24	al	al	PROPN
bjp-26620	86	25	.	.	PROPN
bjp-26620	86	26	,	,	PUNCT
bjp-26620	86	27	2005	2005	NUM
bjp-26620	86	28	)	)	PUNCT
bjp-26620	86	29	.	.	PUNCT
bjp-26620	87	1	in	in	ADP
bjp-26620	87	2	the	the	DET
bjp-26620	87	3	current	current	ADJ
bjp-26620	87	4	study	study	NOUN
bjp-26620	87	5	treatment	treatment	NOUN
bjp-26620	87	6	of	of	ADP
bjp-26620	87	7	h3922	h3922	PROPN
bjp-26620	87	8	cells	cell	NOUN
bjp-26620	87	9	with	with	ADP
bjp-26620	87	10	bryostatin	bryostatin	PROPN
bjp-26620	87	11	i	i	PRON
bjp-26620	87	12	caused	cause	VERB
bjp-26620	87	13	a	a	DET
bjp-26620	87	14	significant	significant	ADJ
bjp-26620	87	15	decrease	decrease	NOUN
bjp-26620	87	16	in	in	ADP
bjp-26620	87	17	the	the	DET
bjp-26620	87	18	expression	expression	NOUN
bjp-26620	87	19	of	of	ADP
bjp-26620	87	20	synuclein	synuclein	NOUN
bjp-26620	87	21	-	-	PUNCT
bjp-26620	87	22	a.	a.	NOUN
bjp-26620	87	23	the	the	DET
bjp-26620	87	24	reduction	reduction	NOUN
bjp-26620	87	25	of	of	ADP
bjp-26620	87	26	synuclein	synuclein	NOUN
bjp-26620	87	27	-	-	PUNCT
bjp-26620	87	28	a	a	DET
bjp-26620	87	29	expression	expression	NOUN
bjp-26620	87	30	by	by	ADP
bjp-26620	87	31	bryostatin	bryostatin	NOUN
bjp-26620	87	32	i	i	PRON
bjp-26620	87	33	treatment	treatment	NOUN
bjp-26620	87	34	was	be	AUX
bjp-26620	87	35	concentration	concentration	NOUN
bjp-26620	87	36	dependent	dependent	ADJ
bjp-26620	87	37	.	.	PUNCT
bjp-26620	88	1	the	the	DET
bjp-26620	88	2	inhibitory	inhibitory	ADJ
bjp-26620	88	3	effect	effect	NOUN
bjp-26620	88	4	of	of	ADP
bjp-26620	88	5	bryostatin	bryostatin	VERB
bjp-26620	88	6	i	i	PRON
bjp-26620	88	7	on	on	ADP
bjp-26620	88	8	expression	expression	NOUN
bjp-26620	88	9	of	of	ADP
bjp-26620	88	10	synuclein	synuclein	NOUN
bjp-26620	88	11	-	-	PUNCT
bjp-26620	88	12	a	a	PRON
bjp-26620	88	13	was	be	AUX
bjp-26620	88	14	further	far	ADV
bjp-26620	88	15	confirmed	confirm	VERB
bjp-26620	88	16	by	by	ADP
bjp-26620	88	17	treatment	treatment	NOUN
bjp-26620	88	18	with	with	ADP
bjp-26620	88	19	its	its	PRON
bjp-26620	88	20	known	know	VERB
bjp-26620	88	21	inhibitor	inhibitor	NOUN
bjp-26620	88	22	,	,	PUNCT
bjp-26620	88	23	cytokine	cytokine	NOUN
bjp-26620	88	24	(	(	PUNCT
bjp-26620	88	25	liu	liu	PROPN
bjp-26620	88	26	et	et	PROPN
bjp-26620	88	27	al	al	PROPN
bjp-26620	88	28	.	.	PROPN
bjp-26620	88	29	,	,	PUNCT
bjp-26620	88	30	2000	2000	NUM
bjp-26620	88	31	)	)	PUNCT
bjp-26620	88	32	.	.	PUNCT
bjp-26620	89	1	treatment	treatment	NOUN
bjp-26620	89	2	of	of	ADP
bjp-26620	89	3	h3922	h3922	PROPN
bjp-26620	89	4	cells	cell	NOUN
bjp-26620	89	5	with	with	ADP
bjp-26620	89	6	bryostatin	bryostatin	PROPN
bjp-26620	89	7	i	i	PRON
bjp-26620	89	8	significantly	significantly	ADV
bjp-26620	89	9	increased	increase	VERB
bjp-26620	89	10	their	their	PRON
bjp-26620	89	11	sensitivity	sensitivity	NOUN
bjp-26620	89	12	to	to	ADP
bjp-26620	89	13	anti	anti	ADJ
bjp-26620	89	14	-	-	ADJ
bjp-26620	89	15	cancer	cancer	ADJ
bjp-26620	89	16	drugs	drug	NOUN
bjp-26620	89	17	.	.	PUNCT
bjp-26620	90	1	bryostatin	bryostatin	VERB
bjp-26620	90	2	i	i	PRON
bjp-26620	90	3	treatment	treatment	NOUN
bjp-26620	90	4	of	of	ADP
bjp-26620	90	5	the	the	DET
bjp-26620	90	6	cells	cell	NOUN
bjp-26620	90	7	followed	follow	VERB
bjp-26620	90	8	by	by	ADP
bjp-26620	90	9	incubation	incubation	NOUN
bjp-26620	90	10	with	with	ADP
bjp-26620	90	11	taxol	taxol	PROPN
bjp-26620	90	12	induced	induce	VERB
bjp-26620	90	13	apoptosis	apoptosis	NOUN
bjp-26620	90	14	in	in	ADP
bjp-26620	90	15	significantly	significantly	ADV
bjp-26620	90	16	higher	high	ADJ
bjp-26620	90	17	proportion	proportion	NOUN
bjp-26620	90	18	of	of	ADP
bjp-26620	90	19	cells	cell	NOUN
bjp-26620	90	20	compared	compare	VERB
bjp-26620	90	21	to	to	ADP
bjp-26620	90	22	the	the	DET
bjp-26620	90	23	taxol	taxol	PROPN
bjp-26620	90	24	treated	treat	VERB
bjp-26620	90	25	cells	cell	NOUN
bjp-26620	90	26	.	.	PUNCT
bjp-26620	91	1	treatment	treatment	NOUN
bjp-26620	91	2	of	of	ADP
bjp-26620	91	3	h3922	h3922	PROPN
bjp-26620	91	4	cells	cell	NOUN
bjp-26620	91	5	with	with	ADP
bjp-26620	91	6	bryostatin	bryostatin	PROPN
bjp-26620	91	7	i	i	PRON
bjp-26620	91	8	showed	show	VERB
bjp-26620	91	9	reduction	reduction	NOUN
bjp-26620	91	10	in	in	ADP
bjp-26620	91	11	the	the	DET
bjp-26620	91	12	cell	cell	NOUN
bjp-26620	91	13	viability	viability	NOUN
bjp-26620	91	14	in	in	ADP
bjp-26620	91	15	concentration	concentration	NOUN
bjp-26620	91	16	dependent	dependent	ADJ
bjp-26620	91	17	manner	manner	NOUN
bjp-26620	91	18	using	use	VERB
bjp-26620	91	19	mtt	mtt	NOUN
bjp-26620	91	20	assay	assay	NOUN
bjp-26620	91	21	.	.	PUNCT
bjp-26620	92	1	the	the	DET
bjp-26620	92	2	results	result	NOUN
bjp-26620	92	3	demonstrated	demonstrate	VERB
bjp-26620	92	4	a	a	DET
bjp-26620	92	5	significant	significant	ADJ
bjp-26620	92	6	reduction	reduction	NOUN
bjp-26620	92	7	in	in	ADP
bjp-26620	92	8	the	the	DET
bjp-26620	92	9	cell	cell	NOUN
bjp-26620	92	10	viability	viability	NOUN
bjp-26620	92	11	by	by	ADP
bjp-26620	92	12	bryostatin	bryostatin	PROPN
bjp-26620	92	13	i	i	PRON
bjp-26620	92	14	treatment	treatment	NOUN
bjp-26620	92	15	.	.	PUNCT
bjp-26620	93	1	in	in	ADP
bjp-26620	93	2	h3922	h3922	PROPN
bjp-26620	93	3	cells	cell	NOUN
bjp-26620	93	4	treatment	treatment	NOUN
bjp-26620	93	5	with	with	ADP
bjp-26620	93	6	bryostatin	bryostatin	PROPN
bjp-26620	93	7	i	i	PRON
bjp-26620	93	8	led	lead	VERB
bjp-26620	93	9	to	to	ADP
bjp-26620	93	10	a	a	DET
bjp-26620	93	11	significant	significant	ADJ
bjp-26620	93	12	(	(	PUNCT
bjp-26620	93	13	p<0.002	p<0.002	NOUN
bjp-26620	93	14	)	)	PUNCT
bjp-26620	93	15	enhancement	enhancement	NOUN
bjp-26620	93	16	in	in	ADP
bjp-26620	93	17	the	the	DET
bjp-26620	93	18	activation	activation	NOUN
bjp-26620	93	19	of	of	ADP
bjp-26620	93	20	the	the	DET
bjp-26620	93	21	histone	histone	NOUN
bjp-26620	93	22	h1	h1	PROPN
bjp-26620	93	23	protein	protein	NOUN
bjp-26620	93	24	.	.	PUNCT
bjp-26620	94	1	the	the	DET
bjp-26620	94	2	phosphorylation	phosphorylation	NOUN
bjp-26620	94	3	of	of	ADP
bjp-26620	94	4	the	the	DET
bjp-26620	94	5	histone	histone	NOUN
bjp-26620	94	6	h1	h1	NOUN
bjp-26620	94	7	was	be	AUX
bjp-26620	94	8	not	not	PART
bjp-26620	94	9	observed	observe	VERB
bjp-26620	94	10	in	in	ADP
bjp-26620	94	11	the	the	DET
bjp-26620	94	12	control	control	NOUN
bjp-26620	94	13	h3922	h3922	PROPN
bjp-26620	94	14	cells	cell	NOUN
bjp-26620	94	15	.	.	PUNCT
bjp-26620	95	1	bryostatin	bryostatin	VERB
bjp-26620	95	2	i	i	PRON
bjp-26620	95	3	treatment	treatment	NOUN
bjp-26620	95	4	of	of	ADP
bjp-26620	95	5	h3922	h3922	PROPN
bjp-26620	95	6	cells	cell	NOUN
bjp-26620	95	7	significantly	significantly	ADV
bjp-26620	95	8	120	120	NUM
bjp-26620	95	9	100	100	NUM
bjp-26620	95	10	80	80	NUM
bjp-26620	95	11	60	60	NUM
bjp-26620	95	12	40	40	NUM
bjp-26620	95	13	20	20	NUM
bjp-26620	95	14	0	0	NUM
bjp-26620	95	15	c	c	PROPN
bjp-26620	95	16	el	el	PROPN
bjp-26620	95	17	l	l	PROPN
bjp-26620	95	18	v	v	X
bjp-26620	95	19	ia	ia	PROPN
bjp-26620	95	20	bi	bi	PROPN
bjp-26620	95	21	lit	light	VERB
bjp-26620	95	22	y	y	PROPN
bjp-26620	95	23	(	(	PUNCT
bjp-26620	95	24	%	%	NOUN
bjp-26620	95	25	)	)	PUNCT
bjp-26620	95	26	0	0	NUM
bjp-26620	96	1	5	5	NUM
bjp-26620	96	2	10	10	NUM
bjp-26620	96	3	15	15	NUM
bjp-26620	96	4	20	20	NUM
bjp-26620	96	5	25	25	NUM
bjp-26620	96	6	30	30	NUM
bjp-26620	96	7	(	(	PUNCT
bjp-26620	96	8	µm	µm	NOUN
bjp-26620	96	9	)	)	PUNCT
bjp-26620	96	10	figure	figure	NOUN
bjp-26620	96	11	3	3	NUM
bjp-26620	96	12	:	:	PUNCT
bjp-26620	96	13	inhibition	inhibition	NOUN
bjp-26620	96	14	of	of	ADP
bjp-26620	96	15	h3922	h3922	NUM
bjp-26620	96	16	breast	breast	NOUN
bjp-26620	96	17	cancer	cancer	NOUN
bjp-26620	96	18	cell	cell	NOUN
bjp-26620	96	19	viability	viability	NOUN
bjp-26620	96	20	by	by	ADP
bjp-26620	96	21	bryostatin	bryostatin	PROPN
bjp-26620	96	22	i.	i.	PROPN
bjp-26620	96	23	the	the	DET
bjp-26620	96	24	cells	cell	NOUN
bjp-26620	96	25	were	be	AUX
bjp-26620	96	26	treated	treat	VERB
bjp-26620	96	27	with	with	ADP
bjp-26620	96	28	5	5	NUM
bjp-26620	96	29	,	,	PUNCT
bjp-26620	96	30	10	10	NUM
bjp-26620	96	31	,	,	PUNCT
bjp-26620	96	32	20	20	NUM
bjp-26620	96	33	,	,	PUNCT
bjp-26620	96	34	25	25	NUM
bjp-26620	96	35	and	and	CCONJ
bjp-26620	96	36	30	30	NUM
bjp-26620	96	37	µm	µm	ADP
bjp-26620	96	38	concentration	concentration	NOUN
bjp-26620	96	39	of	of	ADP
bjp-26620	96	40	bryostatin	bryostatin	NOUN
bjp-26620	96	41	i	i	PRON
bjp-26620	96	42	or	or	CCONJ
bjp-26620	96	43	with	with	ADP
bjp-26620	96	44	dmso	dmso	NOUN
bjp-26620	96	45	alone	alone	ADV
bjp-26620	96	46	for	for	ADP
bjp-26620	96	47	48	48	NUM
bjp-26620	96	48	hours	hour	NOUN
bjp-26620	96	49	followed	follow	VERB
bjp-26620	96	50	by	by	ADP
bjp-26620	96	51	viability	viability	NOUN
bjp-26620	96	52	analysis	analysis	NOUN
bjp-26620	96	53	using	use	VERB
bjp-26620	96	54	mtt	mtt	NOUN
bjp-26620	96	55	assay	assay	VERB
bjp-26620	96	56	.	.	PUNCT
bjp-26620	97	1	the	the	DET
bjp-26620	97	2	experiments	experiment	NOUN
bjp-26620	97	3	for	for	ADP
bjp-26620	97	4	each	each	PRON
bjp-26620	97	5	of	of	ADP
bjp-26620	97	6	the	the	DET
bjp-26620	97	7	concentration	concentration	NOUN
bjp-26620	97	8	were	be	AUX
bjp-26620	97	9	performed	perform	VERB
bjp-26620	97	10	in	in	ADP
bjp-26620	97	11	triplicates	triplicate	NOUN
bjp-26620	97	12	bryostatin	bryostatin	VERB
bjp-26620	97	13	i	i	PRON
bjp-26620	97	14	p	p	PROPN
bjp-26620	97	15	-	-	PUNCT
bjp-26620	97	16	histone	histone	NOUN
bjp-26620	97	17	h1	h1	PROPN
bjp-26620	97	18	histone	histone	NOUN
bjp-26620	97	19	h1	h1	PROPN
bjp-26620	97	20	0	0	NUM
bjp-26620	97	21	5	5	NUM
bjp-26620	97	22	10	10	NUM
bjp-26620	97	23	15	15	NUM
bjp-26620	97	24	20	20	NUM
bjp-26620	97	25	25	25	NUM
bjp-26620	97	26	30	30	NUM
bjp-26620	97	27	(	(	PUNCT
bjp-26620	97	28	µm	µm	NOUN
bjp-26620	97	29	)	)	PUNCT
bjp-26620	97	30	figure	figure	NOUN
bjp-26620	97	31	4	4	NUM
bjp-26620	97	32	:	:	PUNCT
bjp-26620	97	33	bryostatin	bryostatin	VERB
bjp-26620	97	34	i	i	PRON
bjp-26620	97	35	treatment	treatment	NOUN
bjp-26620	97	36	inhibits	inhibit	VERB
bjp-26620	97	37	the	the	DET
bjp-26620	97	38	expression	expression	NOUN
bjp-26620	97	39	of	of	ADP
bjp-26620	97	40	histone	histone	NOUN
bjp-26620	97	41	h1	h1	PROPN
bjp-26620	97	42	protein	protein	NOUN
bjp-26620	97	43	.	.	PUNCT
bjp-26620	98	1	the	the	DET
bjp-26620	98	2	cells	cell	NOUN
bjp-26620	98	3	were	be	AUX
bjp-26620	98	4	incubated	incubate	VERB
bjp-26620	98	5	with	with	ADP
bjp-26620	98	6	25	25	NUM
bjp-26620	98	7	µm	µm	ADP
bjp-26620	98	8	concentration	concentration	NOUN
bjp-26620	98	9	of	of	ADP
bjp-26620	98	10	bryostatin	bryostatin	PROPN
bjp-26620	98	11	i	i	PRON
bjp-26620	98	12	for	for	ADP
bjp-26620	98	13	48	48	NUM
bjp-26620	98	14	hours	hour	NOUN
bjp-26620	98	15	.	.	PUNCT
bjp-26620	99	1	after	after	SCONJ
bjp-26620	99	2	incubation	incubation	NOUN
bjp-26620	99	3	phosphorylation	phosphorylation	NOUN
bjp-26620	99	4	of	of	ADP
bjp-26620	99	5	the	the	DET
bjp-26620	99	6	histone	histone	NOUN
bjp-26620	99	7	h1	h1	NOUN
bjp-26620	99	8	protein	protein	NOUN
bjp-26620	99	9	was	be	AUX
bjp-26620	99	10	analyzed	analyze	VERB
bjp-26620	99	11	using	use	VERB
bjp-26620	99	12	western	western	ADJ
bjp-26620	99	13	blot	blot	NOUN
bjp-26620	99	14	assay	assay	VERB
bjp-26620	99	15	80	80	NUM
bjp-26620	99	16	60	60	NUM
bjp-26620	99	17	40	40	NUM
bjp-26620	99	18	20	20	NUM
bjp-26620	99	19	0	0	NUM
bjp-26620	100	1	c	c	PROPN
bjp-26620	100	2	el	el	PROPN
bjp-26620	100	3	l	l	PROPN
bjp-26620	100	4	c	c	NOUN
bjp-26620	100	5	ou	ou	INTJ
bjp-26620	100	6	nt	not	PART
bjp-26620	100	7	(	(	PUNCT
bjp-26620	100	8	%	%	NOUN
bjp-26620	100	9	)	)	PUNCT
bjp-26620	100	10	g1	g1	PROPN
bjp-26620	100	11	s	s	PROPN
bjp-26620	100	12	g2	g2	PROPN
bjp-26620	100	13	control	control	PROPN
bjp-26620	100	14	compound	compound	PROPN
bjp-26620	100	15	3b	3b	PROPN
bjp-26620	100	16	figure	figure	NOUN
bjp-26620	100	17	5	5	NUM
bjp-26620	100	18	:	:	PUNCT
bjp-26620	100	19	effect	effect	NOUN
bjp-26620	100	20	of	of	ADP
bjp-26620	100	21	bryostatin	bryostatin	VERB
bjp-26620	100	22	i	i	PRON
bjp-26620	100	23	on	on	ADP
bjp-26620	100	24	distribution	distribution	NOUN
bjp-26620	100	25	of	of	ADP
bjp-26620	100	26	h3922	h3922	PROPN
bjp-26620	100	27	cells	cell	NOUN
bjp-26620	100	28	in	in	ADP
bjp-26620	100	29	cell	cell	NOUN
bjp-26620	100	30	cycle	cycle	NOUN
bjp-26620	100	31	.	.	PUNCT
bjp-26620	101	1	the	the	DET
bjp-26620	101	2	cells	cell	NOUN
bjp-26620	101	3	were	be	AUX
bjp-26620	101	4	treated	treat	VERB
bjp-26620	101	5	with	with	ADP
bjp-26620	101	6	bryostatin	bryostatin	PROPN
bjp-26620	101	7	i	i	PRON
bjp-26620	101	8	and	and	CCONJ
bjp-26620	101	9	then	then	ADV
bjp-26620	101	10	analyzed	analyze	VERB
bjp-26620	101	11	by	by	ADP
bjp-26620	101	12	flow	flow	NOUN
bjp-26620	101	13	cytometry	cytometry	NOUN
bjp-26620	101	14	.	.	PUNCT
bjp-26620	102	1	bryostatin	bryostatin	VERB
bjp-26620	102	2	i	i	PRON
bjp-26620	102	3	treatment	treatment	NOUN
bjp-26620	102	4	increased	increase	VERB
bjp-26620	102	5	the	the	DET
bjp-26620	102	6	population	population	NOUN
bjp-26620	102	7	of	of	ADP
bjp-26620	102	8	cells	cell	NOUN
bjp-26620	102	9	in	in	ADP
bjp-26620	102	10	g1	g1	PROPN
bjp-26620	102	11	phase	phase	NOUN
bjp-26620	102	12	with	with	ADP
bjp-26620	102	13	subsequent	subsequent	ADJ
bjp-26620	102	14	reduction	reduction	NOUN
bjp-26620	102	15	in	in	ADP
bjp-26620	102	16	g2	g2	PROPN
bjp-26620	102	17	/	/	SYM
bjp-26620	102	18	m	m	PROPN
bjp-26620	102	19	phase	phase	NOUN
bjp-26620	102	20	618	618	NUM
bjp-26620	102	21	bangladesh	bangladesh	NOUN
bjp-26620	102	22	j	j	PROPN
bjp-26620	102	23	pharmacol	pharmacol	PROPN
bjp-26620	102	24	2016	2016	NUM
bjp-26620	102	25	;	;	PUNCT
bjp-26620	102	26	11	11	NUM
bjp-26620	102	27	:	:	PUNCT
bjp-26620	102	28	615	615	NUM
bjp-26620	102	29	-	-	SYM
bjp-26620	102	30	620	620	NUM
bjp-26620	102	31	(	(	PUNCT
bjp-26620	102	32	p<0.002	p<0.002	NOUN
bjp-26620	102	33	)	)	PUNCT
bjp-26620	102	34	enhanced	enhance	VERB
bjp-26620	102	35	the	the	DET
bjp-26620	102	36	population	population	NOUN
bjp-26620	102	37	of	of	ADP
bjp-26620	102	38	cells	cell	NOUN
bjp-26620	102	39	in	in	ADP
bjp-26620	102	40	the	the	DET
bjp-26620	102	41	g1	g1	PROPN
bjp-26620	102	42	phase	phase	NOUN
bjp-26620	102	43	compared	compare	VERB
bjp-26620	102	44	to	to	ADP
bjp-26620	102	45	the	the	DET
bjp-26620	102	46	control	control	NOUN
bjp-26620	102	47	cells	cell	NOUN
bjp-26620	102	48	.	.	PUNCT
bjp-26620	103	1	the	the	DET
bjp-26620	103	2	increase	increase	NOUN
bjp-26620	103	3	in	in	ADP
bjp-26620	103	4	population	population	NOUN
bjp-26620	103	5	of	of	ADP
bjp-26620	103	6	h3922	h3922	PROPN
bjp-26620	103	7	cells	cell	NOUN
bjp-26620	103	8	in	in	ADP
bjp-26620	103	9	the	the	DET
bjp-26620	103	10	g1	g1	PROPN
bjp-26620	103	11	phase	phase	NOUN
bjp-26620	103	12	was	be	AUX
bjp-26620	103	13	accompanied	accompany	VERB
bjp-26620	103	14	by	by	ADP
bjp-26620	103	15	a	a	DET
bjp-26620	103	16	simultaneous	simultaneous	ADJ
bjp-26620	103	17	reduction	reduction	NOUN
bjp-26620	103	18	in	in	ADP
bjp-26620	103	19	g2	g2	PROPN
bjp-26620	103	20	/	/	SYM
bjp-26620	103	21	m	m	PROPN
bjp-26620	103	22	phase	phase	NOUN
bjp-26620	103	23	.	.	PUNCT
bjp-26620	104	1	matrix	matrix	NOUN
bjp-26620	104	2	metalloproteinases	metalloproteinase	NOUN
bjp-26620	104	3	are	be	AUX
bjp-26620	104	4	the	the	DET
bjp-26620	104	5	most	most	ADV
bjp-26620	104	6	potent	potent	ADJ
bjp-26620	104	7	factors	factor	NOUN
bjp-26620	104	8	associated	associate	VERB
bjp-26620	104	9	with	with	ADP
bjp-26620	104	10	the	the	DET
bjp-26620	104	11	development	development	NOUN
bjp-26620	104	12	of	of	ADP
bjp-26620	104	13	resistant	resistant	ADJ
bjp-26620	104	14	cancer	cancer	NOUN
bjp-26620	104	15	and	and	CCONJ
bjp-26620	104	16	its	its	PRON
bjp-26620	104	17	metastasis	metastasis	NOUN
bjp-26620	104	18	(	(	PUNCT
bjp-26620	104	19	li	li	PROPN
bjp-26620	104	20	et	et	PROPN
bjp-26620	104	21	al	al	PROPN
bjp-26620	104	22	.	.	PROPN
bjp-26620	104	23	,	,	PUNCT
bjp-26620	104	24	2003	2003	NUM
bjp-26620	104	25	)	)	PUNCT
bjp-26620	104	26	.	.	PUNCT
bjp-26620	105	1	it	it	PRON
bjp-26620	105	2	has	have	AUX
bjp-26620	105	3	been	be	AUX
bjp-26620	105	4	demonstrated	demonstrate	VERB
bjp-26620	105	5	that	that	SCONJ
bjp-26620	105	6	inhibition	inhibition	NOUN
bjp-26620	105	7	of	of	ADP
bjp-26620	105	8	the	the	DET
bjp-26620	105	9	expression	expression	NOUN
bjp-26620	105	10	of	of	ADP
bjp-26620	105	11	mmp2	mmp2	NOUN
bjp-26620	105	12	and	and	CCONJ
bjp-26620	105	13	mmp-9	mmp-9	NOUN
bjp-26620	105	14	reduces	reduce	VERB
bjp-26620	105	15	the	the	DET
bjp-26620	105	16	migratory	migratory	ADJ
bjp-26620	105	17	and	and	CCONJ
bjp-26620	105	18	invasive	invasive	ADJ
bjp-26620	105	19	potential	potential	NOUN
bjp-26620	105	20	of	of	ADP
bjp-26620	105	21	the	the	DET
bjp-26620	105	22	cancer	cancer	NOUN
bjp-26620	105	23	cells	cell	NOUN
bjp-26620	105	24	(	(	PUNCT
bjp-26620	105	25	blajeski	blajeski	PROPN
bjp-26620	105	26	et	et	PROPN
bjp-26620	105	27	al	al	PROPN
bjp-26620	105	28	.	.	PROPN
bjp-26620	105	29	,	,	PUNCT
bjp-26620	105	30	2002	2002	NUM
bjp-26620	105	31	)	)	PUNCT
bjp-26620	105	32	.	.	PUNCT
bjp-26620	106	1	in	in	ADP
bjp-26620	106	2	the	the	DET
bjp-26620	106	3	present	present	ADJ
bjp-26620	106	4	study	study	NOUN
bjp-26620	106	5	bryostatin	bryostatin	VERB
bjp-26620	106	6	i	i	PRON
bjp-26620	106	7	treatment	treatment	NOUN
bjp-26620	106	8	significantly	significantly	ADV
bjp-26620	106	9	inhibits	inhibit	VERB
bjp-26620	106	10	the	the	DET
bjp-26620	106	11	level	level	NOUN
bjp-26620	106	12	of	of	ADP
bjp-26620	106	13	expression	expression	NOUN
bjp-26620	106	14	of	of	ADP
bjp-26620	106	15	mmp-2	mmp-2	NUM
bjp-26620	106	16	and	and	CCONJ
bjp-26620	106	17	mmp-9	mmp-9	NOUN
bjp-26620	106	18	in	in	ADP
bjp-26620	106	19	h3922	h3922	PROPN
bjp-26620	106	20	cells	cell	NOUN
bjp-26620	106	21	.	.	PUNCT
bjp-26620	107	1	gelatin	gelatin	NOUN
bjp-26620	107	2	zymography	zymography	PROPN
bjp-26620	107	3	revealed	reveal	VERB
bjp-26620	107	4	that	that	SCONJ
bjp-26620	107	5	the	the	DET
bjp-26620	107	6	expression	expression	NOUN
bjp-26620	107	7	of	of	ADP
bjp-26620	107	8	mmp-2	mmp-2	DET
bjp-26620	107	9	activity	activity	NOUN
bjp-26620	107	10	was	be	AUX
bjp-26620	107	11	reduced	reduce	VERB
bjp-26620	107	12	to	to	ADP
bjp-26620	107	13	16.3	16.3	NUM
bjp-26620	107	14	±	±	NUM
bjp-26620	107	15	2.7	2.7	NUM
bjp-26620	107	16	%	%	NOUN
bjp-26620	107	17	at	at	ADP
bjp-26620	107	18	25	25	NUM
bjp-26620	107	19	µm	µm	ADP
bjp-26620	107	20	concentration	concentration	NOUN
bjp-26620	107	21	of	of	ADP
bjp-26620	107	22	bryostatin	bryostatin	PROPN
bjp-26620	107	23	i.	i.	PROPN
bjp-26620	107	24	similarly	similarly	ADV
bjp-26620	107	25	,	,	PUNCT
bjp-26620	107	26	the	the	DET
bjp-26620	107	27	expression	expression	NOUN
bjp-26620	107	28	of	of	ADP
bjp-26620	107	29	mmp-9	mmp-9	NOUN
bjp-26620	107	30	was	be	AUX
bjp-26620	107	31	found	find	VERB
bjp-26620	107	32	to	to	PART
bjp-26620	107	33	be	be	AUX
bjp-26620	107	34	37.8	37.8	NUM
bjp-26620	107	35	±	±	NUM
bjp-26620	107	36	3.4%at	3.4%at	NOUN
bjp-26620	107	37	25	25	NUM
bjp-26620	107	38	µm	µm	ADP
bjp-26620	107	39	concentrations	concentration	NOUN
bjp-26620	107	40	of	of	ADP
bjp-26620	107	41	bryostatin	bryostatin	PROPN
bjp-26620	107	42	i.	i.	PROPN
bjp-26620	107	43	conclusion	conclusion	PROPN
bjp-26620	107	44	bryostatin	bryostatin	VERB
bjp-26620	107	45	i	i	PRON
bjp-26620	107	46	treatment	treatment	NOUN
bjp-26620	107	47	inhibits	inhibit	VERB
bjp-26620	107	48	the	the	DET
bjp-26620	107	49	viability	viability	NOUN
bjp-26620	107	50	and	and	CCONJ
bjp-26620	107	51	induces	induce	VERB
bjp-26620	107	52	apoptosis	apoptosis	NOUN
bjp-26620	107	53	in	in	ADP
bjp-26620	107	54	breast	breast	NOUN
bjp-26620	107	55	cancer	cancer	NOUN
bjp-26620	107	56	cells	cell	NOUN
bjp-26620	107	57	through	through	ADP
bjp-26620	107	58	suppression	suppression	NOUN
bjp-26620	107	59	of	of	ADP
bjp-26620	107	60	synuclein	synuclein	NOUN
bjp-26620	107	61	-	-	PUNCT
bjp-26620	107	62	a	a	DET
bjp-26620	107	63	expression	expression	NOUN
bjp-26620	107	64	,	,	PUNCT
bjp-26620	107	65	mmp-2	mmp-2	NUM
bjp-26620	107	66	and	and	CCONJ
bjp-26620	107	67	mmp-9	mmp-9	NOUN
bjp-26620	107	68	expression	expression	NOUN
bjp-26620	107	69	and	and	CCONJ
bjp-26620	107	70	can	can	AUX
bjp-26620	107	71	be	be	AUX
bjp-26620	107	72	used	use	VERB
bjp-26620	107	73	for	for	ADP
bjp-26620	107	74	its	its	PRON
bjp-26620	107	75	treatment	treatment	NOUN
bjp-26620	107	76	.	.	PUNCT
bjp-26620	108	1	references	reference	NOUN
bjp-26620	108	2	ali	ali	PROPN
bjp-26620	108	3	s	s	PROPN
bjp-26620	108	4	,	,	PUNCT
bjp-26620	108	5	coombes	coombes	PROPN
bjp-26620	108	6	rc	rc	PROPN
bjp-26620	108	7	.	.	PROPN
bjp-26620	108	8	endocrine	endocrine	PROPN
bjp-26620	108	9	-	-	PUNCT
bjp-26620	108	10	responsive	responsive	ADJ
bjp-26620	108	11	breast	breast	NOUN
bjp-26620	108	12	cancer	cancer	NOUN
bjp-26620	108	13	and	and	CCONJ
bjp-26620	108	14	strategies	strategy	NOUN
bjp-26620	108	15	for	for	ADP
bjp-26620	108	16	combating	combat	VERB
bjp-26620	108	17	resistance	resistance	NOUN
bjp-26620	108	18	.	.	PUNCT
bjp-26620	109	1	nat	nat	PROPN
bjp-26620	109	2	rev	rev	PROPN
bjp-26620	109	3	cancer	cancer	NOUN
bjp-26620	109	4	.	.	PUNCT
bjp-26620	110	1	2002	2002	NUM
bjp-26620	110	2	;	;	PUNCT
bjp-26620	110	3	2	2	NUM
bjp-26620	110	4	:	:	SYM
bjp-26620	110	5	101	101	NUM
bjp-26620	110	6	-	-	SYM
bjp-26620	110	7	12	12	NUM
bjp-26620	110	8	.	.	PUNCT
bjp-26620	111	1	bruening	bruene	VERB
bjp-26620	111	2	w	w	PROPN
bjp-26620	111	3	,	,	PUNCT
bjp-26620	111	4	giasson	giasson	PROPN
bjp-26620	111	5	b	b	PROPN
bjp-26620	111	6	,	,	PUNCT
bjp-26620	111	7	klein	klein	PROPN
bjp-26620	111	8	-	-	PUNCT
bjp-26620	111	9	szanto	szanto	PROPN
bjp-26620	111	10	j	j	PROPN
bjp-26620	111	11	,	,	PUNCT
bjp-26620	111	12	lee	lee	PROPN
bjp-26620	111	13	v	v	PROPN
bjp-26620	111	14	,	,	PUNCT
bjp-26620	111	15	trojanowski	trojanowski	PROPN
bjp-26620	111	16	j	j	PROPN
bjp-26620	111	17	,	,	PUNCT
bjp-26620	111	18	godwin	godwin	PROPN
bjp-26620	111	19	a.	a.	NOUN
bjp-26620	111	20	synucleins	synuclein	NOUN
bjp-26620	111	21	are	be	AUX
bjp-26620	111	22	expressed	express	VERB
bjp-26620	111	23	in	in	ADP
bjp-26620	111	24	the	the	DET
bjp-26620	111	25	majority	majority	NOUN
bjp-26620	111	26	of	of	ADP
bjp-26620	111	27	breast	breast	NOUN
bjp-26620	111	28	and	and	CCONJ
bjp-26620	111	29	ovarian	ovarian	ADJ
bjp-26620	111	30	carcinomas	carcinoma	NOUN
bjp-26620	111	31	and	and	CCONJ
bjp-26620	111	32	in	in	ADP
bjp-26620	111	33	preneoplastic	preneoplastic	ADJ
bjp-26620	111	34	lesions	lesion	NOUN
bjp-26620	111	35	of	of	ADP
bjp-26620	111	36	the	the	DET
bjp-26620	111	37	ovary	ovary	NOUN
bjp-26620	111	38	.	.	PUNCT
bjp-26620	112	1	cancer	cancer	NOUN
bjp-26620	112	2	2000	2000	NUM
bjp-26620	112	3	;	;	PUNCT
bjp-26620	112	4	88	88	NUM
bjp-26620	112	5	:	:	SYM
bjp-26620	112	6	2154	2154	NUM
bjp-26620	112	7	-	-	SYM
bjp-26620	112	8	63	63	NUM
bjp-26620	112	9	.	.	PUNCT
bjp-26620	112	10	blajeski	blajeski	PROPN
bjp-26620	112	11	al	al	PROPN
bjp-26620	112	12	,	,	PUNCT
bjp-26620	112	13	phan	phan	PROPN
bjp-26620	112	14	va	va	PROPN
bjp-26620	112	15	,	,	PUNCT
bjp-26620	112	16	kottke	kottke	PROPN
bjp-26620	112	17	tj	tj	PROPN
bjp-26620	112	18	,	,	PUNCT
bjp-26620	112	19	kaufmann	kaufmann	PROPN
bjp-26620	112	20	sh	sh	PROPN
bjp-26620	112	21	.	.	PUNCT
bjp-26620	112	22	g(1	g(1	NOUN
bjp-26620	112	23	)	)	PUNCT
bjp-26620	112	24	and	and	CCONJ
bjp-26620	112	25	g(2	g(2	PROPN
bjp-26620	112	26	)	)	PUNCT
bjp-26620	112	27	cell	cell	NOUN
bjp-26620	112	28	-	-	PUNCT
bjp-26620	112	29	cycle	cycle	NOUN
bjp-26620	112	30	arrest	arrest	NOUN
bjp-26620	112	31	following	follow	VERB
bjp-26620	112	32	microtubule	microtubule	NOUN
bjp-26620	112	33	depolymerization	depolymerization	NOUN
bjp-26620	112	34	in	in	ADP
bjp-26620	112	35	human	human	ADJ
bjp-26620	112	36	breast	breast	NOUN
bjp-26620	112	37	cancer	cancer	NOUN
bjp-26620	112	38	cells	cell	NOUN
bjp-26620	112	39	.	.	PUNCT
bjp-26620	113	1	j	j	PROPN
bjp-26620	113	2	clin	clin	PROPN
bjp-26620	113	3	invest	invest	PROPN
bjp-26620	113	4	.	.	PUNCT
bjp-26620	114	1	2002	2002	NUM
bjp-26620	114	2	;	;	PUNCT
bjp-26620	114	3	110	110	NUM
bjp-26620	114	4	:	:	SYM
bjp-26620	114	5	91	91	NUM
bjp-26620	114	6	-	-	SYM
bjp-26620	114	7	99	99	NUM
bjp-26620	114	8	.	.	PUNCT
bjp-26620	115	1	dowlati	dowlati	PROPN
bjp-26620	115	2	a	a	PROPN
bjp-26620	115	3	,	,	PUNCT
bjp-26620	115	4	lazarus	lazarus	PROPN
bjp-26620	115	5	hm	hm	PROPN
bjp-26620	115	6	,	,	PUNCT
bjp-26620	115	7	hartman	hartman	PROPN
bjp-26620	115	8	p	p	PROPN
bjp-26620	115	9	,	,	PUNCT
bjp-26620	115	10	jacobberger	jacobberger	PROPN
bjp-26620	115	11	jw	jw	PROPN
bjp-26620	115	12	,	,	PUNCT
bjp-26620	115	13	whitacre	whitacre	PROPN
bjp-26620	115	14	c	c	PROPN
bjp-26620	115	15	,	,	PUNCT
bjp-26620	115	16	gerson	gerson	PROPN
bjp-26620	115	17	sl	sl	PROPN
bjp-26620	115	18	,	,	PUNCT
bjp-26620	115	19	ksenich	ksenich	NOUN
bjp-26620	115	20	p	p	PROPN
bjp-26620	115	21	,	,	PUNCT
bjp-26620	115	22	cooper	cooper	PROPN
bjp-26620	115	23	bw	bw	PROPN
bjp-26620	115	24	,	,	PUNCT
bjp-26620	115	25	frisa	frisa	PROPN
bjp-26620	115	26	ps	ps	PROPN
bjp-26620	115	27	,	,	PUNCT
bjp-26620	115	28	gottlieb	gottlieb	PROPN
bjp-26620	115	29	m	m	PROPN
bjp-26620	115	30	,	,	PUNCT
bjp-26620	115	31	murgo	murgo	PROPN
bjp-26620	115	32	aj	aj	PROPN
bjp-26620	115	33	,	,	PUNCT
bjp-26620	115	34	remick	remick	PROPN
bjp-26620	115	35	sc	sc	PROPN
bjp-26620	115	36	.	.	PROPN
bjp-26620	115	37	phase	phase	NOUN
bjp-26620	115	38	i	i	PRON
bjp-26620	115	39	and	and	CCONJ
bjp-26620	115	40	correlative	correlative	ADJ
bjp-26620	115	41	study	study	NOUN
bjp-26620	115	42	of	of	ADP
bjp-26620	115	43	combination	combination	NOUN
bjp-26620	115	44	bryostatin	bryostatin	VERB
bjp-26620	115	45	i	i	PRON
bjp-26620	115	46	and	and	CCONJ
bjp-26620	115	47	vincristine	vincristine	NOUN
bjp-26620	115	48	in	in	ADP
bjp-26620	115	49	relapsed	relapse	VERB
bjp-26620	115	50	b	b	NOUN
bjp-26620	115	51	-	-	PUNCT
bjp-26620	115	52	cell	cell	NOUN
bjp-26620	115	53	malignancies	malignancy	NOUN
bjp-26620	115	54	.	.	PUNCT
bjp-26620	116	1	clin	clin	PROPN
bjp-26620	116	2	cancer	cancer	NOUN
bjp-26620	116	3	res	re	NOUN
bjp-26620	116	4	.	.	PUNCT
bjp-26620	116	5	2003	2003	NUM
bjp-26620	116	6	;	;	PUNCT
bjp-26620	116	7	9	9	NUM
bjp-26620	116	8	:	:	SYM
bjp-26620	116	9	5929	5929	NUM
bjp-26620	116	10	-	-	SYM
bjp-26620	116	11	35	35	NUM
bjp-26620	116	12	.	.	PUNCT
bjp-26620	117	1	gupta	gupta	PROPN
bjp-26620	117	2	a	a	PROPN
bjp-26620	117	3	,	,	PUNCT
bjp-26620	117	4	inaba	inaba	PROPN
bjp-26620	117	5	s	s	PROPN
bjp-26620	117	6	,	,	PUNCT
bjp-26620	117	7	wong	wong	PROPN
bjp-26620	117	8	ok	ok	PROPN
bjp-26620	117	9	,	,	PUNCT
bjp-26620	117	10	fang	fang	PROPN
bjp-26620	117	11	g	g	PROPN
bjp-26620	117	12	,	,	PUNCT
bjp-26620	117	13	liu	liu	PROPN
bjp-26620	117	14	j.	j.	PROPN
bjp-26620	117	15	breast	breast	PROPN
bjp-26620	117	16	cancer	cancer	PROPN
bjp-26620	117	17	specific	specific	ADJ
bjp-26620	117	18	gene	gene	NOUN
bjp-26620	117	19	1	1	NUM
bjp-26620	117	20	interacts	interact	VERB
bjp-26620	117	21	with	with	ADP
bjp-26620	117	22	the	the	DET
bjp-26620	117	23	mitotic	mitotic	ADJ
bjp-26620	117	24	checkpoint	checkpoint	NOUN
bjp-26620	117	25	kinase	kinase	PROPN
bjp-26620	117	26	bubr1	bubr1	PROPN
bjp-26620	117	27	.	.	PUNCT
bjp-26620	118	1	oncogene	oncogene	NOUN
bjp-26620	118	2	2003	2003	NUM
bjp-26620	118	3	;	;	PUNCT
bjp-26620	118	4	22	22	NUM
bjp-26620	118	5	:	:	PUNCT
bjp-26620	118	6	7593	7593	NUM
bjp-26620	118	7	-	-	SYM
bjp-26620	118	8	99	99	NUM
bjp-26620	118	9	.	.	PUNCT
bjp-26620	119	1	inaba	inaba	PROPN
bjp-26620	119	2	s	s	PROPN
bjp-26620	119	3	,	,	PUNCT
bjp-26620	119	4	li	li	PROPN
bjp-26620	119	5	c	c	PROPN
bjp-26620	119	6	,	,	PUNCT
bjp-26620	119	7	shi	shi	PROPN
bjp-26620	119	8	ye	ye	PROPN
bjp-26620	119	9	,	,	PUNCT
bjp-26620	119	10	song	song	NOUN
bjp-26620	119	11	dq	dq	PROPN
bjp-26620	119	12	,	,	PUNCT
bjp-26620	119	13	jiang	jiang	PROPN
bjp-26620	119	14	jd	jd	PROPN
bjp-26620	119	15	,	,	PUNCT
bjp-26620	119	16	liu	liu	PROPN
bjp-26620	119	17	j.	j.	PROPN
bjp-26620	119	18	synuclein	synuclein	PROPN
bjp-26620	119	19	gamma	gamma	PROPN
bjp-26620	119	20	inhibits	inhibit	VERB
bjp-26620	119	21	the	the	DET
bjp-26620	119	22	mitotic	mitotic	ADJ
bjp-26620	119	23	checkpoint	checkpoint	NOUN
bjp-26620	119	24	function	function	NOUN
bjp-26620	119	25	and	and	CCONJ
bjp-26620	119	26	promotes	promote	VERB
bjp-26620	119	27	chromosomal	chromosomal	ADJ
bjp-26620	119	28	instability	instability	NOUN
bjp-26620	119	29	of	of	ADP
bjp-26620	119	30	breast	breast	NOUN
bjp-26620	119	31	cancer	cancer	NOUN
bjp-26620	119	32	cells	cell	NOUN
bjp-26620	119	33	.	.	PUNCT
bjp-26620	120	1	breast	breast	NOUN
bjp-26620	120	2	cancer	cancer	NOUN
bjp-26620	120	3	res	re	NOUN
bjp-26620	120	4	treat	treat	NOUN
bjp-26620	120	5	.	.	PUNCT
bjp-26620	121	1	2005	2005	NUM
bjp-26620	121	2	;	;	PUNCT
bjp-26620	121	3	94	94	NUM
bjp-26620	121	4	:	:	SYM
bjp-26620	121	5	25	25	NUM
bjp-26620	121	6	-	-	SYM
bjp-26620	121	7	35	35	NUM
bjp-26620	121	8	.	.	PUNCT
bjp-26620	122	1	ji	ji	PROPN
bjp-26620	122	2	h	h	PROPN
bjp-26620	122	3	,	,	PUNCT
bjp-26620	122	4	liu	liu	PROPN
bjp-26620	122	5	ye	ye	PROPN
bjp-26620	122	6	,	,	PUNCT
bjp-26620	122	7	jia	jia	PROPN
bjp-26620	122	8	t	t	PROPN
bjp-26620	122	9	,	,	PUNCT
bjp-26620	122	10	wang	wang	PROPN
bjp-26620	122	11	m	m	PROPN
bjp-26620	122	12	,	,	PUNCT
bjp-26620	122	13	liu	liu	PROPN
bjp-26620	122	14	j	j	PROPN
bjp-26620	122	15	,	,	PUNCT
bjp-26620	122	16	xiao	xiao	PROPN
bjp-26620	122	17	g	g	PROPN
bjp-26620	122	18	,	,	PUNCT
bjp-26620	122	19	joseph	joseph	PROPN
bjp-26620	122	20	bk	bk	PROPN
bjp-26620	122	21	,	,	PUNCT
bjp-26620	122	22	rosen	rosen	PROPN
bjp-26620	122	23	c	c	PROPN
bjp-26620	122	24	,	,	PUNCT
bjp-26620	122	25	shi	shi	PROPN
bjp-26620	122	26	ye	ye	PROPN
bjp-26620	122	27	.	.	PUNCT
bjp-26620	122	28	identification	identification	NOUN
bjp-26620	122	29	of	of	ADP
bjp-26620	122	30	a	a	DET
bjp-26620	122	31	breast	breast	NOUN
bjp-26620	122	32	cancer	cancer	NOUN
bjp-26620	122	33	-	-	PUNCT
bjp-26620	122	34	specific	specific	ADJ
bjp-26620	122	35	gene	gene	NOUN
bjp-26620	122	36	,	,	PUNCT
bjp-26620	122	37	bcsg1	bcsg1	NOUN
bjp-26620	122	38	,	,	PUNCT
bjp-26620	122	39	by	by	ADP
bjp-26620	122	40	direct	direct	ADJ
bjp-26620	122	41	differential	differential	ADJ
bjp-26620	122	42	cdna	cdna	PROPN
bjp-26620	122	43	sequencing	sequencing	NOUN
bjp-26620	122	44	.	.	PUNCT
bjp-26620	123	1	cancer	cancer	NOUN
bjp-26620	123	2	res	re	NOUN
bjp-26620	123	3	.	.	PUNCT
bjp-26620	123	4	1997	1997	NUM
bjp-26620	123	5	;	;	PUNCT
bjp-26620	123	6	57	57	NUM
bjp-26620	123	7	:	:	SYM
bjp-26620	123	8	759	759	NUM
bjp-26620	123	9	-	-	SYM
bjp-26620	123	10	64	64	NUM
bjp-26620	123	11	.	.	PUNCT
bjp-26620	124	1	liu	liu	PROPN
bjp-26620	124	2	j	j	PROPN
bjp-26620	124	3	,	,	PUNCT
bjp-26620	124	4	spence	spence	PROPN
bjp-26620	124	5	mj	mj	PROPN
bjp-26620	124	6	,	,	PUNCT
bjp-26620	124	7	zhang	zhang	PROPN
bjp-26620	124	8	yl	yl	PROPN
bjp-26620	124	9	,	,	PUNCT
bjp-26620	124	10	jiang	jiang	PROPN
bjp-26620	124	11	y	y	PROPN
bjp-26620	124	12	,	,	PUNCT
bjp-26620	124	13	liu	liu	PROPN
bjp-26620	124	14	y	y	PROPN
bjp-26620	124	15	,	,	PUNCT
bjp-26620	124	16	shi	shi	PROPN
bjp-26620	124	17	y.	y.	PROPN
bjp-26620	124	18	transcriptional	transcriptional	PROPN
bjp-26620	124	19	suppression	suppression	NOUN
bjp-26620	124	20	of	of	ADP
bjp-26620	124	21	synuclein	synuclein	PROPN
bjp-26620	124	22	gamma	gamma	NOUN
bjp-26620	124	23	(	(	PUNCT
bjp-26620	124	24	sncg	sncg	PROPN
bjp-26620	124	25	)	)	PUNCT
bjp-26620	124	26	expression	expression	NOUN
bjp-26620	124	27	in	in	ADP
bjp-26620	124	28	human	human	ADJ
bjp-26620	124	29	breast	breast	NOUN
bjp-26620	124	30	cancer	cancer	NOUN
bjp-26620	124	31	cells	cell	NOUN
bjp-26620	124	32	by	by	ADP
bjp-26620	124	33	the	the	DET
bjp-26620	124	34	growth	growth	NOUN
bjp-26620	124	35	inhibitory	inhibitory	ADJ
bjp-26620	124	36	cytokine	cytokine	VERB
bjp-26620	124	37	oncostatin	oncostatin	NOUN
bjp-26620	124	38	m.	m.	NOUN
bjp-26620	124	39	breast	breast	NOUN
bjp-26620	124	40	cancer	cancer	NOUN
bjp-26620	124	41	res	re	NOUN
bjp-26620	124	42	treat	treat	NOUN
bjp-26620	124	43	.	.	PUNCT
bjp-26620	125	1	2000	2000	NUM
bjp-26620	125	2	;	;	PUNCT
bjp-26620	125	3	62	62	NUM
bjp-26620	125	4	:	:	SYM
bjp-26620	125	5	99	99	NUM
bjp-26620	125	6	-	-	SYM
bjp-26620	125	7	107	107	NUM
bjp-26620	125	8	.	.	PUNCT
bjp-26620	126	1	li	li	PROPN
bjp-26620	126	2	jn	jn	PROPN
bjp-26620	126	3	,	,	PUNCT
bjp-26620	126	4	song	song	PROPN
bjp-26620	126	5	dq	dq	PROPN
bjp-26620	126	6	,	,	PUNCT
bjp-26620	126	7	lin	lin	PROPN
bjp-26620	126	8	yh	yh	PROPN
bjp-26620	126	9	,	,	PUNCT
bjp-26620	126	10	hu	hu	PROPN
bjp-26620	126	11	qy	qy	PROPN
bjp-26620	126	12	,	,	PUNCT
bjp-26620	126	13	yin	yin	PROPN
bjp-26620	126	14	l	l	PROPN
bjp-26620	126	15	,	,	PUNCT
bjp-26620	126	16	bekesi	bekesi	PROPN
bjp-26620	126	17	g	g	PROPN
bjp-26620	126	18	,	,	PUNCT
bjp-26620	126	19	holland	holland	PROPN
bjp-26620	126	20	jf	jf	PROPN
bjp-26620	126	21	,	,	PUNCT
bjp-26620	126	22	jiang	jiang	PROPN
bjp-26620	126	23	jd	jd	PROPN
bjp-26620	126	24	.	.	PROPN
bjp-26620	126	25	inhibition	inhibition	NOUN
bjp-26620	126	26	of	of	ADP
bjp-26620	126	27	microtubule	microtubule	NOUN
bjp-26620	126	28	polymerization	polymerization	NOUN
bjp-26620	126	29	by	by	ADP
bjp-26620	126	30	3b	3b	PROPN
bjp-26620	126	31	romopropionylamino	romopropionylamino	PROPN
bjp-26620	126	32	benzoylurea	benzoylurea	PROPN
bjp-26620	126	33	(	(	PUNCT
bjp-26620	126	34	jimb01	jimb01	PROPN
bjp-26620	126	35	)	)	PUNCT
bjp-26620	126	36	,	,	PUNCT
bjp-26620	126	37	a	a	DET
bjp-26620	126	38	new	new	ADJ
bjp-26620	126	39	cancericidal	cancericidal	ADJ
bjp-26620	126	40	tubulin	tubulin	PROPN
bjp-26620	126	41	ligand	ligand	NOUN
bjp-26620	126	42	.	.	PUNCT
bjp-26620	127	1	biochem	biochem	PROPN
bjp-26620	127	2	pharmacol	pharmacol	PROPN
bjp-26620	127	3	.	.	PUNCT
bjp-26620	127	4	2003	2003	NUM
bjp-26620	127	5	;	;	PUNCT
bjp-26620	127	6	65	65	NUM
bjp-26620	127	7	:	:	PUNCT
bjp-26620	127	8	1691	1691	NUM
bjp-26620	127	9	-	-	SYM
bjp-26620	127	10	99	99	NUM
bjp-26620	127	11	.	.	PUNCT
bjp-26620	128	1	lu	lu	PROPN
bjp-26620	128	2	a	a	PROPN
bjp-26620	128	3	,	,	PUNCT
bjp-26620	128	4	zhang	zhang	PROPN
bjp-26620	128	5	f	f	PROPN
bjp-26620	128	6	,	,	PUNCT
bjp-26620	128	7	gupta	gupta	PROPN
bjp-26620	128	8	a	a	PRON
bjp-26620	128	9	,	,	PUNCT
bjp-26620	128	10	liu	liu	PROPN
bjp-26620	128	11	j.	j.	PROPN
bjp-26620	128	12	blockade	blockade	PROPN
bjp-26620	128	13	of	of	ADP
bjp-26620	128	14	ap1	ap1	PROPN
bjp-26620	128	15	trans	trans	PROPN
bjp-26620	128	16	activation	activation	NOUN
bjp-26620	128	17	abrogates	abrogate	VERB
bjp-26620	128	18	the	the	DET
bjp-26620	128	19	abnormal	abnormal	ADJ
bjp-26620	128	20	expression	expression	NOUN
bjp-26620	128	21	of	of	ADP
bjp-26620	128	22	breast	breast	NOUN
bjp-26620	128	23	cancer	cancer	NOUN
bjp-26620	128	24	-	-	PUNCT
bjp-26620	128	25	specific	specific	ADJ
bjp-26620	128	26	gene	gene	NOUN
bjp-26620	128	27	1	1	NUM
bjp-26620	128	28	in	in	ADP
bjp-26620	128	29	breast	breast	NOUN
bjp-26620	128	30	cancer	cancer	NOUN
bjp-26620	128	31	cells	cell	NOUN
bjp-26620	128	32	.	.	PUNCT
bjp-26620	129	1	j	j	PROPN
bjp-26620	129	2	biochem	biochem	PROPN
bjp-26620	129	3	.	.	PUNCT
bjp-26620	130	1	2002	2002	NUM
bjp-26620	130	2	;	;	PUNCT
bjp-26620	130	3	12	12	NUM
bjp-26620	130	4	:	:	SYM
bjp-26620	130	5	31364	31364	NUM
bjp-26620	130	6	-	-	SYM
bjp-26620	130	7	72	72	NUM
bjp-26620	130	8	.	.	PUNCT
bjp-26620	130	9	oz	oz	X
bjp-26620	130	10	hs	hs	PROPN
bjp-26620	130	11	,	,	PUNCT
bjp-26620	130	12	hughes	hughes	PROPN
bjp-26620	130	13	wt	wt	PROPN
bjp-26620	130	14	,	,	PUNCT
bjp-26620	130	15	rehg	rehg	PROPN
bjp-26620	130	16	je	je	PROPN
bjp-26620	130	17	,	,	PUNCT
bjp-26620	130	18	thomas	thomas	PROPN
bjp-26620	130	19	ek	ek	PROPN
bjp-26620	130	20	.	.	PROPN
bjp-26620	130	21	effect	effect	NOUN
bjp-26620	130	22	of	of	ADP
bjp-26620	130	23	cd40	cd40	PROPN
bjp-26620	130	24	ligand	ligand	NOUN
bjp-26620	130	25	and	and	CCONJ
bjp-26620	130	26	other	other	ADJ
bjp-26620	130	27	immunomodulators	immunomodulator	NOUN
bjp-26620	130	28	on	on	ADP
bjp-26620	130	29	pneumocystis	pneumocystis	ADJ
bjp-26620	130	30	carinii	carinii	ADJ
bjp-26620	130	31	infection	infection	NOUN
bjp-26620	130	32	in	in	ADP
bjp-26620	130	33	rat	rat	NOUN
bjp-26620	130	34	model	model	NOUN
bjp-26620	130	35	.	.	PUNCT
bjp-26620	131	1	microb	microb	PROPN
bjp-26620	131	2	pathog	pathog	PROPN
bjp-26620	131	3	.	.	PUNCT
bjp-26620	131	4	2000	2000	NUM
bjp-26620	131	5	;	;	PUNCT
bjp-26620	131	6	29	29	NUM
bjp-26620	131	7	:	:	PUNCT
bjp-26620	131	8	187–90	187–90	NUM
bjp-26620	131	9	.	.	PUNCT
bjp-26620	132	1	pan	pan	PROPN
bjp-26620	132	2	zz	zz	PROPN
bjp-26620	132	3	,	,	PUNCT
bjp-26620	132	4	bruening	bruene	VERB
bjp-26620	132	5	w	w	PROPN
bjp-26620	132	6	,	,	PUNCT
bjp-26620	132	7	giasson	giasson	PROPN
bjp-26620	132	8	bi	bi	PROPN
bjp-26620	132	9	,	,	PUNCT
bjp-26620	132	10	lee	lee	PROPN
bjp-26620	132	11	vm	vm	PROPN
bjp-26620	132	12	,	,	PUNCT
bjp-26620	132	13	godwin	godwin	PROPN
bjp-26620	132	14	ak	ak	PROPN
bjp-26620	132	15	.	.	PROPN
bjp-26620	132	16	gamma	gamma	PROPN
bjp-26620	132	17	-	-	PUNCT
bjp-26620	132	18	synuclein	synuclein	NOUN
bjp-26620	132	19	promotes	promote	VERB
bjp-26620	132	20	cancer	cancer	NOUN
bjp-26620	132	21	cell	cell	NOUN
bjp-26620	132	22	survival	survival	NOUN
bjp-26620	132	23	and	and	CCONJ
bjp-26620	132	24	inhibits	inhibit	VERB
bjp-26620	132	25	stressand	stressand	NOUN
bjp-26620	132	26	chemotherapy	chemotherapy	NOUN
bjp-26620	132	27	drug	drug	NOUN
bjp-26620	132	28	-	-	PUNCT
bjp-26620	132	29	induced	induce	VERB
bjp-26620	132	30	apoptosis	apoptosis	NOUN
bjp-26620	132	31	by	by	ADP
bjp-26620	132	32	modulating	modulate	VERB
bjp-26620	132	33	mapk	mapk	NOUN
bjp-26620	132	34	pathways	pathway	NOUN
bjp-26620	132	35	.	.	PUNCT
bjp-26620	133	1	j	j	PROPN
bjp-26620	133	2	biol	biol	PROPN
bjp-26620	133	3	chem	chem	NOUN
bjp-26620	133	4	.	.	PUNCT
bjp-26620	134	1	2002	2002	NUM
bjp-26620	134	2	;	;	PUNCT
bjp-26620	134	3	277	277	NUM
bjp-26620	134	4	:	:	PUNCT
bjp-26620	134	5	3505060	3505060	NUM
bjp-26620	134	6	.	.	PUNCT
bjp-26620	135	1	spitaler	spitaler	PROPN
bjp-26620	135	2	m	m	PROPN
bjp-26620	135	3	,	,	PUNCT
bjp-26620	135	4	utz	utz	PROPN
bjp-26620	135	5	i	i	PROPN
bjp-26620	135	6	,	,	PUNCT
bjp-26620	135	7	hilbe	hilbe	PROPN
bjp-26620	135	8	w	w	PROPN
bjp-26620	135	9	,	,	PUNCT
bjp-26620	135	10	hofmann	hofmann	PROPN
bjp-26620	135	11	j	j	PROPN
bjp-26620	135	12	,	,	PUNCT
bjp-26620	135	13	grunicke	grunicke	PROPN
bjp-26620	135	14	hh	hh	PROPN
bjp-26620	135	15	.	.	PROPN
bjp-26620	135	16	pkcindependent	pkcindependent	NOUN
bjp-26620	135	17	modulation	modulation	NOUN
bjp-26620	135	18	of	of	ADP
bjp-26620	135	19	multidrug	multidrug	NOUN
bjp-26620	135	20	resistance	resistance	NOUN
bjp-26620	135	21	in	in	ADP
bjp-26620	135	22	cells	cell	NOUN
bjp-26620	135	23	with	with	ADP
bjp-26620	135	24	mutant	mutant	NOUN
bjp-26620	135	25	(	(	PUNCT
bjp-26620	135	26	v185	v185	NUM
bjp-26620	135	27	)	)	PUNCT
bjp-26620	135	28	but	but	CCONJ
bjp-26620	135	29	not	not	PART
bjp-26620	135	30	wild	wild	ADJ
bjp-26620	135	31	-	-	PUNCT
bjp-26620	135	32	type	type	NOUN
bjp-26620	135	33	(	(	PUNCT
bjp-26620	135	34	g185	g185	NUM
bjp-26620	135	35	)	)	PUNCT
bjp-26620	135	36	p	p	NOUN
bjp-26620	135	37	-	-	PUNCT
bjp-26620	135	38	glycoprotein	glycoprotein	NOUN
bjp-26620	135	39	by	by	ADP
bjp-26620	135	40	bryostatin	bryostatin	PROPN
bjp-26620	135	41	i.	i.	PROPN
bjp-26620	135	42	biochem	biochem	PROPN
bjp-26620	135	43	pharmacol	pharmacol	PROPN
bjp-26620	135	44	.	.	PUNCT
bjp-26620	136	1	1998	1998	NUM
bjp-26620	136	2	;	;	PUNCT
bjp-26620	136	3	56	56	NUM
bjp-26620	136	4	:	:	SYM
bjp-26620	136	5	861–69	861–69	NUM
bjp-26620	136	6	.	.	PUNCT
bjp-26620	137	1	shaha	shaha	PROPN
bjp-26620	137	2	sp	sp	NOUN
bjp-26620	137	3	,	,	PUNCT
bjp-26620	137	4	tomic	tomic	PROPN
bjp-26620	137	5	j	j	PROPN
bjp-26620	137	6	,	,	PUNCT
bjp-26620	137	7	shi	shi	PROPN
bjp-26620	137	8	y	y	PROPN
bjp-26620	137	9	,	,	PUNCT
bjp-26620	137	10	pham	pham	PROPN
bjp-26620	137	11	t	t	PROPN
bjp-26620	137	12	,	,	PUNCT
bjp-26620	137	13	mero	mero	PROPN
bjp-26620	137	14	p	p	PROPN
bjp-26620	137	15	,	,	PUNCT
bjp-26620	137	16	white	white	PROPN
bjp-26620	137	17	d	d	PROPN
bjp-26620	137	18	,	,	PUNCT
bjp-26620	137	19	he	he	PRON
bjp-26620	137	20	l	l	NOUN
bjp-26620	137	21	,	,	PUNCT
bjp-26620	137	22	baryza	baryza	PROPN
bjp-26620	137	23	jl	jl	PROPN
bjp-26620	137	24	,	,	PUNCT
bjp-26620	137	25	wender	wender	PROPN
bjp-26620	137	26	pa	pa	PROPN
bjp-26620	137	27	,	,	PUNCT
bjp-26620	137	28	booth	booth	PROPN
bjp-26620	137	29	jw	jw	PROPN
bjp-26620	137	30	,	,	PUNCT
bjp-26620	137	31	spaner	spaner	PROPN
bjp-26620	137	32	de	de	X
bjp-26620	137	33	.	.	PUNCT
bjp-26620	137	34	prolonging	prolong	VERB
bjp-26620	137	35	microtubule	microtubule	NOUN
bjp-26620	137	36	dysruption	dysruption	NOUN
bjp-26620	137	37	enhances	enhance	VERB
bjp-26620	137	38	the	the	DET
bjp-26620	137	39	immunogenicity	immunogenicity	NOUN
bjp-26620	137	40	of	of	ADP
bjp-26620	137	41	chronic	chronic	ADJ
bjp-26620	137	42	lymphocytic	lymphocytic	ADJ
bjp-26620	137	43	leukaemia	leukaemia	NOUN
bjp-26620	137	44	cells	cell	NOUN
bjp-26620	137	45	.	.	PUNCT
bjp-26620	138	1	clin	clin	PROPN
bjp-26620	138	2	exp	exp	NOUN
bjp-26620	138	3	immunol	immunol	NOUN
bjp-26620	138	4	.	.	PUNCT
bjp-26620	139	1	80	80	NUM
bjp-26620	140	1	60	60	NUM
bjp-26620	140	2	40	40	NUM
bjp-26620	140	3	20	20	NUM
bjp-26620	140	4	0	0	NUM
bjp-26620	140	5	e	e	NOUN
bjp-26620	140	6	xp	xp	X
bjp-26620	140	7	re	re	VERB
bjp-26620	140	8	ss	ss	PROPN
bjp-26620	140	9	io	io	PROPN
bjp-26620	140	10	n	n	X
bjp-26620	140	11	le	le	X
bjp-26620	140	12	ve	ve	PROPN
bjp-26620	140	13	l	l	NOUN
bjp-26620	140	14	control	control	NOUN
bjp-26620	140	15	bryostatin	bryostatin	NOUN
bjp-26620	140	16	control	control	NOUN
bjp-26620	140	17	bryostatin	bryostatin	VERB
bjp-26620	140	18	mmp-2	mmp-2	NUM
bjp-26620	140	19	mmp-9	mmp-9	ADJ
bjp-26620	140	20	β	β	NOUN
bjp-26620	140	21	-	-	PUNCT
bjp-26620	140	22	actin	actin	VERB
bjp-26620	140	23	mmp-2	mmp-2	NUM
bjp-26620	140	24	mmp-9	mmp-9	VERB
bjp-26620	140	25	figure	figure	NOUN
bjp-26620	140	26	6	6	NUM
bjp-26620	140	27	:	:	PUNCT
bjp-26620	140	28	effect	effect	NOUN
bjp-26620	140	29	of	of	ADP
bjp-26620	140	30	bryostatin	bryostatin	VERB
bjp-26620	140	31	i	i	PRON
bjp-26620	140	32	on	on	ADP
bjp-26620	140	33	the	the	DET
bjp-26620	140	34	activity	activity	NOUN
bjp-26620	140	35	of	of	ADP
bjp-26620	140	36	matrix	matrix	NOUN
bjp-26620	140	37	metalloproteins	metalloprotein	NOUN
bjp-26620	140	38	.	.	PUNCT
bjp-26620	141	1	h3922	h3922	PROPN
bjp-26620	141	2	cells	cell	NOUN
bjp-26620	141	3	after	after	ADP
bjp-26620	141	4	incubation	incubation	NOUN
bjp-26620	141	5	with	with	ADP
bjp-26620	141	6	bryostatin	bryostatin	PROPN
bjp-26620	141	7	i	i	PRON
bjp-26620	141	8	for	for	ADP
bjp-26620	141	9	48	48	NUM
bjp-26620	141	10	hours	hour	NOUN
bjp-26620	141	11	or	or	CCONJ
bjp-26620	141	12	dmso	dmso	NOUN
bjp-26620	141	13	as	as	SCONJ
bjp-26620	141	14	control	control	NOUN
bjp-26620	141	15	were	be	AUX
bjp-26620	141	16	examined	examine	VERB
bjp-26620	141	17	for	for	ADP
bjp-26620	141	18	the	the	DET
bjp-26620	141	19	expression	expression	NOUN
bjp-26620	141	20	of	of	ADP
bjp-26620	141	21	mmp-2	mmp-2	NUM
bjp-26620	141	22	and	and	CCONJ
bjp-26620	141	23	mmp-9	mmp-9	NOUN
bjp-26620	141	24	by	by	ADP
bjp-26620	141	25	western	western	ADJ
bjp-26620	141	26	blot	blot	NOUN
bjp-26620	141	27	assay	assay	PROPN
bjp-26620	141	28	bangladesh	bangladesh	PROPN
bjp-26620	141	29	j	j	PROPN
bjp-26620	141	30	pharmacol	pharmacol	PROPN
bjp-26620	141	31	2016	2016	NUM
bjp-26620	141	32	;	;	PUNCT
bjp-26620	141	33	11	11	NUM
bjp-26620	141	34	:	:	PUNCT
bjp-26620	141	35	615	615	NUM
bjp-26620	141	36	-	-	SYM
bjp-26620	141	37	620	620	NUM
bjp-26620	141	38	619	619	NUM
bjp-26620	141	39	author	author	NOUN
bjp-26620	141	40	info	info	NOUN
bjp-26620	141	41	li	li	PROPN
bjp-26620	141	42	-	-	PROPN
bjp-26620	141	43	qing	qe	VERB
bjp-26620	141	44	zhou	zhou	PROPN
bjp-26620	141	45	(	(	PUNCT
bjp-26620	141	46	principal	principal	ADJ
bjp-26620	141	47	contact	contact	NOUN
bjp-26620	141	48	)	)	PUNCT
bjp-26620	142	1	e	e	NOUN
bjp-26620	142	2	-	-	NOUN
bjp-26620	142	3	mail	mail	NOUN
bjp-26620	142	4	:	:	PUNCT
bjp-26620	142	5	zhoujunxia11@hotmail.com	zhoujunxia11@hotmail.com	PROPN
bjp-26620	142	6	2009	2009	NUM
bjp-26620	142	7	;	;	PUNCT
bjp-26620	142	8	158	158	NUM
bjp-26620	142	9	:	:	SYM
bjp-26620	142	10	186	186	NUM
bjp-26620	142	11	-	-	SYM
bjp-26620	142	12	98	98	NUM
bjp-26620	142	13	.	.	PUNCT
bjp-26620	143	1	shin	shin	PROPN
bjp-26620	143	2	hj	hj	PROPN
bjp-26620	143	3	,	,	PUNCT
bjp-26620	143	4	baek	baek	PROPN
bjp-26620	143	5	kh	kh	PROPN
bjp-26620	143	6	,	,	PUNCT
bjp-26620	143	7	jeon	jeon	PROPN
bjp-26620	143	8	ah	ah	INTJ
bjp-26620	143	9	,	,	PUNCT
bjp-26620	143	10	park	park	PROPN
bjp-26620	143	11	mt	mt	PROPN
bjp-26620	143	12	,	,	PUNCT
bjp-26620	143	13	lee	lee	PROPN
bjp-26620	143	14	sj	sj	PROPN
bjp-26620	143	15	,	,	PUNCT
bjp-26620	143	16	kang	kang	PROPN
bjp-26620	143	17	cm	cm	PROPN
bjp-26620	143	18	,	,	PUNCT
bjp-26620	143	19	lee	lee	PROPN
bjp-26620	143	20	hs	hs	PROPN
bjp-26620	143	21	,	,	PUNCT
bjp-26620	143	22	yoosh	yoosh	PROPN
bjp-26620	143	23	,	,	PUNCT
bjp-26620	143	24	chung	chung	PROPN
bjp-26620	143	25	dh	dh	PROPN
bjp-26620	143	26	,	,	PUNCT
bjp-26620	143	27	sung	sing	VERB
bjp-26620	143	28	yc	yc	PROPN
bjp-26620	143	29	,	,	PUNCT
bjp-26620	143	30	mckeon	mckeon	PROPN
bjp-26620	143	31	f	f	PROPN
bjp-26620	143	32	,	,	PUNCT
bjp-26620	143	33	lee	lee	PROPN
bjp-26620	143	34	cw	cw	PROPN
bjp-26620	143	35	.	.	PUNCT
bjp-26620	144	1	dual	dual	ADJ
bjp-26620	144	2	roles	role	NOUN
bjp-26620	144	3	of	of	ADP
bjp-26620	144	4	human	human	ADJ
bjp-26620	144	5	bubr1	bubr1	PROPN
bjp-26620	144	6	,	,	PUNCT
bjp-26620	144	7	a	a	DET
bjp-26620	144	8	mitotic	mitotic	ADJ
bjp-26620	144	9	checkpoint	checkpoint	NOUN
bjp-26620	144	10	kinase	kinase	NOUN
bjp-26620	144	11	,	,	PUNCT
bjp-26620	144	12	in	in	ADP
bjp-26620	144	13	the	the	DET
bjp-26620	144	14	monitoring	monitoring	NOUN
bjp-26620	144	15	of	of	ADP
bjp-26620	144	16	chromosomal	chromosomal	ADJ
bjp-26620	144	17	instability	instability	NOUN
bjp-26620	144	18	.	.	PUNCT
bjp-26620	145	1	cancer	cancer	NOUN
bjp-26620	145	2	cell	cell	NOUN
bjp-26620	145	3	.	.	PUNCT
bjp-26620	146	1	2003	2003	NUM
bjp-26620	146	2	;	;	PUNCT
bjp-26620	146	3	4	4	NUM
bjp-26620	146	4	:	:	SYM
bjp-26620	146	5	483	483	NUM
bjp-26620	146	6	-	-	SYM
bjp-26620	146	7	97	97	NUM
bjp-26620	146	8	.	.	PUNCT
bjp-26620	147	1	wall	wall	PROPN
bjp-26620	147	2	nr	nr	PROPN
bjp-26620	147	3	,	,	PUNCT
bjp-26620	147	4	mohammad	mohammad	PROPN
bjp-26620	147	5	rm	rm	PROPN
bjp-26620	147	6	,	,	PUNCT
bjp-26620	147	7	al	al	PROPN
bjp-26620	147	8	-	-	PUNCT
bjp-26620	147	9	katib	katib	PROPN
bjp-26620	147	10	am	am	NOUN
bjp-26620	147	11	.	.	PUNCT
bjp-26620	148	1	bax	bax	NOUN
bjp-26620	148	2	:	:	PUNCT
bjp-26620	148	3	bcl-2	bcl-2	VERB
bjp-26620	148	4	ratio	ratio	NOUN
bjp-26620	148	5	modulation	modulation	NOUN
bjp-26620	148	6	by	by	ADP
bjp-26620	148	7	bryostatin	bryostatin	VERB
bjp-26620	148	8	i	i	PRON
bjp-26620	148	9	and	and	CCONJ
bjp-26620	148	10	novel	novel	ADJ
bjp-26620	148	11	anti	anti	ADJ
bjp-26620	148	12	-	-	ADJ
bjp-26620	148	13	tubulin	tubulin	ADJ
bjp-26620	148	14	agents	agent	NOUN
bjp-26620	148	15	is	be	AUX
bjp-26620	148	16	important	important	ADJ
bjp-26620	148	17	for	for	ADP
bjp-26620	148	18	susceptibility	susceptibility	NOUN
bjp-26620	148	19	to	to	AUX
bjp-26620	148	20	drug	drug	NOUN
bjp-26620	148	21	induced	induce	VERB
bjp-26620	148	22	apoptosis	apoptosis	NOUN
bjp-26620	148	23	in	in	ADP
bjp-26620	148	24	the	the	DET
bjp-26620	148	25	human	human	ADJ
bjp-26620	148	26	early	early	ADJ
bjp-26620	148	27	pre	pre	ADJ
bjp-26620	148	28	-	-	ADJ
bjp-26620	148	29	b	b	ADJ
bjp-26620	148	30	acute	acute	ADJ
bjp-26620	148	31	lymphoblastic	lymphoblastic	ADJ
bjp-26620	148	32	leukemia	leukemia	NOUN
bjp-26620	148	33	cell	cell	NOUN
bjp-26620	148	34	line	line	NOUN
bjp-26620	148	35	,	,	PUNCT
bjp-26620	148	36	reh	reh	PROPN
bjp-26620	148	37	.	.	PUNCT
bjp-26620	149	1	leuk	leuk	PROPN
bjp-26620	149	2	res	res	PROPN
bjp-26620	149	3	.	.	PUNCT
bjp-26620	149	4	1999	1999	NUM
bjp-26620	149	5	;	;	PUNCT
bjp-26620	149	6	23	23	NUM
bjp-26620	149	7	:	:	PUNCT
bjp-26620	149	8	881	881	NUM
bjp-26620	149	9	-	-	SYM
bjp-26620	149	10	88	88	NUM
bjp-26620	149	11	.	.	PUNCT
bjp-26620	150	1	wu	wu	PROPN
bjp-26620	150	2	k	k	PROPN
bjp-26620	150	3	,	,	PUNCT
bjp-26620	150	4	weng	weng	PROPN
bjp-26620	150	5	z	z	PROPN
bjp-26620	150	6	,	,	PUNCT
bjp-26620	150	7	tao	tao	PROPN
bjp-26620	150	8	q	q	X
bjp-26620	150	9	,	,	PUNCT
bjp-26620	150	10	lin	lin	PROPN
bjp-26620	150	11	g	g	PROPN
bjp-26620	150	12	,	,	PUNCT
bjp-26620	150	13	wu	wu	PROPN
bjp-26620	150	14	x	x	PROPN
bjp-26620	150	15	,	,	PUNCT
bjp-26620	150	16	qian	qian	PROPN
bjp-26620	150	17	h	h	PROPN
bjp-26620	150	18	,	,	PUNCT
bjp-26620	150	19	zhang	zhang	PROPN
bjp-26620	150	20	y	y	PROPN
bjp-26620	150	21	,	,	PUNCT
bjp-26620	150	22	ding	de	VERB
bjp-26620	150	23	x	x	SYM
bjp-26620	150	24	,	,	PUNCT
bjp-26620	150	25	jiang	jiang	PROPN
bjp-26620	150	26	y	y	PROPN
bjp-26620	150	27	,	,	PUNCT
bjp-26620	150	28	shi	shi	PROPN
bjp-26620	150	29	ye	ye	PROPN
bjp-26620	150	30	.	.	PUNCT
bjp-26620	150	31	stage	stage	NOUN
bjp-26620	150	32	-	-	PUNCT
bjp-26620	150	33	specific	specific	ADJ
bjp-26620	150	34	expression	expression	NOUN
bjp-26620	150	35	of	of	ADP
bjp-26620	150	36	breast	breast	NOUN
bjp-26620	150	37	cancer	cancer	NOUN
bjp-26620	150	38	specific	specific	ADJ
bjp-26620	150	39	gene	gene	NOUN
bjp-26620	150	40	gamma	gamma	NOUN
bjp-26620	150	41	-	-	PUNCT
bjp-26620	150	42	synuclein	synuclein	NOUN
bjp-26620	150	43	.	.	PUNCT
bjp-26620	151	1	stage	stage	NOUN
bjp-26620	151	2	-	-	PUNCT
bjp-26620	151	3	specific	specific	ADJ
bjp-26620	151	4	expression	expression	NOUN
bjp-26620	151	5	of	of	ADP
bjp-26620	151	6	breast	breast	NOUN
bjp-26620	151	7	cancer	cancer	NOUN
bjp-26620	151	8	-	-	PUNCT
bjp-26620	151	9	specific	specific	ADJ
bjp-26620	151	10	gene	gene	NOUN
bjp-26620	151	11	gamma	gamma	NOUN
bjp-26620	151	12	-	-	PUNCT
bjp-26620	151	13	synuclein	synuclein	NOUN
bjp-26620	151	14	.	.	PUNCT
bjp-26620	152	1	cancer	cancer	NOUN
bjp-26620	152	2	epidemiol	epidemiol	PROPN
bjp-26620	152	3	biomarkers	biomarkers	PROPN
bjp-26620	152	4	prev	prev	X
bjp-26620	152	5	.	.	PUNCT
bjp-26620	153	1	2003	2003	NUM
bjp-26620	153	2	;	;	PUNCT
bjp-26620	153	3	12	12	NUM
bjp-26620	153	4	:	:	PUNCT
bjp-26620	153	5	920	920	NUM
bjp-26620	153	6	-	-	SYM
bjp-26620	153	7	25	25	NUM
bjp-26620	153	8	.	.	PUNCT
bjp-26620	154	1	620	620	NUM
bjp-26620	154	2	bangladesh	bangladesh	NOUN
bjp-26620	154	3	j	j	PROPN
bjp-26620	154	4	pharmacol	pharmacol	PROPN
bjp-26620	154	5	2016	2016	NUM
bjp-26620	154	6	;	;	PUNCT
bjp-26620	154	7	11	11	NUM
bjp-26620	154	8	:	:	PUNCT
bjp-26620	154	9	615	615	NUM
bjp-26620	154	10	-	-	SYM
bjp-26620	154	11	620	620	NUM
bjp-26620	154	12	your	your	PRON
bjp-26620	154	13	feedback	feedback	NOUN
bjp-26620	154	14	about	about	ADP
bjp-26620	154	15	this	this	DET
bjp-26620	154	16	paper	paper	NOUN
bjp-26620	154	17	1	1	NUM
bjp-26620	154	18	.	.	PUNCT
bjp-26620	154	19	number	number	NOUN
bjp-26620	154	20	of	of	ADP
bjp-26620	154	21	times	time	NOUN
bjp-26620	154	22	you	you	PRON
bjp-26620	154	23	have	have	AUX
bjp-26620	154	24	read	read	VERB
bjp-26620	154	25	this	this	DET
bjp-26620	154	26	paper	paper	NOUN
bjp-26620	154	27	2	2	NUM
bjp-26620	154	28	.	.	PUNCT
bjp-26620	154	29	number	number	NOUN
bjp-26620	154	30	of	of	ADP
bjp-26620	154	31	times	time	NOUN
bjp-26620	155	1	you	you	PRON
bjp-26620	155	2	have	have	AUX
bjp-26620	155	3	seen	see	VERB
bjp-26620	155	4	the	the	DET
bjp-26620	155	5	video	video	NOUN
bjp-26620	155	6	clip	clip	NOUN
bjp-26620	155	7	3	3	NUM
bjp-26620	155	8	.	.	PUNCT
bjp-26620	155	9	quality	quality	NOUN
bjp-26620	155	10	of	of	ADP
bjp-26620	155	11	paper	paper	NOUN
bjp-26620	155	12	4	4	NUM
bjp-26620	155	13	.	.	PUNCT
bjp-26620	156	1	your	your	PRON
bjp-26620	156	2	comments	comment	NOUN
bjp-26620	156	3	text1	text1	X
bjp-26620	156	4	:	:	PUNCT
bjp-26620	156	5	dropdown2	dropdown2	PROPN
bjp-26620	156	6	:	:	PUNCT
bjp-26620	157	1	[	[	X
bjp-26620	157	2	click	click	VERB
bjp-26620	157	3	]	]	PUNCT
bjp-26620	157	4	dropdown3	dropdown3	PROPN
bjp-26620	157	5	:	:	PUNCT
bjp-26620	158	1	[	[	X
bjp-26620	158	2	0	0	X
bjp-26620	158	3	]	]	X
bjp-26620	158	4	dropdown4	dropdown4	PROPN
bjp-26620	158	5	:	:	PUNCT
bjp-26620	159	1	[	[	X
bjp-26620	159	2	0	0	X
bjp-26620	159	3	]	]	PUNCT
bjp-26620	159	4	dateprinted	dateprinte	VERB
bjp-26620	159	5	:	:	PUNCT
bjp-26620	159	6	this	this	DET
bjp-26620	159	7	article	article	NOUN
bjp-26620	159	8	was	be	AUX
bjp-26620	159	9	downloaded	download	VERB
bjp-26620	159	10	by	by	ADP
bjp-26620	159	11	you	you	PRON
bjp-26620	159	12	on	on	ADP
bjp-26620	159	13	:	:	PUNCT
bjp-26620	159	14	jun	jun	PROPN
bjp-26620	159	15	13	13	NUM
bjp-26620	159	16	,	,	PUNCT
bjp-26620	159	17	2016	2016	NUM